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The incidence of bronchopulmonary dysplasia, the main respiratory complication of 
preterm birth, has remained unchanged, despite improved survival. Small airway 
function appears to decline in infancy, in infants conventionally ventilated at birth.  
Pulmonary hypertension has been described in babies born extremely preterm.  
Methods: In a randomized controlled multi-center study, high frequency oscillation 
(HFO) was compared to conventional ventilation (CV) in 797 extremely preterm babies 
immediately after birth (UKOS). There were no significant differences in mortality or 
the incidence of BPD. Comprehensive lung function assessments and an 
echocardiogram were undertaken and respiratory, health related quality of life and 
functional assessment questionnaires were completed when the UKOS children were 
11-14 years old. The results were compared to those of children born at term. 
Results: 318 children from the UKOS cohort completed the study. The HFO group 
had superior small airway function (z score FEF75, mean difference 0.23 SD (95%CI 
0.02,0.45), p = 0.04), superior large airway function (FEV1 z score mean difference 
0.35 SD (95% CI 0.02, 0.45), p=0.008) and diffusion capacity of the alveo-capillary 
membrane (DLCO z score mean difference 0.31 SD (95% CI 0.04, 0.58), p=0.02), 
without poorer functional outcomes.  
Prematurely born children had significantly worse lung function than term born 
children: z FEV1 mean difference 0.62 SD (95%CI -0.85, -0.38), p<0.001, z FEF75 
mean difference 0.55 SD (95%CI -0.77, -0.33), p<0.001 , z DLCO mean difference 
0.78 SD (95%CI 0.53, 1.02), p<0.001, and higher pulmonary pressures (mean MAP 
24.6 vs 20.5 mmHg, p<0.001).   
	 7	
Conclusions: HFOV used immediately after birth in extremely premature babies was 
associated with better lung function outcomes without evidence of poorer functional 
outcomes.  Airway obstruction is significantly worse in preterm children at school age 
than in term born children. Children born very prematurely have significantly higher 
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ATPD - Ambient temperature, ambient pressure, and dry  
ATPS - Ambient temperature and pressure saturated with water vapour  
BPD – broncho -  pulmonary dysplasia 
BTPS - Body temperature (i.e. 37 ̊C), ambient pressure, saturated with 
water vapour  
C - Centigrade 
cm - Centimeters  
CLD – chronic lung disease 
COHb – Carboxy-haemoglobin  
DL,CO - Diffusing capacity for the lungs measured using carbon 
monoxide, also known as transfer factor  
DL,CO/VA - Diffusing capacity for carbon monoxide per unit of alveolar 
volume, also known as KCO  
DM - Membrane-diffusing capacity 
ERV - Expiratory reserve volume  
EVC - Expiratory vital capacity  
FEF25-75% - Mean forced expiratory flow between 25% and 75% of FVC  
FEV1 - forced expiration volume of air exhaled in the first second  
FEF25- forced expiratory flow at the 25% of exhaled FVC 
FEF50- forced expiratory flow at the 50% of exhaled FVC 
FEF75- forced expiratory flow at the 75% of exhaled FVC 
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FEF25-75 - The mean forced expiratory flow between 25% and 75% of the  FVC 
FVC - forced vital capacity 
FRC - Functional residual capacity 
GI – gastro intestinal 
H2O - Water 
Hb - Haemoglobin 
Hg - Mercury 
Hz - Hertz 
IC - Inspiratory capacity 
IVC - Inspiratory vital capacity 
IVH – intra-ventricular hemorrhage  
KCO - Transfer coefficient of the lung (DL,CO/VA)  
Kg - Kilograms 
kPa - Kilopascals 
L - Litres 
Lmin-1    - Litres per minute 
lb – Pounds (weight) 
MFVL - Maximum flow–volume loop 
mg - Milligrams 
MIF - Maximal inspiratory flow 
mL - Millilitres 
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MMEF - Maximum mid-expiratory flow 
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MVV - Maximum voluntary ventilation 
NEC – necrotizing enterocolitis 
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PaCO2 - Alveolar carbon dioxide partial pressure 
PaO2 - Alveolar oxygen partial pressure 
PB - Barometric pressure 
PDA – persistent ductus arteriosus 
PEF – peak expiratory flow  
PMA -  post menstrual age 
ROP – retinopathy of prematurity 
RV - Residual volume 
s - seconds 
STPD - Standard temperature (273 K, 0 ̊C), pressure (101.3 kPa,760 mmHg) and dry 
TGV (or VTG) - Thoracic gas volume 
TLC - Total lung capacity 
Tr- Tracer gas 
VA - Alveolar volume 
VA,eff - Effective alveolar volume 
VC - Vital capacity 
Vc - Pulmonary capillary blood volume 
VD - Dead space volume 
VI - Inspired volume 
VS - Volume of the expired sample gas  
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Study was funded by NIHR HTA. Grant was obtained by Prof Anne Greenough and 
Prof Janet Peacock. 
Protocol 
Protocol for the assessment of the respiratory and education outcomes was designed 
for the grant application (NIHR HTA) by Prof Anne Greenough and Prof Janet 
Peacock. 
Measurements 
All lung function measurements were performed by me, assisted by a research nurse. 
We were both blinded to the ventilation group of the preterm children. The results of 
the measurements were all checked by a paediatric lung physiologist (Mr Alan Lunt) 
and once verified, were entered into an online database. 
All ECHOs were performed by me and the results checked by a paediatric cardiologist 
(Dr Kuberan Pushparaja). 
The reproducibility of ECHO was established by scanning a group of 20 children 
simultaneously with the paediatric cardiology consultant. Scans were than analysed 
blinded to each other’s findings. 
Analysis of statistics 
The study statisticians, Prof Janet Peacock and Miss Jessica Lo, did analysis of lung 
function outcomes, respiratory health symptoms and educational outcomes from the 
questionnaires for the comparison of the ventilation groups, as published in the New 







Despite the advances in neonatal care, extremely premature birth is still associated 
with major complications involving the respiratory system. The main short-term 
respiratory complication of prematurity is known as broncho-pulmonary dysplasia 
(BPD). Worryingly, the long-term respiratory complications of prematurity in later 
childhood and adulthood are increasingly recognised worldwide, as the new 
generation of preterm children matures.  
Endotracheal intubation and mechanical ventilation, although necessary for survival of 
majority of extremely preterm infants, have significant consequences on the fragile 
developing lungs of these infants. Throughout several decades, clinicians have strived 
to find the optimal mode of ventilation that would minimize ventilator-induced injury. 
This thesis explores whether high frequency oscillation, as a mode of ventilation of 
extremely premature infants, could reduce long term respiratory morbidity and lung 
function abnormalities when compared to conventional mechanical ventilation. 
Preservation of small airway function, by use of lower tidal volumes, should 
subsequently reduce the risk of COPD in the adulthood. 
Both conventional ventilation and high frequency oscillatory ventilation have their 
advantages and disadvantages. Distortion of the lung caused by the large swings in 
pulmonary volumes during conventional ventilation (CV) at rates of 30 – 60 seems to 
be the main disadvantage of this mode. Various strategies with CV appear to reduce 
acute lung injury. These include avoiding high tidal volumes, using positive end 
expiratory pressure (PEEP) and using short inspiratory times and faster rates. There is 
evidence in preterm infants that strategies to synchronise ventilation reduce the rate of 
	28	
pneumothorax and the duration of ventilation. 
High frequency oscillatory ventilation (HFOV) at rates of 600 - 800 per minute was 
developed in order to achieve more uniform lung inflation, as first shown on animal 
models. HFOV also allows for de-coupling of oxygenation and ventilation, as it is 
possible to increase one independently of the other. Therefore, it is expected to 
reduce the severity of lung pathology produced by intermittent positive pressure during 
conventional ventilation. Animal studies show that lung volume maintenance with 
HFOV prevents lung injury, although there is no evidence to date that these strategies 
reduce the rate of BPD at 36 weeks postmenstrual age in humans.  
There is a high incidence of airway obstruction, bronchial hyper reactivity and exercise 
intolerance in adolescents and young adults born prematurely. In this thesis, the lung 
function of preterm children will be compared to a control group of healthy children 
born at term, to assess the degree of lung function impairment associated with 
prematurity. 
Abnormalities of pulmonary vasculature and pulmonary hypertension have been 
associated with the incidence of BPD and increased mortality in preterm infants. 
Therefore, this study will assess the degree of pulmonary hypertension in preterm 
children at school age, in comparison with term born children, and its association with 
lung function abnormalities.  
Strategy for reviewing literature: A systematic literature search was undertaken to 
explore the background of the thesis, using PubMed, Google Scholar and the 
Cochrane database. Studies evaluating neonatal ventilation at birth, fetal lung 
development, ventilation-induced injury, broncho-pulmonary dysplasia and long-term 
outcomes were included. Besides randomised controlled trials (RCTs), other study 
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designs were included. Studies described in the introduction of this thesis are dated 
prior to start of the study in March 2011. Studies referenced in the discussion of 
separate result chapters and the main discussion chapter include studies after this 
date until submission of the thesis in April 2016. 
 
1.2.	Bronchopulmonary	dysplasia	–	overview	
Bronchopulmonary dysplasia (BPD) was first described by Northway and colleagues 
in 1967. (Northway et al., 1967) They described characteristic clinical, radiographic 
and pathological changes following mechanical ventilation for respiratory distress 
syndrome in 32 premature infants. Children with BPD have increased risks of post-
neonatal mortality(Schmidt et al., 2003), long-term pulmonary problems such as 
asthma,(Greenough, 2008) pulmonary hypertension(Bush et al., 1990), growth 
failure(Vohr et al., 1991), cognitive impairment and cerebral palsy(Hughes et al., 1999, 
Skidmore et al., 1990). 
Over the past decades, many improvements have been made to the care of preterm 
babies. However, despite several advances in neonatal care, bronchopulmonary 
dysplasia remains one of the most prevalent consequences of premature birth. 
(Fanaroff et al., 2007)    
Since the first description of BPD by Northway, survival of preterm infants has 
significantly improved. This improvement in survival has been followed by the changes 
in the BPD pathology. (Northway, 1990) The histology of the first described, “old” BPD 
was characterized by interstitial fibrosis, alveolar over-distension, regions of 
atelectasis and airway abnormalities such as squamous metaplasia and excessive 
muscularisation.(Northway et al., 1967) The “new” BPD has a different histological 
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pattern with a reduced number of alveoli and alveoli that are larger in diameter. This is 
consistent with impaired alveolar development at the canalicular and saccular stages 
in lung development.(Husain et al., 1998) 
Furthermore, in the late 1980s it has become apparent that premature infants who did 
not receive mechanical ventilation can also develop BPD. (Shennan et al., 1988) This 
led to a new definition of BPD as oxygen requirement at 28 days of postnatal 
age.(Avery et al., 1987) Additionally, Shennan and co-workers determined that 
supplemental oxygen at 36 weeks of corrected gestational age was a more accurate 
predictor of pulmonary outcome in infancy and proposed it as the new definition. 
(Rojas et al., 1995, Shennan et al., 1988, Davis et al., 2002)  
The main risk factors associated with BPD include: lower gestational age, lower birth 
weight, male sex, white race, family history of asthma and being small for gestational 
age. (Ambalavanan et al., 2008, Hakulinen et al., 1988, Palta et al., 1991, Reiss et al., 
2003) Additionally, genetic factors have been implicated to contribute towards the 
susceptibility to BPD.(Lavoie et al., 2008)  
Since the 1990s, the main contributory factors implicated in the development of BPD 
are ventilator induced trauma, oxygen toxicity and inflammatory response. Those 
mechanisms of injury have been investigated in the numerous studies to date, and are 





Preterm birth seems to be increasing worldwide. (Denney et al., 2008, Martin et al., 
2005)   
Field and co-workers looked prospectively at the influence of rates of very preterm 
delivery, below 32 weeks of gestation, on neonatal mortality in nine European 
countries. Rates of very preterm delivery showed marked variations across Europe, 
but seemed particularly high in the UK. The very preterm birth rate for the nine 
European countries was 13.2 per 1000 births (95% CI 12.9 to 13.5). Two UK regions 
had significantly higher rates than all other regions and were similar to each other 
(Trent 16.7, Northern region 17.1 very preterm births/1000 births). High rates of very 
preterm delivery were associated with high rates of neonatal mortality. (Field et al., 
2009) 
Very prematurely born infants suffer significantly higher respiratory morbidity during 
the first years after birth compared to infants born at term. Predominant problems are 
wheeze and cough and frequent hospital admissions.  In the follow up study of 459 
infants median gestational age 26.5 weeks, recruited into the United Kingdom 
Oscillation Study (UKOS), more than 40% were found to have frequent wheeze or 
cough when reviewed at 11 to 15 months of age.  The main risk factors were male 
sex, oxygen dependency at 36 weeks postmenstrual age and having a sibling less 
than five years of age (Greenough et al., 2004). A study of 126 infants born at a 
median gestational age of 28.7 weeks found that cough occurred in 80% and wheeze 
in 44% at the ages of 1-3 years (Pramana et al., 2011). 
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In a large population based study in the United States (US) involving 3787 infants born 
between 2002 and 2005, at a mean gestational age of 26 weeks, 45% of the infants 
had been re-hospitalized by the age of 22 months.  Respiratory problems were the 
main reason for admission in 43.7% (Ambalavanan et al., 2011).   A study from 
Canada (Landry et al.) reported very high rehospitalisation rates of 83% in first two 
years, in 32 infants born below 28 weeks of gestation (Landry et al., 2011).  
Brissaud et al. compared rehospitalisation rates in infancy in children born less than 
33 weeks of gestational age between 1997 and 2002, no change was demonstrated 
over time. Again, in this study respiratory disease was the commonest reason for 
rehospitalisation indicating that, despite advances in neonatal care during the past 
decade, respiratory symptoms in premature children continue to present a challenge 
for the health care system(Brissaud et al., 2005) 
 
Respiratory symptoms and airway obstruction are common from infancy through to 
school age and adulthood in preterm children. Several studies have produced 
evidence of the burden of prematurity and BPD on health care and respiratory 
morbidity of the population. Gross and co workers measured lung function of a group 
of 125 children born from 24 to 31 weeks of gestation and compared them to term 
children at 7 years of age. Preterm children previously diagnosed with BPD had 
significantly more airway obstruction. They were also twice as often more likely to 
have a positive bronchodilator response.(Gross et al., 1998) In a study of 126 children 
born before 32 weeks of gestation, there was a significant reduction in exercise 
capacity when they were assessed at 10 years of age compared to term born children. 
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The exercise capacity of preterm born children was half of those born at term.(Smith 
et al., 2008) 
 
From the Epicure cohort, 182 children born at or below 25 weeks of gestational age 
were assessed at 11 years of age. When compared to term born children, they had 
significantly more chest deformities and respiratory symptoms. Twice as many 
preterm children were diagnosed with asthma than term children. Baseline spirometry 
was significantly reduced and bronchodilator responsiveness increased in preterm 
children. Furthermore, half of the children with evidence of airway obstruction were not 
receiving treatment. (Fawke et al., 2010) Vrijlandt and co workers studied the 
prevalence of respiratory symptoms in young adults born prematurely in a prospective 
cohort study. They assessed 690 adults at 19 years of age who were born below 32 
weeks of gestation. The prevalence of wheeze, shortness of breath and doctor 
diagnosed asthma was much higher than in general population.(Vrijlandt et al., 2006, 








Lung development and the development of pulmonary circulation occur at the same 
time. Structural re-modeling and changes in growth and maturation take place during 
each period of gestation. (Burri and Tarek, 1990). 
Lung growth has traditionally been divided into five stages (Chakraborty et al., 2010):  
• embryonic  
• pseudoglandular 
• canalicular 
• saccular  
• alveolar 
 
This chronological division of lung growth has been historically decided by the 
International Congress of Anatomists meeting in Leningrad, 1970 (Nomina 





The lung appears as a ventral bud of the esophagus (Burri and Tarek, 1990). Lung 
buds appear by fourth week and lobar structure becomes evident by six weeks of 
	 35	
gestation. The branching pattern is driven by signals from the mesenchyme to the 
budding airway. Pulmonary arteries bud from sixth aortic arch and pulmonary vein 
appears as a small tubule growing out from the left atrial portion of the heart.(Burri, 




All the conducting airways are created during this stage. The complete branching 
structure of the bronchial tree gets laid down and 20 generations of the conducting 
airways are complete. At the same time as the airways the arterial tree branches with 
the veins running through connective tissue septa. By the end of this period the pre-
acinar vascular pattern is complete.  
Cellular differentiation of the conducting airways commences from the proximal end to 
the distal end.  Airway tubes are lined with high columnar epithelium. By 12 weeks of 
gestation cartilage and smooth muscle cells are seen in the trachea and segmental 
bronchi. Mucous glands are also present. Differentiation into cuboidal epithelium 
commences in the distal region. These distal cuboidal cells represent immature type II 
alveolar epithelial cells that will eventually secrete surfactant into the alveoli reducing 
the surface tension in the lungs and preventing alveolar collapse.(Burri, 1984, Burri 
and Tarek, 1990, Joshi and Kotecha, 2007) 
1.4.3.	Canalicular	stage	(17-27	weeks	of	GA)	
	
This stage of development is characterized by early development of the pulmonary 
parenchyma, the non-airway tissue and the multiplication of capillaries. The two main 
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processes in this period are the formation of a thin air-blood barrier and the beginning 
of secretion of surfactant into the air spaces. Peripheral branching, lengthening and a 
marked widening of distal airspaces occur at the expense of the intervening 
mesenchyme. This ensures development of increased surface area for gas exchange. 
Distal air spaces become wider and come into close contact with cuboidal epithelium, 
which begins to flatten and a thin air-blood barrier appears. Increased vessel 
proliferation and centralization into a capillary network around airspaces occurs. 
Capillaries form a loose three-dimensional network in the mesenchyme. At about 23 
weeks this network closely approaches the alveolar epithelium, forming the blood-air 
barrier. From about 24 weeks, it is possible to identify the type II alveolar epithelial 
cell, containing the precursor to surfactant production. (Burri, 1984, Smith et al., 2010, 
Morrisey and Hogan, 2010) 
1.4.4.Saccular	stage	(28-36	weeks	of	GA)	
	
Increasing amounts of tubular myelin in the airspace is evidence of the increasing 
secretory activity of the type II cells. At the beginning of this period, the airways end in 
clusters of thin-walled terminal saccules. The last generations of airways, alveolar 
ducts and, at the periphery, the alveolar sacs are produced by these saccules by term. 
Alveoli can be first seen as early as 32 weeks of gestation, but are more recognizable 
at 36 weeks. 
In the saccular period there is a marked vascular expansion, blood vessels grow in 
length and diameter and new arteries and veins are also formed.  Gas exchange 
surface increases which leads to a thinning of interstitial tissue. Formation of the thin 
air-blood barrier continues and changes in the capillary network result in the formation 
of a double capillary layer which is followed by alveolar formation.(Smith et al., 2010) 
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The surfactant system matures between 29 and 32 weeks of gestation and is one of 
the last systems to develop before birth. Surfactant is made of phospholipids (80%), 
neutral lipids (12%) and protein (8%). It coats the thin layer of alveolar fluid inside the 
alveoli. The water molecules within the lining fluid of the inner surface of the alveoli 
have strong attractive forces between them. Without surfactant, these forces would 
cause increased surface tension and collapse of the alveoli, leading to atelectasis, 
ventilation perfusion mismatch and respiratory failure. Surfactant provides the stability 
of alveoli by preventing collapse at low lung volumes and by decreasing the surface 
tension and so facilitating expansion of the lungs. It is, therefore, very important in 
helping to reduce the volume induced trauma in the ventilation of preterm 
infants.(Merkus et al., 1996, Smith et al., 2010)       
Surfactant molecules can be found inside type  two alveolar cells  between 20 and 24 
weeks of gestation. The secretion into the alveoli begins at 30 weeks of 
gestation.(Smith et al., 2010) Therefore, at the time of extremely preterm birth, below 
28 weeks of gestation, surfactant is not yet present in the alveoli and hence the 
immature lung is non-compliant. 
There is also an increase in fetal concentrations of circulating cortisol during this 
stage. This increase is critical for lung maturation. Cortisol stimulates surfactant 
synthesis and secretion, alveolar epithelial cell differentiation, tissue remodeling and 
the reabsorption of lung liquid. (Jobe and Ikegami, 2000) 
Exogenous	antenatal	steroids:	
	
Several studies have been published since the early 1970s describing the effect of 
exogenous antenatal steroids on decreasing the risk of RDS and neonatal mortality 
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(Liggins and Howie, 1972, Taeusch et al., 1979, Gamsu et al., 1989).  The Cochrane 
review on the use of antenatal corticosteroids for accelerating the fetal lung maturation 
highlighted that treatment with antenatal steroids resulted in significant reductions in 
neonatal death and respiratory distress syndrome(Roberts and Dalziel, 2006). Other 
benefits for the neonate were noted, including less necrotizing enterocolitis (NEC), 
infection, intra ventricular hemorrhage (IVH) and less need for mechanical ventilation, 
but there were no significant reductions in the incidence of chronic lung disease.  Later 
on in childhood, there were several beneficial effects, such as less developmental 
delay and fewer children with cerebral palsy. (Roberts and Dalziel, 2006)  
McEvoy and co-workers compared respiratory compliance and functional residual 
capacity results in infants randomized to a rescue course of antenatal steroid or 
placebo, in a randomized, double-blinded trial. They enrolled 44 mothers (56 infants) 
to receive rescue antenatal steroids and 41 mothers (57 infants) to receive placebo. 
Measurements were undertaken within 72 hours form birth. Infants in the antenatal 
steroids group had an increased respiratory compliance (1.21 vs 1.01 mL/cm H2O/kg; 
adjusted 95%CI 0.01-0.49; p < 0.043) compared with placebo. Thirteen percent of the 
babies in the antenatal steroids group vs 29% in the placebo group required >30% 
oxygen (p < 0.05).(McEvoy et al., 2010) 
 
There is, however, conflicting evidence that antenatal corticosteroids improve lung 
function at school age or adulthood.  
Smolders-de Haas and co-workers assessed 10-12 years old children whose mothers 
participated in a randomized, double blind, placebo-controlled trial of antenatal 
betamethasone.  Fifty children in the corticosteroid group and 34 children in the 
	 39	
placebo group were examined.  Medical history, physical examination and neuro-
developmental examination, children performed spirometry. No differences were found 
in the FEV1, FVC and FEV1/FVC between the two groups.(Smolders-de Haas et al., 
1990)   
Dalziel and co-workers assessed 534 young adults at the age of 30 years, whose 
mothers had participated in the first RCT of antenatal betamethasone. Their lung 
function was assessed by portable spirometric testing. There were no differences in 
lung function between antenatal betamethasone group and placebo exposed group 
(mean (SD) FVC in the betamethasone and placebo groups, 105.9 (12.0) v 106.6 
(12.6)% predicted, p = 0.59; mean (SD) FEV1 in the betamethasone and placebo 




The process of alveolarization in humans begins at approximately 36 weeks of 
gestational age.(Burri, 1984, Burri, 2006) At birth, only around 15% of alveoli have 
developed, with the remaining number developing in the first few years of life. This 
process involves transforming the immature saccular lung with a limited gas exchange 
area to a mature lung with a large internal surface area through thinning of the 
alveolar walls, growth of capillary network and extensive subdivision of gas exchange 
units. Interstitial fibroblast proliferation occurs while epithelial cells flatten and 
decrease in number, resulting in a thin net of distal airspace walls. Simultaneously, the 
alveolar capillary network becomes more complex. The process of alveolar septation 
continues as secondary crests extend from primary alveolar walls, through deposition 
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of new basement membrane, growth of epithelial cells, myofibroblasts and elastin 
deposition.(Joshi and Kotecha, 2007, Smith et al., 2010) 
The structure of the alveolus: 
 Significant morphological differences exist between the two epithelial cell types. Type 
1 cells are thin and flat and they cover 90% of the surface of the alveolus. They are in 
such close contact with capillary endothelial cells that their basement membranes are 
fused and form the blood-air barrier. Type 2 cells are cuboidal and found in the corner 
of the alveolus. They occupy roughly 10% of the surface area.(Smith et al., 2010) 
It is important to note that preterm babies born below 29 weeks of gestation, such as 
the preterm cohort recruited into the UKOS study, were born during saccular stage of 
the lung development before alveolarization process has started. Therefore, neonatal 
ventilation needs to achieve optimal gas exchange in the immature lung with limited 
gas exchange surface area. 
 
Alveolar development begins in late gestation. The endothelial plexus becomes tightly 
associated with the distal epithelial saccules. The epithelium of the developing 
saccules, the primary septae, differentiates into several important cell types, including 
AEC1 cells (alveolar epithelial cells type 1) during saccular phase. 
Maturation of the alveoli is marked by generation of secondary septae, which involves 
growth of alveolar crests. Crest formation requires elastin deposition and 
myofibroblast development (Boström et al., 1996). 
The histological sections demonstrated the change in distal lung morphology from the 
canalicular/saccular stages through to the adult where mature alveoli are found with 
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secondary septae. They’ve shown the importance of thinning of the interstitium and 
expansion of air spaces that will allow sufficient gas exchange (from Edward E. 
Morrisey and Brigid L.M. Hogan, Preparing for the First Breath: Genetic and Cellular 
Mechanisms in Lung Development, 2009) 
Alveolar septation is always associated with capillary invasion although it is not clear 
whether capillary invasion stimulates alveolar septation or vice versa(deMello et al., 
1997). Burri and co-workers studied serial electron microscopic sections of lung 
parenchyma in growing rats and found that the capillary bed develops by formation of 
intravascular tissue pillars. They have called this type of growth intussusceptive 




Evidence suggests that the extent and pattern of lung growth is independent of neural 
control, although the lung is extensively innervated from early fetal life. Hislop and co-
workers performed lung denervation in immature rats when alveoli were still 
developing, soon after birth. They found that denervation alone was associated with 
normal lung growth and development when animals were terminated and examined at 
6 months of age. (Hislop et al., 1990) However, a study by Wigglesworth and co-
workers proved that spinal cord transection in the foetal rabbit lung leads to poor 
expansion of lungs in utero and pulmonary hypoplasia.  They concluded that lung 
development was dependent on the normal function of the phrenic nerve, regulating  
respiratory movements. (Wigglesworth and Desai, 1979) 
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Normal lung development depends on rhythmic diaphragmatic contractions in the 
fetus (fetal breathing). (Harding and Hooper, 1996)In the absence of fetal breathing, 
the main physical factor influencing lung development will be lacking. The lung recoil 
will increase, due to low resistance of the upper airways, and result in lung collapse. 
(Harding and Hooper, 1996, Miller et al., 1993) 
Miller and co-workers conducted experiments to determine the role of fetal breathing 
movements in the maintenance of fetal lung liquid volume. They selectively abolished 
fetal breathing movements in five fetal sheep by paralyzing their phrenic nerve for 48 
hours with continuous tetrodotoxin infusion. They measured lung liquid volumes and 
secretion rates on three occasions: before each treatment, after 48 hours of 
tetrodotoxin infusion and 24 hours after stopping the infusion. Blocking the phrenic 
nerve reduced the fetal lung liquid volume from 27.6 to 21.8 ml/kg and increased lung 
liquid secretion rates from 3.8 to 6.2 ml/kg/h. This experiment demonstrated that the 
fetal lung is maintained at the level of expansion much greater than the static 
relaxation volume and that the volume of liquid in the fetal lungs is dependent on the 
diaphragmatic contractions associated with fetal breathing movements.(Miller et al., 
1993) Prenatal vagotomy was associated with inhibited surfactant synthesis which 
resulted in atelectasis and compromised gas exchange during transition from fetal to 





There are two basic processes of lung vascular growth : vasculogenesis–formation of 
new blood vessels from endothelial cells and angiogenesis–formation of new vessels 
from capillaries via sprouting. 
The bronchial blood vessels develop with pre-acinar airways around 16 weeks of 
gestation. They do not participate in gas exchange. Pre-acinar pulmonary arteries, 
supplied by the right heart, grow into the intra-acinar region, following the airway 
growth. They fuse with the peripheral microvasculature that has formed from the 
mesenchyme by vasculogenesis. 
A complex pattern of pulmonary blood vessels develops from a single avascular bud. 
From 4-16 weeks of gestation, arteries and veins develop by vasculogenesis from the 
mesenchyme around airway buds. There is an increase in vessel length and diameter 
and by the twentieth  week of gestation the full number of pre-acinar pulmonary 
vessels is present in each segment. Intra-acinar arteries and veins develop in late 
gestation and up to two years of age. This is accompanied by alveoli formation at the 
same time (after 30 weeks and continued up to two years) and therefore there is a 
rapid increase in the number of small pre- and post-capillary vessels at that time. After 
two years of age the lung grows by increasing the surface area of the alveoli and the 
area of the capillary bed increases alongside. (Hislop and Pierce, 2000) 
Angiogenesis is necessary for alveolarization and growth of the small pulmonary 
arteries is significantly interrupted due to premature birth.(Schraufnagel, 1990) 
Disruption of vascular development leads to inhibition of alveolar growth. Jakkula and 
co workers studied the effects on alveolarization of two anti-angiogenic agents, 
thalidomide and fumagillin, in infant rats during first two weeks of life. Compared to 
controls, they found reduced pulmonary arterial density by 36% and reduced 
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alveolarization by 22%. To exclude potential non-specific effects of those two agents 
on developing lung, they studied the effects of Su-5416, an inhibitor of vascular 
endothelial growth factor receptor. This produced a similar outcome, with decreased 
alveolarization and decreased arterial density.(Jakkula et al., 2000) 
Bronchial arteries are responsive to angiogenic stimuli throughout life. In chronic 
pulmonary hypertension, bronchial vessels grow even though peripheral pulmonary 
vessels are lost (Bukhalovskii and Popov, 1979).   Schraufnagel and co-workers 
investigated angiogenesis in the blood vessels of the lungs in an experimental model 
of pulmonary hypertension induced by giving newborn rats the alkaloid monocrotaline. 
Light microscopy findings after the insult showed evidence of angiogenesis on the 
pleural surface and in the broncho-vascular bundle, but not in the alveolar capillaries, 
suggesting a basic difference in how these two vascular systems respond to 
angiogenic stimuli and that they are independent from each other. If alveolar 
capillaries are unable to undergo angiogenesis, this could have potential impact on the 
pulmonary vessels structure, especially the capillary bed, long after the initial lung 
insult has resolved.(Schraufnagel, 1990)  One of the most common causes of 
abnormal lung development in humans is preterm birth. (Jobe and Ikegami, 2001, 
Ambalavanan et al., 2011) The most common respiratory consequence of preterm 
birth is BPD (broncho-pulmonary dysplasia), defined as oxygen dependency at 28 
days of life and the severity determined at 36 weeks of post menstrual age according 
to on going respiratory support requirements. (Jobe and Ikegami, 2001) This thesis 
will predominantly investigate the abnormal lung development as a consequence of 
extreme premature delivery and the degree of pulmonary hypertension as a 





“New BPD” can occur despite initially minimal or even absent respiratory distress and 
is due to the disruption of lung development, more specifically arrest in alveolar 
septation and vascularisation. (Jobe and Ikegami, 2001, Jobe and Ikegami, 2000) 
There is little information on the pathology of the underlying process of the “new BPD”, 
although the main characteristics of it, such as simplified acinar structure, poorly 
formed secondary crests, dysmorphic alveolar capillaries and blunted expression of 
angiogenic factors and their receptors, have been described. (Jobe and Ikegami, 
2001) New evidence obtained by using hyperpolarized helium-3 magnetic resonance 
(MRI) suggests that alveolarisation continues throughout childhood into adulthood. 
This model could potentially explain the long term catch up growth that occurs in these 
survivors of extreme prematurity, although the extent of it is still unknown. (Narayanan 
et al., 2013) 
1.7.	Factors	Influencing	Lung	Growth	
	
Several factors of induced lung growth have been investigated and there is significant 
amount of evidence regarding factors related to prenatal and postnatal lung growth 
(see below). The fundamental difference between prenatal and postnatal lung growth 
is that prenatal alveolar tissue arises from undifferentiated mesenchyme, whereas 
postnatal alveolar growth is determined by an already highly differentiated structure. 
Therefore, lung development of babies born premature, at the saccular and early 
alveolar stage of development, is likely to be altered in comparison to the term born 
babies whose lung development has continued in utero. This thesis will aim to further 
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investigate the differences between preterm and term lung function and the 
differences in vascular development of the lung of these two groups. 
1.7.1.	Inflammatory	response	and	abnormal	lung	growth	
	
The “inflammation” process is an important component of ventilation-induced injury of 
the lungs in premature infants. The extracellular matrix has an important regulatory 
role in lung development and inflammatory process within the extracellular matrix 
could be one of the pathophysiological processes causing the altered lung 
development associated with extreme prematurity (Hsia, 2004). It regulates pulmonary 
cell growth, their differentiation and migration. Pulmonary cells regulate production of 
extracellular matrix. Prenatally, multiple proteins and proteoglycans contained in the 
extracellular matrix, regulate branching of the airways. Postnatally, the regulatory 
proteins will further regulate the alveolar septal formation and deposition of important 
structural protein, elastin.(ad hoc Statement Committee, 2004) 
However, in case of the lung repair after any lung injury, inflammatory cells will enter 
into the alveolar space from extracellular matrix and alter the concentration of many 
regulatory peptides. Effects of these peptides will determine if the repair process will 
restore normal pulmonary structure or progress to fibrosis and impairment of gas 
exchange.(Hsia, 2004) 
In the immature lung with impaired surfactant production, widespread atelectasis 
occurs resulting in ventilation/perfusion inequality. Immature central drive and a highly 
compliant chest wall compromise the ability to meet the increase in respiratory work. 
Therefore, supplemental oxygen and assisted ventilation are needed to maintain 
adequate oxygenation.(Ozdemir et al., 1997) This induces the host response through 
platelet, neutrophil and alveolar macrophage activation (Figure 1.5). Subsequently, the 
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release of pro inflammatory cytokines (TNF, IL-1,  IL-6), chemokines and eicosanoids 
together with oxygen free radicals, elastase and fibronectin, causes further lung injury. 
To date, more than 50 cytokines have been identified that control local and systemic 
response to injury, inflammation and tissue repair, including fibrosis. The cytokines are 
released from monocytes/macrophages, T lymphocytes and other cells such as 
leukocytes, fibroblasts and epithelial cells in response to endotoxin, cellular injury, 
hypoxia and hyperoxia.(Ozdemir et al., 1997) 
They bind to cell surface receptors and cause alteration of gene expression in target 
cells. Their production is transient and they are able to regulate their own synthesis, 
either in stimulatory or inhibitory fashion. The feedback mechanism that controls the 
secretion of cytokines’ initial inflammatory response is vitally important in the healing 
process. This is followed by reparative process with suppression of the inflammatory 
cascade. If the inflammation and cytokine release persists, this will stimulate fibroblast 
proliferation and alter the collagen synthesis, subsequently leading to tissue fibrosis of 
the lung.(Ozdemir et al., 1997) 
 
The immune system of a preterm infant is deficient and this will also have an impact at 
the alveolar level. There is a decreased activity of monocytes, macrophages and poly 
morpho nuclear cells (PMNs), diminished humoral immunity and low complement 
concentration. Barotrauma and oxygen toxicity caused by mechanical ventilation 
together with hypoxia, insufficient surfactant production and low level of antioxidant 
enzymes will cause significant inflammatory process. (Pierce and Bancalari, 1995) 
(Ozdemir et al., 1997).  
Pro-inflammatory cytokine expression has been observed in human preterm infants 
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after ventilation, with higher cytokines concentrations observed in those who develop 
BPD. To determine the influence of the potent pro-fibrotic cytokine transforming 
growth factor beta-I (TGFβ-1) on the development of BPD, Kotecha and co-workers 
determined the concentration of active and total TGFβ-1 in broncho-alveolar lavage 
fluid obtained from three groups of preterm infants of different gestation of ages. In the 
first group there were 18 infants who subsequently developed BPD. The infants were 
born at mean gestation of 25.7 weeks and had a mean birth weight of 816 gm.  In the 
second group there were 15 infants who recovered from the respiratory distress 
syndrome, born at a mean gestational age of 29.8 weeks and mean birth weight of 
1493 gm. In the third group there were seven control infants born at a mean 
gestational age of 35 weeks and mean birth weight of 2441 gm. The concentration of 
both active and total TGFβ-1was increased in the infants with BPD when compared 
with other two groups: active TGFβ-1, 39.5 vs 4.6 ng/ml; total TGFβ-1, 43.8 vs 13.8 
ng/ml. The increase in active and total TGFβ-1 was greatest on day four after birth 
(Kotecha, 1996, Kotecha et al., 1996).  




Systemic use of corticosteroids is a frequent clinical practice in neonatal units 
worldwide, as an anti-inflammatory treatment, to wean babies from the ventilator. 
However, systemic use of corticosteroids has been associated with a number of 
serious adverse effects, including adrenal suppression, sepsis, myocardial 
hypertrophy, gastrointestinal bleeding, gastric perforation and most importantly 
adverse neurodevelopmental outcomes (Halliday et al., 2009a, Halliday et al., 2009b).  
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Halliday and co-workers (2010) undertook a systematic review of RCTs on the early 
use of corticosteroids in prevention of broncho-pulmonary dysplasia to determine if 
early postnatal corticosteroid treatment was of benefit in preterm infants prior to 8th 
day of life. (Halliday et al., 2010) 
It included 28 RCTs, undertaken between 1966 and 2008, which enrolled a total of 
3740 participants. Although the meta-analysis of those trials demonstrated significant 
benefits with regards to earlier extubation and decreased risks of BPD at both 28 days 
and 36 weeks’ postmenstrual age, the combined outcome of death or BPD at 28 days 
and 36 weeks’ PMA, PDA and ROP, it showed that there were important adverse 
effects, including increased risks of GI bleeding and intestinal perforation, 
hyperglycemia, hypertension, hypertrophic cardiomyopathy and growth failure.  
Twelve trials reported late outcomes and several adverse neurological outcomes were 
found at follow-up examinations including developmental delay, cerebral palsy and 
abnormal neurological examination.	
There was a significant increase in the rate of cerebral palsy with corticosteroids in 12 
studies, 1452 infants (RR 1.45, 95% CI 1.06, 1.98), but there was a non-significant 
increase in the combined outcome, death or cerebral palsy (RR 1.09, 95% CI 0.95, 
1.25).  Abnormal neurological examination was significantly more frequent in five 
studies and 829 infants (RR 1.81, 95% CI 1.33, 2.47) and in the combined outcome of 
death or abnormal neurological examination (typical relative risk 1.23, 95% CI 1.06, 
1.42).  The criteria for this diagnosis varied between studies, although the size of the 
difference in the trials where similar.   However, the rates of the combined outcomes 
of death or cerebral palsy, or of death or major neurosensory disability were not 
significantly increased.  Dexamethasone was used in 20 studies, and eight studies 
used hydrocortisone. Most of the beneficial and harmful effects were attributable to 
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dexamethasone. Hydrocortisone had little effect on any outcomes except for an 
increase in intestinal perforation and a borderline reduction in PDA, in particular there 
were no significant differences in the rates of neonatal or subsequent mortality, 
infection, severe IVH, PVL, NEC or pulmonary hemorrhage.(Halliday et al., 2009a, 
Halliday et al., 2010) 
The Cochrane review by Halliday and co-workers (2009), on the late use of 
corticosteroids in prevention of chronic lung disease, aimed to determine the effects of 
late postnatal corticosteroid treatment in preterm infants (after day 7 of life). Nineteen 
randomized controlled trials between 1966 and 2008 were included, with a total of 
1345 participants eligible for inclusion in the meta-analysis.  Beneficial effects of 
corticosteroid treatment after 7 days of life included reductions in extubation failure, 
BPD at 28 days and 36 weeks’ postmenstrual age, home oxygen therapy and the 
combined outcome of death or BPD at both 28 days and 36 weeks’ postmenstrual 
age. Late steroid treatment was associated with a reduction in neonatal mortality (at 
28 days) but not mortality at discharge or last reported age. There was a trend 
towards an increase in risk of infection and GI bleeding but not NEC. Short-term 
adverse affects included hyperglycaemia, glycosuria and hypertension. There was an 
increase in severe ROP, but no significant increase in blindness. There was a trend 
towards a reduction in severe IVH but only 247 infants had this outcome reported. 
There was a trend to an increase in cerebral palsy and abnormal neurological 
examination but also a trend towards reduction in death before late follow-up. The 
combined rate of death or major neurosensory disability was not significantly different 
between steroid and control groups. There were no substantial differences between 
groups for other outcomes in later childhood at 5 years of age, including respiratory 
health or function, blood pressure, or growth.(Halliday et al., 2009b) 
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Systematic review and meta-analysis looking at the use of hydrocortisone for 
prevention or treatment of BPD in preterm infants by Doyle and co-workers, included 
eight RCT studies. A total of 880 participants were enrolled in the meta-analysis. With 
regards to mortality and acute lung morbidity, there was no evidence that 
hydrocortisone reduced mortality or the rate of BPD at 36 weeks of post menstrual 
age (PMA), the combined outcome of death or BPD at 36 weeks PMA, discharge on 
home oxygen, or the rate of extubation failure.  With regards to complications during 
the primary hospitalization, hydrocortisone significantly increased the risks of GI 
perforation. The number needed to treat to cause one case with GI perforation (NNT) 
was 20 (95% CI 8–151). Hydrocortisone reduced the risk of PDA; the number needed 
to treat to prevent one case with PDA (NNT) was 14 (95% CI 8–203). There were no 
significant effects on NEC, severe IVH, PVL, infection, or severe ROP.  Follow up data 
were available for five out of eight studies. The rates of cerebral palsy or combined 
mortality and cerebral palsy were not substantially altered by hydrocortisone. (Doyle et 
al., 2010)  
To potentially avoid harmful catabolic side-effects of steroids, Gesche and co-workers 
have investigated the effect of keratinocyte growth factor (KGF)  in comparison to 
betamethasone on surfactant production in fetal type II pneumocytes (PN-II). Neonatal 
rats were treated with recombinant human (rh)KGF, betamethasone, or their 
combination for 48 hr. Body weight, surfactant, and tissue phosphatidylcholines (PC) 
were investigated at postnatal day 3, 7, 15 and 21. Pneumocyte proliferation, 
surfactant protein (SP) expression and SP-B/C in lung lavage fluid (LLF) were also 
determined. While all treatments increased secreted surfactant PC, betamethasone 
compromised animal growth whereas rhKGF did not. Betamethasone inhibited PN-II 
proliferation and increased surfactant PCs at the expense of tissue PCs. rhKGF 
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however increased surfactant PCs without decreasing other PC species. These 
results encourage investigation of the mechanisms by which rhKGF improves 
surfactant secretion and its efficacy in neonatal lung injury models with a view to 
implementing it as a potential non-catabolic surfactant-increasing therapy.(Gesche et 
al., 2011) 
 
There is limited evidence on the use of other anti-inflammatory treatments, such as 
the antioxidant enzymes. Therefore, minimizing the ventilation induced injury and 




There is evidence of a major regulatory role of mechanical signals in both initiation 
and progression of lung growth, emphasizing the importance of appropriate amount of 
pressure and volume applied through neonatal ventilation that could potentially affect 
the premature lung.  
Pressure and volume applied during mechanical ventilation are significant 
components that cause mechanical strain on the lung tissue in preterm infants. 
Increased mechanical lung strain and its effects on lung cell proliferation have been 
described in several animal models. Positive pressure lung inflation rapidly increases 
mRNA levels for a number of pro-collagens, fibronectin, basic fibroblast growth factor 
(FGF) and transforming growth factor (TGF). Application of continuous positive airway 
pressure increases lung protein and DNA content (Zhang et al., 1996).  
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Zhang and co-workers investigated the relationship between mechanical strain and 
lung growth. They tracheotomised two groups of ferrets and exposed one group to 
continuous airway pressure (CPAP) of 6 cmH2O and the other group to atmospheric 
pressure as control. When measured after two weeks, total lung capacity (TLC) was 
40% higher in CPAP exposed ferrets. In the CPAP group they also found increase in 
lung weight and increase in total lung protein and DNA content. There was no 
difference in lung recoil.  Those data suggest that an appropriate amount of positive 
pressure leads to acceleration of lung growth that does not involve simple lung 
distension but remodelling of lung parenchyma.(Zhang et al., 1996) 
 
 
Ingber and co-workers described a model of cytoskeletal network composed of elastic 
strings and sticks (elements that redistribute cell tension to maintain cell shape), to 
explain the strain induced signal transduction within and between the cells. The 
mechanical transduction is mediated via cytoskeletal proteins called integrins and 
various adhesion molecules. The cell surface receptors transmit the tension to the 
nucleus by re-arranging the cytoplasmic proteins, causing physical alteration in the 
molecules within the nucleus and activation of biochemical pathways. This model 
could explain the potential mechanism of continuous airway pressure on the alveolar 







There is a mechanical interaction between thorax and lung growth (Hsia, 2004). 
Outward recoil of the growing ribcage generates distending pressure that exerts 
mechanical traction on the alveolar septa and the resulting tissue tension provides a 
major signal for cellular lung growth. Lung growth relieves tissue tension and allows 
the rib cage to expand further.(Hsia, 2004) This results in negative intra thoracic 
pressure, which initiates cellular activity of tissue growth. Growth of lung tissue in turn 
reduces the strain created by growth of the thorax. This process continues in a 
feedback loop until somatic maturity is reached and the epiphysis close, ending further 
enlargement(Hsia, 2004).  
It is likely that altered elastic fibre morphology contributes to persistence of BPD by 
altering lung mechanics. Extracellular matrix and elastic fibres play an important role 
in cell proliferation and differentiation. Elastin is the main component of septal 
interstitium. The elastin gene expression is first noticed during the pseudoglandular 
faze of lung development and peaks during alveolarization, when elastin fibres localize 
to the tips of alveolar crests, form rings around alveolar entrances and bundles within 
alveolar walls. These elastin fibres and elastin expressing cells determine the septal 
mechanical properties and strain related signal transduction. Mechanical stresses 
provide signals for the orientation and differentiation of alveolar myofibroblasts as well 
as directional organisation of elastic fibre network (Mariani et al., 1997).  
During alveolarization, the walls of terminal respiratory units become thinner by 
apoptosis and a single layer of capillaries replaces the double capillary network 
(McGowan, 1992). New septae arise at bends in alveolar walls, effectively increasing 
gas exchange surface. Altered stress and strain on alveolar wall changes the wall 
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angle at the bend. BPD is characterized by increased elastin turnover but a paucity of 
elastin fibres in alveolar walls (Bruce et al., 1992).  
Elastin fibre damage in the lungs of preterm babies could be secondary to the 
inflammatory response within the lungs. Bruce and co-workers have described 
inflammatory response of the immature lung to high concentrations of oxygen and the 
effect of this response on the elastin fibres within lung parenchyma. They have 
demonstrated inflammatory response in the lung of ventilated neonates, in a form of 
high neuthrophil concentration in tracheal secretions and subsequent increase of 
uninhibited neutrophil elastase. To determine the risk of proteolytic destruction of 
elastic fibres within lung parenchyma, they obtained concentrations of lung elastase in 
tracheal secretions of 65 ventilated neonates, gestational age 26 to 39 weeks. They 
found that elastase was not detected in tracheal secretions if infants were ventilated 
for less than 3 days, but was significantly increased in neonates ventilated for more 
than 5 days in >60% oxygen. Autopsy specimens of 3 neonates that died showed 
abnormal elastic fibres within lung parenchyma, with minimal secondary septa 




Normal lung development involves a balanced growth of all the intra-acinar tissue 
components, conducting structures as well as the muscular and bony parts of thorax, 
which all leads to optimal gas exchange and hemodynamics of the lungs. 
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In broncho-pulmonary dysplasia, conducting airways and blood vessels that form in 
fetal life, demonstrate limited growth when compared to the growth of acinar tissue in 
postnatal life.(Kennedy, 1999) 
Hypoxia and Dysanaptic Lung Growth 
Chronic hypoxia has been associated with enhancement of alveolar growth without 
corresponding enhancement in the growth of conducting structures, resulting in so 
called dysanaptic (unequal) growth. In other words, this creates an airway limitation 
that diminishes the overall functional benefit of alveolar growth.  
The effects of chronic hypoxia on dysanaptic lung growth have been investigated in 
studies comparing lung function at high altitudes to lung function of people living in low 
altitudes, showing airflow limitations in comparison to lung volumes.(Brody et al., 
1977)  
It has also been shown on an animal model, that hypoxia in rats impairs lung growth 
without affecting airspace dimensions. Hypoxia increases lung growth overcoming 
nutritional effects but this growth is dysanaptic. (Sekhon and Thurlbeck, 1996) 
Dysanaptic lung growth could also occur as a long-term sequelae of BPD or chronic 
lung disease of prematurity where small airway obstruction persists despite 







To date, lung function studies have suggested that children with BPD have evidence 
of reduction in expiratory flow rates with air trapping. The abnormalities are probably 
due to small airway narrowing, reduction in alveolar number and reduction in elastic 
recoil. (Hsia, 2004) 
There are a number of studies that are highlighting the extent to which very 
prematurely born infants suffer from small airway abnormalities:   
Mallory and co-workers studied a small group of patients with severe BPD in 1991. 
They longitudinally studied maximal expiratory flow-volume curves by the forced 
deflation technique in 11 infants who had previous tracheostomy with moderate to 
severe BPD. Patients were classified into: those who were mechanically ventilated for 
less than 5 months (moderate) and those who were ventilated for 10 or more months 
(severe). The maximum expiratory flow at 25% FVC (FEF75) at 6 months of age was 
6.9 in the first group and 8.1 mL.kg-1.s-1 in the second group. FEF75 gradually 
increased in the moderate BPD group, reaching 18.0 mL.kg-1.s-1 at 36 months of 
age, whereas in the severe group it was severely decreased at the same age (3.5 
mL.kg-1.s-1).  That study, although very small, has demonstrated that in patients with 
BPD small airway obstruction persists, although in those with moderate BPD gradual 
improvement is seen. Those findings suggest that in BPD, small airway obstruction 
does not resolve during the first three years of life. (Mallory et al., 1991) 
Koumbourlis and co-workers (1996) measured serial lung function over an 8 year 
period in 17 children aged five to eight years, with mild BPD. Their mean gestational 
age was 29.1 +/- 1.9 weeks, with a mean birth weight of 1120 +/- 190 g, and they had 
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received supplemental oxygen, with or without mechanical ventilation, for 40.4 +/- 23.8 
days during the neonatal period. Lung function was measured from the age of 8.2 +/- 
1.2 years to the age of 15.1 +/- 1.6 years. They found growth of lung volumes and 
reduction in air trapping, but small airway obstruction (FEF25-75) did not change over 
time (Koumbourlis et al., 1996). 
 
Iles and co-workers (1997) investigated 33 infants to assess the longitudinal changes 
of interstitial and airway disease in resolving BPD. They measured mean arterial 
oxygen saturation, PaCO2 and PaO2 while breathing 50% oxygen and calculated 
alveolar arterial difference (A-a)DO2 close to term and every three months until one 
year of age. Measurements of (A-a)DO2 showed slow improvement in pulmonary 
shunt (V-Q mismatch) and therefore slow improvement in the lung interstitium and 
alveolar function. Simultaneously, they measured the VmaxFRC as a measure of 
small airway function at the same visits. The VmaxFRC of six healthy infants was 
measured for the purpose of comparison. Mean values for children with BPD were 
less than 50% of predicted values. Longitudinal change in the VmaxFRC showed 
significantly slower improvement in airway function in infants with BPD. Although there 
was no decline in lung function observed, the improvement was slow and normal 
values were not reached at one year of age. (Iles and Edmunds, 1997) 
 
Gross et al. (1998) measured the lung function of 125 children aged seven years who 
were born between 24 and 31 weeks of gestation. They found significantly worse 
pulmonary function in the prematurely born children compared the controls, 
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particularly with reduced forced expiratory flows, 25%-75% of vital capacity (FEF25-
75).(Gross et al., 1998) 
Hoffius et al. (2002) measured maximal flow at functional residual capacity 
(VmaxFRC), at 6 and 12 months in infants with BPD, who were initially treated with 
either high frequency oscillatory ventilation (HFOV) or conventional mechanical 
ventilation (CMV).  Between 6 and 12 months they noted significant worsening of 
VmaxFRC  in the infants supported by CMV and that the  mean VmaxFRC was 
significantly better in the group who had been supported by HFOV (Hofhuis et al., 
2002).  
Although the study was not randomised, the findings suggest that initial support of 
very premature babies with HFOV may lead to less small airway damage.  The main 
aim of this thesis will be to test that hypothesis by assessing very prematurely born 
children at school age, who were randomised at birth to receive either HFOV or CMV 
(UKOS, see later). 
Robin and colleagues (2004) measured lung function of 28 children less than three 
years of age, who had had BPD.  They used the raised-volume rapid thoraco 
abdominal compression (RVRTC) to measure forced expiratory flows and 
demonstrated significantly decreased FEF75-25 in the children who had BPD 
compared to normal controls healthy infants born at term (Robin et al., 2004).   
Vrijlandt and co-workers (2006)  investigated whether lung function was affected by 
BPD, as measured by the forced oscillation technique (FOT) and the interruption 
technique (Rint) in forty three – five years old children born preterm (mean GA 28 
weeks).  By FOT they measured respiratory resistance (Rrs) and respiratory 
reactance (Xrs) and with the Rint technique they measured respiratory resistance. For 
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comparison they measured a group of 36 children born preterm without BPD (mean 
GA 29 weeks). They measured 73 healthy term born children as a reference 
population. They tested the reversibility of airway obstruction by administration of 
bronchodilator (400 microg of Salbutamol). Lung function measurements showed 
significantly higher Rrs and lower Xrs in the children with BPD. Lower reactance 
indicated decreased compliance of the lung, which is noticed in small airway 
obstruction. (Vrijlandt et al., 2006, Vrijlandt et al., 2007).  
Infants diagnosed with BPD, however, have worse lung function during infancy than 
children without BPD.(Sanchez-Solis et al., 2012) Sanchez Solis and co-workers 
(2009) have measured lung function in 43 preterm infants with BPD and in 32 preterm 
infants without BPD at a chronological age range of 2–28 months, born at a mean 
gestational age of 29 weeks. Maximal expiratory volume curves were obtained by 
means of rapid thoracic compression with raised volume technique. Maximal flow at 
functional residual capacity was measured using rapid thoracic compression at tidal 
volume. They found that BPD was associated with significantly lower flows (for FEF50, 
FEF75, FEF85, FEF25–75) and associated with an additional decrease of lung 
function during the first 2 years of life in infants born preterm.(Sanchez-Solis et al., 
2012) 
Brostrom and co-workers (2010) described wide spread small airway changes on 
thoracic high resolution computed tomography in eight year old children who had 
BPD. Those findings of wide spread peripheral airway changes suggest an increased 
risk of chronic obstructive pulmonary disease (COPD) later on in life(Broström et al., 
2010). 
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Landry and co-workers published another study looking into association of BPD and 
expiratory flow obstruction in 2011. In a retrospective review of 322 hospital records of 
preterm infants born below 37 weeks of gestation (mean gestational age of 27.9 
weeks) between January 1980 and December 1992, the initial severity of BPD was 
associated with hospital re-admissions in the first two years of life, the presence of 
developmental delay and reduction in FEV1 and FVC between 8 years and 15 years 
of age.   BPD was defined as the need for supplemental oxygen at 28 days of life. 
They found that initial BPD severity was an important predictor of lung function 
abnormality and health care use during childhood. Results of pulmonary function tests 
were recorded when available and long term complications were abstracted from 
written reports. Disease severity was graded based on an assessment at 36 weeks of 
gestational age into 3 groups:  mild (breathing room air, FiO2 21%), moderate (FiO2 
<30%) and severe (FiO2>30% or requiring positive pressure ventilation).  When lung 
function was compared between the groups, FEV1 and the FEV1/FVC ratio were 
significantly associated with BPD severity (p 0.006). FEV1 was also associated with 
total duration of oxygen therapy (p<0.001). The lung function results showed no 
differences in lung volumes according to BPD severity but large differences in flow 
obstruction. (Landry et al., 2011) 
Prior to the start of this thesis (2011), Lum and co-workers published a study 
investigating the nature of pathophysiological changes in the lungs of extremely 
preterm children at school age, to ascertain whether respiratory morbidity primarily 
reflects alterations in the lung periphery or more centralized airway function.  They 
performed spirometry, plethysmography, diffusing capacity, exhaled nitric oxide, 
multiple-breath washout, skin tests and methacholine challenge in a subgroup of the 
1995 EPICure cohort of 49 extremely preterm children born below 25 weeks of 
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gestation. They performed the same tests in 52 control children. Lung function 
abnormalities were found in 78% of extremely preterm children, with evidence of 
airway obstruction of small and large airways, ventilation inhomogeneity and gas 
trapping. The lung function abnormalities were largely obstructive in nature. The two 
measurements of small airway function were significantly worse in the preterm group, 
with the mean z score FEF25-75 SD-1.98 in preterm group vs SD-0.59 in term group of 
children, p<0.0001 and mean LCI of 7.3 for the preterm group vs 6.5 for the term 
group, p<0.0001).(Lum et al., 2011) 
Atopy and prematurity 
Several studies have excluded a high prevalence of atopy or an increase in exhaled 
nitric oxide (FENO) with large airway obstruction in extremely prematurely born 
children. Nitric oxide (NO) plays an important role in the physiologic regulation of 
vessel and airway tone within the lung. Exhaled nitric oxide (FENO) is considered to 
be an indirect measure of airway inflammation. 
Fillipone et al (2003) undertook a longitudinal study of pulmonary function at 24 
months and school age years involving 18 children with moderate to severe BPD. 
They found that FEV1 and FEF25-75 were lower than normal in 15 of the 18 children at 
school age with a significant positive correlation with VmaxFRC at 24 months. The 
large airway obstruction was unresponsive to salbutamol in 10 of the 15 children. 
There was no increase in FENO in any of the children (Filippone et al., 2003). 
Baraldi and co-workers (2005)  measured exhaled nitric oxide together with spirometry 
in 31 school aged children born below 31 weeks of gestation, who were previously 
diagnosed with BPD. They compared this group with equal groups of preterm children 
without BPD (N=31), healthy term children (N=31) and term children previously 
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diagnosed with asthma (N=31). Although preterm children with BPD had the most 
significant large airway obstruction out of the four groups, they had significantly lower 
measurements of FeNO  than any other group.  Those findings led the authors to 
conclude that large airway obstruction as a consequence of BPD, has a different 
underlying pathophysiology that the airway obstruction in term children with asthma. 
This could be due to structural airway changes that develop through remodelling 
process that follows BPD.(Baraldi et al., 2005) 
In a study by Jones and co-workers conducted in 2009, they demonstrated 
persistently reduced expiratory flows in the presence of normal forced vital capacity 
and the absence of catch up growth in the airway function, suggesting that premature 
birth is associated with altered lung development. They compared lung function of 62 
preterm infants who had no respiratory symptoms and were born between 30 and 34 
weeks, with full term born controls (N=27), and found that asymptomatic premature 
infants had reduced lung function in the first year of life when compared to term 
infants. Lung function was measured using the raised volume-rapid thoracic 
compression technique at one month of age. Longitudinal assessment of lung function 
was conducted in a subgroup of 26 asymptomatic preterm infants and 24 full term 
controls at 1 month and 13 months subsequently. There were no differences between 
preterm and term infants with respect to the forced vital capacity,  however, the 
reduction in flows was sustained in the second year of life in the preterm 
group.(Jones, 2009) 
Lum et al. (2011) demonstrated a high prevalence of lung function abnormalities in 
fifty 11 year old children born below 25 weeks of gestation compared to age matched 
controls born at term. Twenty one of the extremely premature children exhibited an 
obstructive pattern, whilst only five had evidence of restrictive lung disease. While 
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29% of the preterm children had previously diagnosed asthma, they had no increase 
in the prevalence of atopy or level of FeNO (Lum et al., 2011).  
 
Bronchial hyper responsiveness 
 
Several studies have documented increased bronchial hyper responsiveness in 
preterm children:  Motoyamana et al (1987) showed airway reactivity at three weeks of 
age in 32 premature infants born at a mean gestational age of 27 weeks.  They 
obtained maximal expiratory flow-volume (MEFV) curves by manual inflation of the 
lung followed by forced deflation with a negative pressure. At each test MEFV curves 
were obtained in three conditions: baseline; after broncho provocation with normal 
saline aerosol with manual ventilation as a control; and after bronchodilator. Maximal 
expiratory flow at 25% of FVC (Vmax25) was markedly decreased at baseline and 
remained decreased after saline control. After bronchodilator, there was a marked 
increase in Vmax25. Of 23 Infants studied after 3 weeks of postnatal age, 21 exhibited 
a more than 30% increase In Vmax25 above control (defined as airway reactivity). 
There was a highly significant correlation between the degree of airway reactivity and 
the severity of respiratory disease, determined by the duration of ventilator 
dependence. (Motoyama et al., 1987)  Pelkonen et al (1997) evaluated bronchial 
responsiveness in 29 prematurely born children with BPD aged 7 to 12 years and 
compared their results to those of term controls. Baseline spirometry results were 
significantly lower in the prematurely born children and they were significantly more 
responsive to a histamine challenge (Pelkonen et al., 1997).    
Snepvangers et al. (2004) measured Crs (respiratory system compliance) and Rrs 
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(respiratory system resistance) at birth in a cohort of 77 preterm children, mean GA 
29.4 weeks, and than carried out bronchial challenge tests at 2 years of age using 
isotonic saline and methacholine provocation, monitoring for wheeze and drop in 
SatO2 below 90%. Decreased neonatal Crs was significantly related to bronchial 
responsiveness at 2 years of age.  Only 4% of the infants had a diagnosis of BPD. 
Hence, prematurity per se may be related to subsequent BHR development. 
(Snepvangers et al., 2004) 
 
Although BHR has been found after premature birth in several studies investigating 
lung function in preterm children, the aetiology is not clear. It may be due to damage 
to the airway mucosa by inflammation and mechanical ventilation.  It may also be a 
manifestation of prematurity per se, as it has been found in children born prematurely 
who did not have a diagnosis of RDS or BPD. In this thesis, I will aim to assess the 
impact of neonatal ventilation on BHR development, by performing a cold air 
challenge in children with FEV1>70% predicted.  
	
Premature birth at 25 weeks of gestation coincides with the saccular stage of lung 
development.  Histology findings in lung parenchyma of infants born between 24 and 
30 weeks of gestation have shown marked simplification of acinar structure with 
reduced alveolar number and decreased internal surface area. Those findings are 
consistent with the reduced pulmonary diffusing capacity (DLCO) demonstrated in 
both BPD and non-BPD prematurely born children when compared to term controls 
(Hakulinen 1996) (Hakulinen et al., 1996).    
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Balinotti et al (2010) measured DLCO and alveolar volume, using a single breath-hold 
manoeuvre at elevated lung volume, in 39 infants born prior to 29 weeks of gestation 
and at a mean of 11.6 months corrected age at the time of testing. They found 
decreased diffusing capacity in comparison with normal controls, consistent with 
impaired alveolar development after premature birth (Balinotti et al., 2010).     
Thirty-four children with BPD studied at eight years of age had significantly reduced 
DLCO in comparison with 34 term controls.(Korhonen et al., 2004)  Therefore, in this 
thesis, the degree of alveo-capillary membrane impairment will be assessed with the 
single breath gas transfer method, and compared with the alveo-capillary membrane 
function of term children. 
 
1.9.	Pulmonary	hypertension	
Abnormalities of the pulmonary circulation in prematurely born infants, including the 
development of pulmonary hypertension (PH), complicate the course of BPD and 
contribute to late morbidity.  
1.9.1.	Histological	evidence	of	changes	in	pulmonary	vasculature		
	
Hislop et al (1990) studied the lungs of 17 preterm infants (below 37 weeks of 
gestation), who died and had had BPD. They found an increase in pulmonary arterial 
medial thickness, but no evidence of cor pulmonale.  The infants had a reduced 
number of alveoli, but normal alveoli to arterial ratio; the total number of arteries was 
significantly reduced. Those findings suggest that infants who recover from RDS might 
have significant vascular abnormalities (Hislop and Haworth, 1990).   
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The two main processes of the pulmonary vasculature growth, vasculogenesis and 
angiogenesis, are regulated by several angiogenic factors, including VEGF (vascular 
endothelial growth factor).(Ferrara, 1999a, Ferrara, 1999b, Ferrara and Alitalo, 1999) 
Bhatt et al. (2001) have found decreased VEGF mRNA and a decreased number of 
angiogenic receptors in infants who were born below 27 weeks of GA, had BPD and 
died (Bhatt et al., 2001). 
A significant number of preterm births is due to maternal preeclampsia. There is a link 
between maternal preeclampsia (PE) and BPD, which has been established in many 
epidemiological studies. (Goldenberg et al., 2008). Soluble vascular endothelial 
growth factor receptor-1 (soluble VEGFR1), also known as soluble fms-like tyrosine 
kinase 1, or sFlt-1), is an endogenous antagonist of vascular endothelial growth factor 
(VEGF), and is markedly elevated in amniotic fluid and maternal blood in PE.  Tang 
and co-workers have shown that amniotic sFlt-1 decreased alveolar number, reduced 
pulmonary vessel density, and caused right and left ventricular hypertrophy in 14-day-
old rats. Intra-amniotic sFlt-1 treatment suppressed activation of lung VEGF receptor-2 
and increased apoptosis in endothelial and mesenchymal cells in the newborn lung. 
They concluded that exposure to excess sFlt-1 in amniotic fluid causes reduction in 
alveolarization and pulmonary vascular growth in rats.(Tang et al., 2012) 
1.9.2.	Diagnosis	of	pulmonary	hypertension	
	
Pulmonary arterial hypertension in children is defined as the mean pulmonary artery 
pressure ≥25 mm Hg, pulmonary capillary wedge pressure ≤15 mm Hg (Galiè et al., 
2009).  Paediatric PH is thought to be similar to adult disease, however some older 
studies have shown worse prognosis in untreated paediatric PH with a median 
survival estimated at 10 months compared with 2.8 years in the adult .(Barst, 1999) 
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Treatment of PH in children has subsequently improved with the introduction of new 
treatments such as intravenous epoprostenol, bosentan and sildenafil. The five year 
survival is estimated between 57-72%, depending on the etiology of PH.(Haworth and 
Hislop, 2009) 
Patients with chronic lung disease of prematurity are a growing population and it is 
estimated that 12% of paediatric patients with pulmonary hypertension have an 
associated respiratory disease, with bronchopulmonary dysplasia being most 
frequent.(2009, Haworth and Hislop, 2009) 
The diagnosis of pulmonary hypertension (PH) is often difficult because the symptoms 
may be subtle and masked by coexisting respiratory problems. 
To determine the role of pulmonary vascular tone in pulmonary hypertension, Mourani 
et al (2004) studied 10 patients with BPD who underwent cardiac catheterisation for 
evaluation of pulmonary pressures. The patient’s median age was 10 years (range 6 
months to 27 years). They assessed the acute effects of nitric oxide (NO), oxygen and 
calcium channel blockers on the mean pulmonary artery pressure (MPAP). Inhaled 
NO and oxygen significantly decreased the MPAP, achieving near normal values of 
pulmonary pressures. They concluded that high pulmonary vascular tone contributed 
to pulmonary vascular disease in children with BPD. Pulmonary hypertension 
persisted to adolescence and, in addition to structural changes, vascular tone 
continued to contribute to hypertension and remained responsive to oxygen and 
NO(Mourani et al., 2004).  
Khemani and co-workers (2007) found that infants with BPD and PH are at an 
increased risk of death, particularly in first 6 month of life. They studied 42 preterm 
babies below 32 weeks of gestation with BPD who were diagnosed with pulmonary 
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hypertension at a median age of 4.8 months. Pulmonary pressures were measured by 
ECHO in 42 patients and 13 patients also underwent cardiac catheterisation. Severe 
pulmonary hypertension was detected in 43% of the patients, defined as the right 
ventricular pressure being equal or above to systemic blood pressure. During the 
follow up period, 38% of the patients died and estimated survival for the group was 
64% at 6 months and 53% at 2 years after diagnosis of PH. In patients who survived, 
pulmonary pressures improved when re-measured at 10 months of age in 89% of the 
cases.(Khemani et al., 2007) 
Mourani and co-workers (2008) described the clinical utility of echocardiography 
(ECHO) in the diagnosis of pulmonary vascular disease in children with BPD. They 
assessed 29 patients with BPD who had an ECHO in the first two years after birth and 
subsequently underwent cardiac catheterisation. Tricuspid regurgitation was 
detectable in 19 children, allowing estimation of the systolic pulmonary artery pressure 
(SPAP) in 61% of the patients. Cardiac catheterisation confirmed PH in 23 patients 
(74%). Although examination by ECHO can underestimate or overestimate SPAP in 
comparison with the gold standard cardiac catheterisation, it has been advised as a 
valuable screening tool (Mourani et al., 2008). 
Slaughter et al (2011) published findings with regards to increased mortality risk, in a 
prospective study conducted in a single centre between 2003 and 2009. Amongst 
1156 babies who were born ELBW (extremely low birth weight), 216 (19%) had BPD 
and required prolonged PPV (positive pressure ventilation). In babies that were 
screened by echocardiography (41% of BPD diagnosed babies), 37% had evidence of 
PH. Logistic regression analysis has shown that babies with diagnosis of PH were 4 
times more likely to die (adjusted OR 4.6, 95%CI 1.3-16.5) when compared with 
infants with BPD who did not have evidence of PH.(Slaughter et al., 2011)  
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There are, however, few data about the degree of pulmonary hypertension (PH) in 
extremely prematurely born children of school age and a further aim of this thesis is to 
provide such data. 
Doppler echocardiography is a non-invasive method and it is commonly used to 
screen for PH. It can simultaneously provide information on the right ventricular 
systolic pressure (RVSP), functional and morphologic sequelae of PH and identify 
possible cardiac causes of the PH (Abbas et al., 2003, Arcasoy et al., 2003, Er et al., 
2010).  One of the aims of this thesis was to use Doppler echocardiography to assess 
a cohort of very prematurely born children at school age and compare the findings 
with a cohort of term children of the same age. The main targets for assessments 
were differences in pulmonary pressures, to assess the impact of the ventilation mode 
on pulmonary pressures at school age and the degree of potentially high pulmonary 





Ventilation induced injury is one of the main factors in the development of BPD, 




Gross barotrauma is clinically manifested as pneumothorax or less commonly as 
pneumo-mediastinum, which are visible consequences of lung damage caused by 
application of high airway pressure. 
1.10.1.2.	Volutrauma 
Volutrauma is explained by high inspiratory pressure creating high tidal volume that 
causes over-distension of small airways and alveoli. (Tremblay et al., 1997) 
The concept of volutrauma was proposed during the 1980’s. Dreyfuss and co-workers 
have performed animal studies on mechanically ventilated healthy rats subjected to 
use of high airway pressure, with their chest walls strapped and unable to expand. 
When the chest wall was strapped, airway pressures were extremely high but tidal 
volumes were modest and lung lesions were absent. When the chest wall was not 
strapped, the corresponding tidal volume was much higher for a given airway pressure 
and pulmonary lesions were dramatic. The trans-pulmonary pressure represents the 
distending force of the lung. When the chest wall elastance is artificially increased, as 
in the case of the rats with a strapped thorax, then pleural pressure, for a given tidal 
volume, must increase. Therefore, a higher airway pressure and a higher pleural 
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pressure will be recorded, but the resulting trans-pulmonary pressure will be normal. 
On the other hand, when the chest wall is free to expand, the pleural pressure is 
relatively low but high airway pressures are now associated with high trans-pulmonary 
pressures, causing high tidal volumes and lung structural damage. Therefore, the 
development of VILI will depend on the transpulmonary pressure and resulting tidal 
volume.(Dreyfuss et al., 1988)  
1.10.1.3.	Atelectotrauma 
Atelectotrauma happens due to insufficient positive end expiratory pressure (PEEP) 
that causes repetitive opening and collapse of lung units causing regional atelectasis 
and over distension (Dreyfuss et al., 1988, Markos et al., 1993) 
Animal models have shown that ventilation incorporating positive end expiratory 
pressure (PEEP) reduces oedema formation and cell damage (Dreyfuss et al., 1988). 
PEEP also helps to reduce inflammatory cell recruitment during prolonged ventilation 
(Markos et al., 1993). High tidal volumes and no PEEP ventilation result in increased 
cytokine concentrations in an animal model (Tremblay et al., 1997).   The benefits of 
PEEP have been observed with high frequency oscillatory ventilation (HFOV). 
(Matsuoka et al., 1994) 
1.10.1.4.	Biotrauma,  
Infection, inflammation and high oxygen concentrations will cause oxidative stress and 
free radical-induced injury of the lung.  (Saugstad, 2003) 
If mechanical strain applied to the lungs is not reaching the levels of physical rupture 
of collagen fibers, the cells anchored to the lung skeleton will be abnormally stretched. 
This leads to activation of cellular mechanisms that causes cytokine release and 
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further development of the inflammation process. As described before, the 
cytoskeleton of alveolar and endothelial cells is connected to the extracellular matrix 
via the integrin system. Therefore, spatial changes occurring in either the lung fibrous 
skeleton or the anchored alveolar epithelial cells can be sensed by the cytoskeleton, 
the integrins, and the ion channels (collectively acting as mechanosensors), and they 
are then transduced in a biochemical signal through the activation of specific intra- 
cellular pathways (mechanotransduction). This could potentially lead to remodeling of 
extracellular matrix, releasing of the cytokines and recruitment of the white cells, 




Over the past decades clinicians have strived to find a method of respiratory support 
that will minimize ventilation-induced trauma of extremely prematurely born infants.  
1.11.1.	Principles	of	mechanical	ventilation	
	
According to La Place law, the larger the curvature of the surface is, the lower 
pressure will be needed to overcome its’ surface tension and prevent its’ collapse. 
This is an important principle, applied through the use of positive end expiratory 
pressure (PEEP) during mechanical invasive and non-invasive ventilation. If PEEP is 
too high or if there is inadequate expiratory time for the lung to empty, gas trapping 
may occur. Equally, if flow is set too low, gas volumes may be too small and 
ventilation will be inadequate (Donn and Sinha, 2006, Attar and Donn, 2002) 
The use of higher pressures results in increased FRC (functional residual capacity), 
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lower compliance, lung overexpansion, barotrauma and volutrauma. The use of 
pressures below this ‘‘safe zone’’ results in decreased functional residual capacity, 
lower compliance, alveolar collapse, and atelectotrauma. 
Application of the basic principles of mechanical ventilation and choosing the proper 
strategy should optimise pulmonary gas exchange and reduce lung injury. Avoidance 
of the ‘‘mechanical’’ elements of ventilator induced lung injury— barotrauma, 
volutrauma and atelectotrauma— can be accomplished by ventilating the lung close to 






Conventional time cycled, pressure limited ventilation is a method during which  
clinician sets the PIP (positive inspiratory pressure), PEEP (positive end expiratory 
pressure) and the Tin (inspiratory time). Tidal volume of breaths during this type of 
ventilation will depend on the difference between PIP and PEEP. The rate of 
mechanical breaths per minute will be determined by the Tin and expiratory time 
(Tex). This mode of ventilation is also called IPPV (intermittent positive pressure 
ventilation).(Hummler and Schulze, 2009)  
SIMV (synchronized intermittent mechanical ventilation) supports pre determined 
number of breaths and allows for spontaneous breathing in between.  A/C (assist 
control) ventilation responds to all detected spontaneous breaths and delivers a full 
mechanical breath.  Both SIMV and A/C use trigger devices to synchronize the 
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spontaneous respiratory effort of the baby with the pressure delivered by the 
ventilator.   Synchronising the mechanical ventilation in a way that the positive airway 
pressure given by the ventilator coincides with the baby’s spontaneous inspiration is 
postulated to be an important aspect of minimizing barotrauma. Therefore, lower peak 
airway pressures would be required for achieving adequate ventilation if the 
mechanical ventilation is synchronised with baby’s spontaneous breathing.  
In the Cochrane review published in 2008, eleven eligible randomised controlled trials 
were included in the meta-analysis. The trials compared HFPPV (high frequency 
positive pressure ventilation), triggered ventilation modes PTV (patient triggered 
ventilation) and SIMV (synchronised intermittent mechanical ventilation) with CMV 
(conventional mechanical ventilation). HFPPV compared to CMV was associated with 
the reduction in the air leak. PTV/SIMV were associated with shorter duration of 
ventilation when compared to CMV. However, there was no evidence that either 





PSV (pressure support ventilation) supports spontaneous respiratory efforts. 
Compared with A/C which has a set Tin (inspiratory time), the Tin in PSV depends on 
the characteristics of the inspiratory flow. Flow sensor initiates triggering of 
mechanical breaths. Maximum inspiratory ventilator pressure and a maximum 
inspiratory time limit is set by the clinician. Importantly, when the end of the breath is 
reached, the reducing inspiratory flow terminates the mechanical support. Termination 
occurs when the inspiratory flow crosses a pressure limit or the inspiratory time limit. 
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The operator sets the breath-termination flow threshold as a proportion of the 
measured peak inspiratory flow. The patient controls the rate and the inspiratory time 
of the mechanical assistance. This improves synchrony and patient comfort. PSV can 
be used as a stand-alone mode of ventilation or in combination with SIMV, to provide 
a back up respiratory rate in case of apnea or poor respiratory effort (Donn and Sinha, 
2006, Sarkar and Donn, 2007) 
Olsen and co-workers compared pressure support ventilation (PSV) with volume 
guarantee (VG) to synchronized intermittent mandatory ventilation (SIMV) in infants 
with respiratory distress syndrome (RDS). 
It was a small randomized, crossover study that enrolled 14 infants with mean birth 
weight of 2.5+/-0.7 kg, GA 34+/-2 weeks and age of 49+/-26 hours. Infants received 4 
hours of each mode of ventilation, with the first mode selected randomly. During both 
ventilatory modes, end expiratory volume (EEV) was measured.  They found that 
minute ventilation was greater with PSV+VG than with SIMV (p=0.012). There was no 
difference in pCO2. Mean airway pressure was higher during PSV+VG (p=0.023). 
There was no difference in the arterial/alveolar oxygen tension (a/A) ratio or in the 
specific dynamic compliance (sCdyn). (Olsen et al., 2002) 
Reyes and co-workers compared synchronized intermittent mandatory ventilation 
(SIMV) and synchronized intermittent mandatory ventilation plus pressure support 
(SIMV + PSV) in weaning from mechanical ventilation and the duration of 
supplemental oxygen dependency in preterm infants with respiratory failure.  They 
randomized107 infants weighing 500 to 1000 g at birth, who required mechanical 
ventilation during the first postnatal week. Outcomes were assessed during the first 28 
days and until discharge or death. During the first 28 days, infants in the synchronized 
intermittent mandatory ventilation plus pressure support group reached minimal 
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ventilator settings and were extubated earlier than infants in the synchronized 
intermittent mandatory ventilation group. Total duration of mechanical ventilation, 
duration of oxygen dependency, and oxygen need at 36 weeks postmenstrual age 
alone or combined with death did not differ between groups. However, infants in the 
synchronized intermittent mandatory ventilation plus pressure support group, within 
the birth weight subgroup of 700 – 1000 g, had a shorter oxygen dependency.(Reyes 




Volume guarantee is a mode of ventilation that has been introduced as a variation of 
conventional ventilation, potentially lung protective ventilation strategy that would limit 
the barotrauma by delivering minimal inspiratory pressure necessary to achieve the 
sufficient tidal volume.  
In the Cochrane review in 2010, twelve randomized trials were included in the 
analysis. The use of VTV (volume targeted) modes resulted in a reduction in the 
combined outcome of death or bronchopulmonary dysplasia.  VTV modes also 
resulted in reductions in pneumothorax, days of ventilation, hypocarbia and the 
combined outcome of periventricular leukomalacia or grade 3-4 intra-ventricular 
hemorrhage. These findings indicated importance of limiting the barotauma while 
using optimal volume during ventilation of extremely preterm neonates with 





Proportional assist ventilation is a form of patient triggered ventilation that allows the 
infant to fully control frequency, timing, and amplitude of lung inflation the respiratory 
musculature. This form of ventilation allows the amount of pressure given by the 
ventilator to be proportion to the instantaneous tidal volume and inspiratory airflow 
generated by the baby.(Hummler and Schulze, 2009)  In a small study published in 
2001, Shultze and co-workers showed that PA safely maintains gas exchange with 
smaller trans-pulmonary pressure changes compared with A/C and IMV. They 
stratified 36 infants by birth weight (600 to 750,751 to 900, and 901 to 1200 g) and 
exposed to consecutive 45-minute periods of the 3 modalities in a sequence chosen at 
random. Tidal volumes of 4 to 6 mL/kg were targeted during A/C (assist control) and 
IMV (intermittent mandatory ventilation). The IMV rate was matched to the rate during 
an A/C test period. PA was adjusted to unload the resistance of the endotracheal tube 
and the disease-related increase in lung elastic recoil.  Compared with A/C and IMV, 
PA maintained similar arterial oxygenation with lower airway and trans-pulmonary 
pressures (15% to 44% reduction depending on the index variable) and the 
oxygenation index decreased by 28% during PA. Similar results were obtained within 




As previously described in this chapter, respiratory distress syndrome (RDS) is 
caused by a deficiency of surfactant. The discovery of surfactant dates back to 
1929, when the first experiments suggesting presence of surfactant in the lungs 
and it’s relevance to the newborn’s breathing were performed and published by 
Kurt von Neergaard. Von Neergaard performed experiments on porcine lung and 
concluded that “Surface tension is responsible for the greater part of total lung 
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recoil compared to tissue elasticity “ and  “A lower surface tension would be useful 
for the respiratory mechanism because without it pulmonary retraction might 
become so great as to interfere with adequate expansion”. 
 
Since then, a variety of surfactant products have been formulated and studied in 
clinical trials, including synthetic surfactant and animal derived surfactant.  
Several randomized controlled studies and meta analysis have shown that there is an 
improved survival if multiple doses are given over a single dose (Soll and Ozek, 2009), 
early surfactant is given versus delayed selective treatment (Yost and Soll, 2000, 
Stevens et al., 2007) and when natural surfactant is used as opposed to synthetic 
surfactant (Soll and Blanco, 2001).  
The last Cochrane review prior to starting of this thesis, published in 2009, assessed 
the effect of administration of animal derived surfactant extract on mortality, chronic 
lung disease and other morbidities associated with prematurity in preterm infants with 
established respiratory distress syndrome. Subgroup analysis was performed 
according to the specific surfactant product, the degree of prematurity, and the 
severity of disease. 
Thirteen randomized controlled trials were included in the analysis. The studies 
demonstrated an initial improvement in oxygenation and decreased need for ventilator 
support. There was a significant decrease in the risk of neonatal mortality (typical 
relative risk 0.68, 95% CI 0.57, 0.82; typical risk difference -0.09, 95% CI -0.13, -0.05), 
a significant decrease in the risk of mortality prior to hospital discharge (typical relative 
risk 0.63, 95% CI 0.44, 0.90; typical risk difference -0.10, 95% CI -0.18, -0.03) and a 
significant decrease in the combined risk of bronchopulmonary dysplasia (BPD) or 
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death at 28 days of age (typical relative risk 0.83, 95% CI 0.77, 0.90; typical risk 
difference -0.11, 95 CI -0.16, -0.06). The meta-analysis also showed a significant 
decrease in the risk of pneumothorax (typical relative risk 0.42, 95% CI 0.34, 0.52; 
typical risk difference -0.17, 95% CI -0.21, -0.13), and a significant decrease in the risk 
of pulmonary interstitial emphysema (typical relative risk 0.45, 95% CI 0.37, 0.55; 
typical risk difference -0.20, 95% CI -0.25, -0.15). No differences were reported in the 
risk of PDA (patent ductus arteriosus), NEC (necrotizing enterocolitis), IVH 





Several studies have suggested that the inflammatory process has an important role 
in development of chronic lung disease (Groneck and Speer, 1995, Merritt et al., 1983, 
Arnon et al., 1993) 
Yeh and co-workers conducted a randomized controlled study to investigate whether 
early post-natal (<12 hours) dexamethasone therapy reduces the incidence of chronic 
lung disease in preterm infants with respiratory distress syndrome. 
This was a multicenter, double-blind clinical trial. They randomized 262 preterm 
infants, birth weight <2000 g.  One hundred and thirty infants were assigned to saline 
placebo and 132 to dexamethasone. All infants had respiratory distress syndrome and 
required mechanical ventilation shortly after birth. Infants in the dexamethasone group 
received dexamethasone every 12 hours intravenously on days 1 through 7, days 8 
through 14, days 15 through 21 and on days 22 through 28. The diagnosis of chronic 
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lung disease based on oxygen dependence and abnormal chest x-ray was made at 28 
days of age. To assess the effect of dexamethasone on pulmonary inflammatory 
response, serial tracheal aspirates were assayed for cell counts, protein, leukotriene 
B4, and 6-keto prostaglandin F1.  They found that infants in the dexamethasone group 
had a significantly lower incidence of chronic lung disease than infants in the placebo 
group, at 28 days of age but also at 36 weeks of gestation. More infants in the 
dexamethasone group than in the placebo group were extubated during the study. 
There was no statistically significant difference between the groups in mortality 
(39/130 vs 44/132). However, a higher proportion of infants in the dexamethasone 
group died in the late study period, probably attributable to infection or sepsis. There 
was no difference between the groups in duration of oxygen therapy and 
hospitalization. Early postnatal use of dexamethasone was associated with a 
significant decrease in tracheal aspirate cell counts, protein, leukotriene B4, and 
prostaglandin, suggesting a suppression of pulmonary inflammatory response. 
Significantly more infants in the dexamethasone group had either bacteremia or 
clinical sepsis (43/132 vs 27/130). Other side effects observed in the dexamethasone 
group were an increase in blood glucose and blood pressure, cardiac hypertrophy, 
hyperparathyroidism, and a transient delay in the rate of growth.(Yeh et al., 1997) 
However, the last Cochrane review prior to starting of this thesis has shown that the 
benefits of early postnatal corticosteroid treatment, started within 7 days of life, may 
not outweigh the known or potential adverse effects. The review examined the 
outcomes of 28 randomized controlled trials enrolling a total of 3740 participants. A 
meta-analysis demonstrated significant benefits regarding earlier extubation and 
decreased risk of CLD, combined risk of death or CLD, risk of PDA and ROP. There 
were no significant differences in the rates of neonatal or subsequent mortality, 
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infection, severe IVH, PVL, NEC or pulmonary hemorrhage. Important adverse effects 
were gastrointestinal bleeding and intestinal perforation, and the risks of 
hyperglycaemia, hypertension, hypertrophic cardiomyopathy and growth failure. In the 
twelve trials that reported late outcomes, several adverse neurological effects were 
found at follow-up including: developmental delay, cerebral palsy and abnormal 
neurological examination. However, major neurosensory disability was not significantly 
increased, and the rates of the combined outcomes of death or cerebral palsy, or of 
death or major neurosensory disability were not significantly increased. Therefore, the 
authors concluded that early corticosteroid treatment facilitates extubation and 
reduces the risk of chronic lung disease and patent ductus arteriosus, it causes 
significant short-term adverse effects. Long-term follow-up studies report an increased 
risk of abnormal neurological examination and cerebral palsy and there is a 
compelling need for the long-term follow-up and reporting of late outcomes (Halliday et 
al., 2009a). 
Interestingly, a study by Dani and co-workers aimed to evaluate if high-frequency 
oscillatory ventilation might reduce lung inflammation in preterm infants with 
respiratory distress syndrome in comparison with the early application of pressure 
support ventilation plus volume guarantee (PSV + VG). They enrolled infants at less 
than 30 weeks of gestation with RDS in the study if they required mechanical 
ventilation, and randomly allocated them to receive HFOV or PSV + VG. They 
obtained bronchial aspirates before surfactant was administered and measured 
interleukin (IL)-1beta, IL-8, and IL-10. Subsequent samples were obtained after 6-18 
hours of ventilation, after 24-48 hours of ventilation and before extubation. Thirteen 
patients were enrolled in the HFOV group, and 12 in the PSV + VG group. The mean 
values of IL-1beta, IL-8, and IL-10 before extubation were lower in the HFOV group 
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than in the PSV + VG group. This study demonstrated that early treatment with HFOV 
is associated with a reduction of lung inflammation in comparison with PSV + VG in 
preterm infants with RDS.(Dani et al., 2006) 
1.11.2.7.	Permissive	hypercapnia	
	
Volutrauma has been previously identified as a cause of lung injury in preterm 
infants.(Tremblay et al., 1997, Bhutani, 2002) The first clinical evidence of this 
concept, when Kraybill and co-workers noticed that infants with highest pCO2 had the 
lowest incidence’ of chronic lung disease.(Kraybill et al., 1989) 
Subsequently, Marianni and co-workers have performed a randomized controlled 
study to determine whether a ventilation strategy of permissive hypercapnia reduces 
the duration of assisted ventilation. They randomized 49 surfactant-treated preterm 
infants with the mean birth weight: 854 +/- 163 g and gestational age of 26 +/- 1.4 
weeks during the first 24 hours of age to a permissive hypercapnia group (PaCO2 of 
45-55 mm Hg) or to a normocapnia group (PaCO2 of 35-45 mm Hg).   Ventilated 
patients in the permissive hypercapnia group had a higher PaCO2 and lower peak 
inspiratory pressure, mean airway pressure, and ventilator rate than did those in the 
normocapnia group. The percentage of patients requiring re-intubation within 24 hours 
post-extubation (17% permissive hypercapnia vs 28% normocapnia), supplemental 
oxygen at 28 days of life (43% permissive hypercapnia vs 64% normocapnia) and the 
mean of total days of oxygen supplementation (15 permissive hypercapnia vs 32 
normocapnia ) did not differ significantly between the groups. There were no 
significant differences in mortality, air leaks, intra-ventricular hemorrhage, 
periventricular leukomalacia, retinopathy of prematurity, or patent ductus arteriosus. 
However, this was a small study, underpowered for important neonatal outcomes. 
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(Mariani et al., 1999) 
 
Another study by Carlo and co-workers aimed to determine whether minimal 
ventilation decreased death or broncho-pulmonary dysplasia (BPD). 
They randomly assigned 220 infants with birth weight 501 g to 1000 g, mechanically 
ventilated less than 12 hours, to minimal ventilation (partial pressure of carbon dioxide 
(target pCO2 >52 mm Hg) or routine ventilation (target pCO2 <48 mm Hg) and a 
tapered dexamethasone course or saline placebo for 10 days, using a 2 x 2 factorial 
design.   Unfortunately, the trial had to be stopped because of unanticipated non-
respiratory adverse events related to dexamethasone therapy, so the sample size 
studied was not powered to assess the risk of death or BPD. However, the proportion 
of babies needing ventilator support at 36 weeks was significantly reduced in the 
minimal ventilation group (1% vs 16%, p<0.001). The relative risk for death or BPD at 
36 weeks in the minimal versus routine ventilation groups was 0.93 (95% CI, 0.77-
1.12; p =0.43). Major morbidities and long-term outcome were comparable in both 
treatment groups, suggesting that permissive hypercapnia is not the strategy of choice 
to improve the major outcomes in preterm infants who are in need of invasive 
ventilator support.(Carlo et al., 2002) 
Woodgate and Davies published a Cochrane review in 2001, aimed to assess whether 
a strategy of permissive hypercapnia improves short and long term outcomes, in 
mechanically ventilated neonates.  Meta-analysis of combined data was performed on 
two trials involving 269 newborn infants. There was no evidence that permissive 
hypercapnia reduced the incidence of death or chronic lung disease at 36 weeks (RR 
0.94, 95% CI 0.78, 1.15), IVH grade 3 or 4 (RR 0.84, 95% CI 0.54, 1.31) or PVL (RR 
1.02, 95% CI 0.49, 2.12). There were no significant differences in any other reported 
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outcomes. Long-term neurodevelopmental outcomes were not reported. One trial 
reported that permissive hypercapnia reduced the incidence of chronic lung disease in 
the 501 to 750 gram subgroup. Therefore, they could not recommended permissive 
hypercapnia strategy to reduce mortality, or pulmonary and neurodevelopmental 
morbidity. (Woodgate and Davies, 2001) Therefore, the question of limiting the 
volutrauma and subsequently improving respiratory outcomes and survival still 





Lung protective ventilation strategy would depend on whether the lung is affected with 
severe respiratory distress syndrome and persistent atelectasis or whether the 
atelectasis is minimal, with mild RDS. 
1) Where there is minimal atelectasis, limiting damage to the vulnerable preterm lung 
involves avoidance of over distension. This can be achieved by setting positive end-
expiratory pressure at the lowest value that maintains oxygenation and restricting tidal 
volume using a volume-targeted mode of ventilation.  
- Avoidance of ventilation in the first days after birth by initiation of nasal CPAP in 
preterm babies with mild RDS:  there is evidence from pooled data of three clinical 
trials that in babies of less than 29 weeks gestation with mild RDS, there could be 
some benefits of initial CPAP over intubation and ventilation, with a reduction in 
duration of ventilatory support and trends towards better survival without BPD.(Morley 
et al., 2008, Finer et al., 2010, Dunn et al., 2011)  
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2) In severe RDS, ventilation approach would include recruiting the lung with increase 
in pressure, in search of an optimal point at which to maintain ventilation, followed by 
reduction of pressure when this point is reached. This form of lung protection is more 
effectively applied with high-frequency oscillatory ventilation than on a conventional 
ventilator. (Dunn et al., 2011) 
-Avoidance of high tidal volumes, over inflation of the lung causes injury (volutrauma), 
which in the preterm lung can occur with a few excessively large inflations.(Björklund 
et al., 1997) 
- Avoidance of atelectasis and ventilation of a diseased lung in which most airspaces 
are open, allowing the delivered volume to be evenly distributed rather than directed 
only towards the ventilated portions of a largely atelectatic lung.(Attar and Donn, 2002) 
-Avoidance of high oxygen concentration. Exposure to supplemental oxygen has the 
potential to cause oxidative lung injury involving both the airways and distal airspaces. 







Yendell Henderson, in the 1915, observed that panting dogs achieve adequate gas 
exchange with very small tidal volumes.(Lunkenheimer et al., 1972) 
In the early 1970s, Lunkenheimer and colleagues found that endotracheal high 
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frequency oscillations produce efficient elimination of CO2, even in the absence of 
significant excursions of the chest wall , while measuring myocardial response to 
pericardial oscillations in large animals. They fitted an electromagnetic pulse generator 
onto the endotracheal tube in three dogs and measured the volume of intra-thoracic 
air shifted, which varied between 10 and 20 ml, depending on the vibration frequency 
and the pressure amplitude. This was the first time that ventilation was observed 
without excursions of the chest wall (Lunkenheimer et al., 1972). 
In 1980, Butler and colleagues reported successful ventilation of one hour duration in 
12 patients aged from 3 days to 74 years by applying oscillatory volumes of 1.5 to 3.0 
ml/kg of body weight, delivered using a piston pump operating at a frequency of 15 
Hz. They also noticed a reduction in V/Q mismatch in two patients with chronic 
obstructive lung disease, with significant reduction of their pulmonary shunt.(Butler et 
al., 1980)  
In an animal model, Yoder and colleagues demonstrated that HFOV improved lung 
mechanics, lung function and lung inflammation. They compared the effects of 
prolonged ventilation in 18 prematurely born baboons, treated with surfactant after 
birth and randomized to either HFOV or low volume positive pressure ventilation (LV-
PPV). Their results showed significantly better lung function measured by 
plethysmography and significantly less inflammation when tracheal aspirates were 
analyzed for interleukin-6 (IL-6), IL-8, tumor necrosis factor-alpha (TNF), IL-1 and IL-




Prior to discovery of HFOV, it was understood that gas exchange takes place in the 
lungs due to the tidal volume in the alveoli exceeding the dead space (conducting 
airways) volume. Discovery of HFOV has made evident that gas exchange can be 
achieved with tidal volumes equal to the dead space, if they are applied at sufficiently 
high frequencies. During high frequency oscillation ventilation, small pressure 
variations oscillate around the mean airway pressure (MAP) at very high rates (up to 
900 cycles per minute) creating small tidal volumes. (Slutsky and Drazen, 2002) 
The main advantage of HFOV is that CO2 elimination during HFOV is uniquely related 
to the oscillatory flow rate, independent of mean airway pressure. Therefore, even in a 
noncompliant, surfactant deficient lung, HFOV provides an option of eliminating CO2 
at a low mean airway pressure and mean lung volumes or high mean airway pressure 
and mean lung volumes without compromising control of pCO2. (Slutsky and Drazen, 
2002) 
Using a rabbit animal model, McCulloh and coworkers investigated whether low or 
high alveolar volume strategy should be used with HFOV for prevention of ventilation 
induced lung injury in atelectasis prone lungs. They ventilated 20 anaesthetized, 
surfactant deficient, tracheostomized rabbits in one of three ways: HFO at a high lung 
volume, HFO at low lung volume or conventional mechanical ventilation.    
The rabbits were made surfactant-deficient by lung lavage. All groups received 100% 
oxygen for the duration of the experiment. They examined oxygenation, lung 
mechanics, and lung pathology.  There were significant differences in oxygenation 
achieved between ventilation groups. In rabbits ventilated with HFOV low volume 
strategy and CMV rabbits, arterial oxygen tensions were 70 to 100 mm Hg. Mean lung 
volumes were 7.8 and 4.3 ml/kg, respectively. Pressure levels were similar between 
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CMV and HFOV high volume group, however no animals survived after 4 hours in the 
CMV group. The low volume strategy HFOV group had much lower mean airway 
pressures. 
They examined lung mechanics and lung pathology:   
Total respiratory system pressure-volume curves (P-V curves) showed that  
animals ventilated with the HFOV high volume strategy had better total respiratory 
system compliance at the end of ventilation period of seven hours Animals ventilated 
with the HFOV high volume strategy had less hyaline membranes and less severe 
airway epithelial damage. 
This study indicated that maintenance of alveolar volume is a key mechanism in the 
prevention of lung injury during mechanical ventilation of the atelectasis-prone lung. 
For optimal outcome using high frequency oscillatory ventilation, alveoli must be 
actively re-expanded and then kept expanded using adequate mean airway pressure. 
(McCulloch et al., 1988) 
1.12.3.	Modes	of	gas	transport	during	HFOV	
	
Gas exchange during HFOV is achieved by several different mechanisms that interact 
with each other and have regional distribution.(Wolf et al., 2007, Wolf and Arnold, 
2007a) 
Alveolar recruitment is essential for gas exchange and alveolar ventilation (VCO2) is a 
function of oscillation (f) and squared tidal volume (VT). (Wolf et al., 2010, Wolf et al., 
2007, Wolf and Arnold, 2007b, Wolf and Arnold, 2007a) 
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The mechanism of gas exchange during HFOV has been explained to by 5 modes of 
gas transport, collectively responsible for the ventilation by HFOV in different parts of 
the lung (Slutsky and Drazen, 2002): 
- Bulk convection 
- High frequency pendelluft 
- Convective dispersion 
- Taylor’s dispersion 
- Molecular diffusion 
	
1) Direct ventilation by bulk convection  
	
Due to considerable asymmetry of the human bronchial tree, when a small tidal 
volume is inspired, the front of the fresh gas may reach alveoli that are more proximal, 
but not the distal ones. Each tidal breath may reach a certain fraction of the total 
alveoli, resulting in direct ventilation of these units. (Slutsky and Drazen, 2002) 
	
2) High frequency “pendelluft”, mixing of gases among alveolar units with 
varying time constant (Slutsky and Drazen, 2002)  
Different lung units have different time constant (r), due to differences in resistance  
(R) and compliance (C). Time constant is a product of these two quantities (r= R x   
C). During rapid breathing rate, the rate of filling and emptying will be determined  by 
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resistance. Slow unit will empty into fast unit at the end of expiration and at the end of 
inspiration, slow unit will inspire from the fast unit.  
3) Convective dispersion due to asymmetric velocity profiles 
This is a mechanism by which material may be transported during oscillatory flow 
through a bifurcating network, such as the bronchial tree. Schroter and Sudlow 
reported that the velocity profiles in the inspiratory flow are more skewed than those in 
the expiratory flow. If a bolus of a non-diffusible marker is dispersed in a tube, it will 
initially form a uniform block. As a result of a rightward flow in the tube, and the 
velocity profile being parabolic, it will be dispersed to the right. On reverse stroke, 
marker material will be transported uniformly to the left. As a result of to-and-fro 
motion, a net dispersion of initial bolus has occurred, with particles near center of the 
tube dispersed to the right and particles near the wall displaced to the left.  By this 
mechanism it is proposed that axial asymmetry of inspiratory and expiratory gas flow 
creates separation of fresh gas and exhaled gas by distributing each along opposite 
walls of the airway.(Schroter and Sudlow, 1969) 
4) Longitudinal (Taylor’s ) dispersion  
According to Taylor’s dispersion concept, explaining the laminar dispersion in a long 
straight tube, the tracer material near the center of the tube will always move much 
faster than that near the tube wall. In the same time, radial diffusion will occur as a 
result of the radial concentration gradient. Once a molecule diffuses out of the central 
flow, it will not be able to move as rapidly as molecules remaining in the center. 
Therefore, highly diffusible material will disperse less rapidly in the longitudinal 
direction than one that has a low molecular diffusivity.  
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Also, efficient gas mixing is likely to occur along the parabolic inspiratory gas front in 
high frequency oscillation because this provides an increased area along which 
diffusion can occur. 
 
5) Molecular diffusion near the alveo-capillary membrane  
This is a transport mechanism arising from random thermal oscillation of the molecule. 
As long as the molecules in a mixture have a temperature above absolute zero, 
molecular diffusion always occurs. 
Overall, ventilation by HFO seems to be a combination of all five methods of transport 
mentioned above. These methods are not mutually exclusive and interact between 
each other. Different modes may be dominant in different zones of the lung.  
1.12.4.	Ventilator	settings	
	
Animal studies have shown that, during HFOV, CO2 elimination is a function of 
frequency and the square of the tidal volume. (Boynton et al., 1989) 
Tidal volume is positively correlated with the amplitude of oscillation (“delta P”) and is 
inversely related to the frequency (Hz). 
Alveolar recruitment is positively correlated with the mean airway pressure (MAP) and 
the ratio of inspiratory time to expiratory time (I:E).(Pillow et al., 1999) 
Higher frequency ranges provide conditions of lowest lung impedance and 
consequently lower pressure trauma. 
During HFOV, MAP, delta P, frequency and I:E are all directly controlled by the 
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operator. 
If a baby is transitioned from conventional ventilation to HFOV, MAP on HFOV is 
typically set 2 cmH2O (up to 5 cmmH2O) above the one last used during CV, in order 
to achieve adequate recruitment. 
Amplitude (delta P) is set while observing the adequacy of chest wall vibrations. 
Frequencies of 10-12 Hz are generally used on small infants. 
In “open lung” ventilation strategy, MAP is slowly titrated upward in 1-2 cmH2O 
increments, with the goal of reducing the FiO2 to <0.6 while maintaining the oxygen 
saturation of >90%.  
Hypercarbia is normally addressed by increasing the amplitude in 2-3 cmH2O 
increments. (Ventre and Arnold, 2004) 
The above strategy of ventilation should aim to maintain the ventilation in the safety 
window of optimal volume and optimal pressure, sufficient to prevent atelectasis and 









neonates	prior	to	starting	of	this	thesis) (Cools et al., 2009) 
This review included seventeen eligible studies of 3,652 infants, and showed similar 
trends as previous reviews in 2003 and 2007 (Henderson-Smart et al., 2003, 
Henderson-Smart et al., 2007). There was no clear evidence of advantage of HFOV 
over CV with regards to mortality, although there was a small reduction in the rate of 
CLD with HFOV use, but the evidence was inconsistent across trials.  
Mortality: there were no significant differences in the rates of mortality by 28 - 30 
days reported on 2060 infants in 9 trials (RR 1.09, 95% CI 0.88, 1.35). There were no 
significant differences in the rates of mortality by 36 - 37 weeks of age or discharge  
reported on 2885 infants in 15 trials  (RR 0.98, 95% CI 0.83, 1.14). This was 
consistent for every individual trial and the overall analyses. (Table 1.1) 
Chronic Lung Disease:  
When defined as oxygen therapy at 28 - 30 days, reported for 1043 infants in six 
trials, did not show any significant difference between the HFOV and CV groups in the 
meta- analysis or the individual trials (RR 0.98 (95% CI 0.88, 1.10). 
When defined as oxygen or mechanical ventilation and the presence of an 
abnormal chest x- ray at 28-30 days of age, it was reported for 820 infants in four 
trials. Two trials, Clark 1992 (150) and Gerstmann 1996 (Clark et al., 1992, 
Gerstmann et al., 1996), showed a  significantly lower incidence of this outcome in the 
HFOV group and there was a trend towards a reduced incidence in the overall 
analysis (RR 0.86 (95% CI 0.74, 1.01). The meta-analysis showed significant 
heterogeneity (I2 = 71.3%) and a random effects model was used. The summary RR 
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was 0.66 (95% CI 0.41, 1.07). 
The combined outcome of mortality and CLD at 28 - 30 days was reported in five 
trials involving 1160 infants. Two trials showed a significant decrease of this combined 
outcome in the HFOV group (Clark et al., 1992, Gerstmann et al., 1996). There was a 
non-significant trend towards a reduced risk of ’death or CLD at 28- 30 days’ in the 
HFOV group in the overall analysis (RR 0.94 (95% CI 0.85, 1.04). 
When defined as oxygen requirement at 36 - 37 weeks PMA or at discharge in 
survivors, CLD was reported for 2369 infants in 15 trials. There was a significant 
decrease of this outcome in the HFOV group reported in 4 trials (Clark 1992, 
Gerstmann 1996, Durand 2001, Vento 2005)(Clark et al., 1992, Gerstmann et al., 
1996, Durand et al., 2001, Vento et al., 2005). The overall analysis had significant 
heterogeneity (I2 = 57%). Using a random effects model, meta-analysis gave a non-
significant summary RR of 0.85 (95% CI 0.70, 1.04). 
 Subgroup analyses 
The subgroup analysis by high volume strategy on HFOV: 
This analysis for CLD at 36 weeks, when done on 8 trials, 1216 infants, showed non 
significant RR 0.86 (95% CI 0.73, 1.00). Similar results were found in the subgroups of 
high volume strategy HFOV with target FiO2 < 0.30, on 6 trials,1066 infants (RR 0.93, 
95% CI 0.81, 1.06).  
The subgroup analysis by use of routine surfactant: 
 Only one small trial of 51 infants (Clark 1992) reported CLD at 36 weeks and did not 
use surfactant. This trial showed a significant reduction of CLD in the HFOV group 
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(RR 0.23, 95% CI 0.07, 0.73). Subgroup analysis of the other 14 trials involving 2318 
infants in which surfactant was used showed similar result to the overall analysis (RR 
0.91, 95% CI 0.82, 1.01). 
Overall, subgroup analysis of trials showed: 
- Significant reduction in CLD with HFOV when no surfactant was used (RR 0.23, 95% 
CI 0.07, 0.73). 
- Borderline significant reduction in the combined outcome of death and CLD in the 
HFOV group when piston oscillators were used for HFOV (RR 0.88, 95% CI 0.79, 
0.99). 
- When lung protective strategies for CV were not used, there was a significant 
reduction of death or CLD combined outcome with HFOV (RR 0.56, 95% CI 0.38, 
0.81). 
- When randomisation occurred at two to six hours of age, there was a significant 
reduction in death or CLD with HFOV (RR 0.79, 95% CI 0.68, 0.91). 
- When inspiratory:expiratory (I:E) ratio of 1:2 was used for HFOV, there was a 
significant reduction in death or CLD in the HFOV group (RR 0.87, 95% CI 0.77, 0.98), 
however not significant using random effects model (RR 0.81, 95% CI 0.63, 1.04). 
Pulmonary air leak 
Any pulmonary air leak was reported in 12 involving 2766 infants. In two trials, Thome 
1998(Thome et al., 1998) and Schreiber 2003(Schreiber et al., 2003), there was a 
significant increase in any air leak in the HFOV group (Thome : RR 1.38 (95% CI 1.01, 
1.89), Schreiber: RR 1.67, 95% CI 1.15, 2.43). Overall analysis of the twelve trials 
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shows a small but significant increase in the HFOV group (RR 1.19, 95% CI 1.05, 
1.34). 
Retinopathy of prematurity 
The ROP rate was reduced overall in the HFOV group. Significant ROP (grade 2 or 
more) was reported in 10 trials with 2364 surviving infants. The overall analysis 
showed a significant decrease in the HFOV group with no heterogeneity (RR of 0.84, 
95% CI 0.72, 0.97). (Cools et al., 2009)  
 
Short-term neurological morbidity 
All grades of IVH 
A total of 11 trials, involving 2996 infants reported all grades of IVH and showed no 
significant difference in the rate of IVH of all grades between the ventilation treatment 
groups in individual trials or in the overall analysis (RR 1.05, 95% CI 0.96, 1.15). 
Severe grades of IVH (3 and 4) 
This outcome was reported for 16 trials, 3625 infants. Two trials, the HIFI study (1989) 
that was published in 1989 and the trial led by Moriette published in 2001(Moriette et 
al., 2001), found increased rates of Grade 3 or 4 intra-ventricular hemorrhage (IVH) 
and periventricular leukomalacia (PVL). However, overall analysis of all trials showed 
no significant difference in the rates of more severe grades of IVH between the HFOV 
and CV groups (RR 1.11, 95% CI 0.95, 1.30). 
PVL (periventricular leukomalacia)  
PVL was reported in 15 studies, for 3539 infants. There was a non-significant trend 
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towards an increased rate of PVL with HFOV in the HIFI study  (RR 1.61, 95% CI 
0.99, 2.60). However, there was no significant difference in the overall analysis (RR 
1.10, 95% CI 0.85, 1.43). 
 
Long-term neurodevelopment was reported for seven studies: 
HIFI study (1989): Neurodevelopmental status was assessed at 16 to 24 
months corrected age in 77% of survivors using the 
Bayley scale and central nervous system examinations.  
The rate of moderate to severe abnormality was higher  
in the HFOV group (RR 1.28, 95% CI 1.02, 1.60).  The  
rate of cerebral palsy was 11% in both groups. (1990a) 
 
Ogawa (1993): One year follow-up showed no significant difference in motor 
and mental development. The method of neurological 
assessment was not given. 
Gerstmann (1996)  
 
Neurodevelopmental status was assessed at a mean of 6.4 
years for 87% of the infants. No significant difference in mean 
scores (Wechsler Scale for Children, Bruinink-Oseretsky 
motor test) was found between the two groups. 
Johnson (2002) - 
UKOS 
 
Neurodevelopmental outcomes were reported at 22 - 28 
months corrected age. They were based on paediatric report 
for 73% of survivors and on parent questionnaires for 49% of 
survivors. No significant differences between HFOV and CV 
	 99	
groups were found. 
Van Reempts 
(2003) 
Seventy infants in the HFOV group and 68 in the CV group, 
representing 57% and 51% respectively of survivors in the 
whole trial, were followed up at seven to twelve months 
corrected age (Bayley motor and mental developmental 
scale). There was no significant difference between the 
ventilation groups. 
Schreiber (2003) 168 survivors were followed up at two years of age (84 in 
each group). Data were available for 66 (78.6%) of those in 
the HFOV group and 72 (85.7%) in the CV group (Bayley’s 
Scales). There were no differences between the ventilation 
groups. 
Moriette (2001) Neuro-motor outcomes were assessed at the corrected age 
of two years in 192 of 212 survivors (90%) using a physician 
questionnaire. The risk of spastic cerebral palsy was 
significantly lower for infants ventilated with HFOV (4% 








Table 1.1, summary of the primary outcomes from the meta-analysis (Elective 
high frequency oscillatory ventilation versus conventional ventilation for acute 









Risk Ratio ( 95% CI) 
 
 






1.09 (0.88, 1.35) 
 
Mechanical ventilation at 28 -





1.08 (0.86, 1.35) 
 






0.98 (0.88, 1.10) 
 
CLD at 28-30 days (O2 and x-
ray changes) in survivors 
4 820 
 
0.86 (0.74, 1.01) 
 
Death or CLD at 28-30 days 5 1160 
 
0.94 (0.85, 1.04) 
 




0.98 (0.83, 1.14) 
 
CLD at 36-37 weeks PMA or 
discharge in survivors 
15 2369 0.89 (0.81, 0.99) 
Death or CLD at 36-37 weeks 
PMA or discharge 
15 2885 
 
0.90 (0.78, 1.03) 
 
Any pulmonary air leak 12 2766 1.19 (1.05, 1.34) 
Gross pulmonary air leak  10 1829 1.30 (0.99, 1.70) 
Intraventricular hemorrhage - 
 all grades  
11 2996 1.05 (0.96, 1.15) 
 
Intraventricular hemorrhage - 
grade 3 or 4  
16 3625 
 
1.11 (0.95, 1.30) 
 
Periventricular leukomalacia  15 3539 1.10 (0.85, 1.43) 
 
Retinopathy of prematurity 
 (grade 2 or more)  






Pulmonary function tests, symptoms and growth at follow-up 
HIFI trial:  
Pulmonary mechanics were determined during spontaneous breathing via a face 
mask or through the ET tube attached to the pneumotachometer in a small subgroup 
of patients (n=22 for CMV and n=21 for HFOV) during first four weeks of life. Values 
compared between groups were: trans-pulmonary pressure, compliance , resistance 
and flow-resistive work of breathing. No significant differences were found between 
the ventilation groups(Abbasi et al., 1991) 
A subgroup of patients from the HIFI study, 26 babies from the CMV group and 27 
babies from the HFOV group, had their respiratory flows determined by 
pneumotachygraphy, oesophageal pressure measured through a water-filled feeding 
tube, and functional residual capacity determined by N2 washout prior to discharge 
from the neonatal unit. At the time of testing their mean weight was 1830 +/- 340 and 
mean age was 68 +/- 24 days. There were no significant differences in lung function 
between the two treatment groups.(Gerhardt et al., 1989) 
Pulmonary function tests were performed in 43% of survivors from seven of the ten 
centres at nine months corrected age. There were no significant differences in 
respiratory function tests including compliance, resistance and lung volumes. There 
were no differences in the incidence of respiratory tract infections, hospital re-
admissions, respiratory symptoms and signs or in growth between the two groups. 
(1990b) 
Gerstmann 1996 : 
Follow up at a mean age of 6.4 years was done in 87% of the infants (n=33 for HFOV 
and n=36 for CV). They performed spirometry, plethysmography, single-breath 
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technique for measurement of carbon monoxide diffusion to determine lung diffusing 
capacity and alveolar volume. The ratio of alveolar volume (VA) to total lung capacity 
(TLC) was used as an index of maldistribution of inspired air. Patients initially 
randomized to CV showed decreased peak expiratory flow, increased residual lung 
volume, and increased maldistribution of ventilation.(Gerstmann et al., 2001) 
Additional subgroup analysis (2010) (Cools et al., 2010) 
Meta-analysis of individual patients’ data, of the trials identified for the Cochrane 
review, was done by the PreVILIG collaboration from 3229 participants in ten 
randomized controlled trials, with the primary outcomes of death or broncho-
pulmonary dysplasia at 36 weeks’ postmenstrual age, death or severe adverse 
neurological event, or any of these outcomes. 
Subgroup analysis was done on the basis of gestational age, birth weight, oxygenation 
index at the time of randomization, administration of antenatal steroids, chronological 
age at randomization, sex of the infant, presence of chorioamnionitis, and timing of 
first dose of exogenous surfactant from study entry. 
Pre-specified subgroup analyses were done by high-frequency ventilator type and by 
ventilation strategy both for HFOV (optimal lung volume strategy or not) and for 
conventional ventilation, to explore effects by trial characteristics. 
Relative risk of death or BPD at 36 weeks’ postmenstrual age for infants ventilated 
with HFOV was 0.95 (95% CI 0.88–1.03), and RR of death or severe adverse 
neurological event was 1.00 (0.88–1.13). No subgroup of infants described above 
benefited more or less from HFOV as opposed to CV. This treatment effect did not 





The United Kingdom Oscillation Study (UKOS) uniquely tested the hypothesis that the 
mode of ventilation in the first hour after birth in extremely prematurely born infants 
would affect outcome. It was a multi-centre, randomised trial. The infants were 
randomised within one hour after birth to either CMV or HFOV. 
 Eight hundred and seventy infants underwent randomization between August 1998 
and January 2001. Eight hundred and four were subsequently enrolled in the trial, and 
data from 797 were analyzed. All infants were born at less than 29 weeks of gestation. 
High volume strategy was used in the HFOV arm.  
Infants who were randomly assigned to either ventilation group received ventilation for 
a median of 7 days (range 3 to 21 days for HFOV and 2 to 20 days for CV, p=0.58). 
Infants received HFOV for a median of three days (interquartile range 1 to 6 days), 
since the majority was switched to conventional ventilation for weaning.  
There were no significant differences between groups in the primary outcome (death 
or BPD) or the secondary outcomes (serious brain injury and air leak). There were no 
differences in oxygen requirement at term between the two groups (41 percent HFOV 
vs. 39 percent CV, p=0.54). There was  no difference in the use of postnatal systemic 
corticosteroids for weaning from the ventilator (31 percent in HFOV group vs 28 
percent in CV group, p=0.37).  
The incidence of serious abnormalities on cranial ultrasound (parenchymal bleeding, 
ventriculomegaly or parenchymal cysts) was lower in the HFOV group but not 
significant after Bonferorni  correction (uncorrected p=0.04, Bonferroni-corrected 
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p=0.44). There were no differences in the rates of retinopathy of prematurity or 
hearing loss between the ventilation groups.(Johnson et al., 2002)    
Pulmonary function was measured in a subgroup of 76 infants at 11-14 months of age.  
Functional residual capacity was measured by whole-body plethysmography 
(FRCpleth), inspiratory and expiratory airway resistance (Raw) by plethysmography 
and functional residual capacity measured by helium dilution (FRCHe).  No differences 
in the lung function results were demonstrated between the two groups but of note, 
small airway function was only assessed by assessment of FRCHe: FRCpleth (Thomas 
et al., 2003, Johnson et al., 2002).  
Despite the initial results that showed no difference in primary outcomes, the UKOS 
cohort provides a unique opportunity to test the hypothesis that HFOV, when used 
optimally, protects small airway function and whether it has any other advantages or 





At school age, it is possible to obtain more reproducible measurements of forced 
expiratory flows. Small airway function can be assessed by spirometry (FEF25-75), the 
forced oscillation technique and the multiple breath washout technique. Multiple breath 
washout technique would assess the degree of ventilation maldistribution known as 
lung clearance index (LCI). 
Small airway function will be assessed by spirometry as an indirect measure of airway 
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resistance. It is regarded as an invaluable screening test of respiratory health (Miller et 
al., 2005b).  Spirometry is a physiological test that measures the volume or flow of air 
as a function of time during inhalation and exhalation. It has been the gold standard of 
lung function measurement for several decades and it is invaluable as a screening test 
of general respiratory health. It requires forced inspiratory and expiratory manoeuvres 
and therefore a high degree of cooperation from the child.(Miller et al., 2005b)  
Reference ranges for school age children of 11-12 years of age, the age of UKOS 
children at the time of assessment, have been well established (Rosenthal et al., 
1993a).  
Direct assessment of small airway resistance will also be done by impulse oscillometry 
(IOS). It has greater sensitivity to peripheral airway disease than spirometry (Skloot et 
al., 2004). It relies on the frequency dependant distribution of oscillatory pressures 
within the airway tree and hence assesses large and small airways separately (Farré 
et al., 1999). Several studies evaluated the sensitivity and specificity of IOS 
parameters to quantify changes in airflow obstruction in comparison with forced 
expiratory volume in the first second (FEV1) and peak expiratory flow (PEF) 
measurements and found better sensitivity and specificity of impulse oscillometry 
measurements (Vink et al., 2003, Song et al., 2008, Marotta et al., 2003). 
 
Inhomogeneity of ventilation distribution, which reflects small airway function, will be 
assessed by the multiple breath technique to determine lung clearance index (LCI). 
LCI reflects abnormalities of the smaller airways (Davies et al, 2008). It is a sensitive 
indicator of small airway function and is derived from Multiple Breath Washout (MBW) 
tests. The test involves following the washout of an inert tracer gas from the lungs 
during relaxed tidal breathing.  Tracer gas must first be washed into the lungs to 
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equilibrium, it should be inert and neither absorbed nor excreted by the body to any 
significant degree.  With each successive breath of the washout, there will be a fall in 
the peak concentration of exhaled tracer gas. 
A multi breath washout with ultrasonic flow sensor using 4% hexafluoride (SF6) as 
tracer gas, was used for this thesis. The technique has been verified using the gold 
standard, mass spectrometry, demonstrating close agreement of measurements 
(Fuchs et al, 2006)(Horsley et al., 2008, Pillow et al., 2004).  
We have considered carefully the choice of the inert gas, as this has important 
implications for the performance and interpretation of the LCI test. Three different 
tracer gases have been used and described in the literature: SF6, N2 and He. These 
gases have significantly different molar mass. SF6 is a heavy gas and behaves 
differently than N2 and He, which are lighter. (Gustafsson et al., 2003) Also, N2 is an 
endogenous gas and, therefore, there is a greater contribution of gas from very slowly 
ventilated units. This is evident from the greater difference in SF6 method measured 
LCI and N2 method measured LCI in subjects with significant air trapping, as shown in 
some recent studies (Nielsen et al., 2013, Jensen et al., 2013). In subjects with 
uneven ventilation (ventilation inhomogeneity), the washout time for N2 is increased in 
comparison to SF6, as it takes longer to clear the endogenous tracer gas from the 
slowly ventilated units. (Gustafson 2003) The longer washout time may limit the 
feasibility of the N2 method in paediatric population. The SF6 method was expected to 




Another important point is that nitrogen washout method uses 100% oxygen, which as 
a bronchodilator and pulmonary vasodilator, could have potentially influenced 
subsequent lung function tests and pulmonary pressures measurements by ECHO.    
A study by Nielsen and co-workers has shown that there is a significant difference 
between the LCI measured by SF6 and He, as exogenous gases, and N2 as an 
endogenous gas. This can potentially be due to washout of endogenous tracer gas 
from poorly ventilated lung units, effects of body nitrogen from different tissues or use 
of pure oxygen during washout. (Nielsen et al., 2013, Robinson et al., 2013) 
Large airway function will be assessed by spirometry and by impulse oscillometry.  
Airway hyperactivity will be assessed by cold air bronchial challenge tailored to the 
child’s baseline lung function. The baseline lung function (FEV1), will be measured 
prior to the bronchial challenge. To demonstrate the reversible flow limitation of the 
airways, it is necessary to measure the response to broncho provocation and broncho 
dilatation using spirometry. If the FEV1 decreases significantly, the test is considered 
to be positive.(Filuk et al., 1989) 
Cooling and drying of the airways are the main factors that trigger airway obstruction 
during exercise.(Strauss et al., 1977) Theoretically, bronchospasm is induced by water 
loss from the airways and by cooling of the airways. The water loss increases 
osmolality in the cells that line the airways, which induces release of certain 
mediators. Cooling induces rapid re warming, which causes reactive hyperaemia and 
oedema.(Anderson and Smith, 1991)   
There are two ways of conducting a cold air challenge, the isocapnic hyperventilation 
cold air challenge and cold air challenge during exercise. In the isocapnic 
hyperventilation, subfrigid dry air is administered while the patient hyperventilates at 
	108	
70% of their MVV (maximal voluntary ventilation) for three minutes, without exercise. 
The reasons for using this test as opposed to an exercise test were: 
1) Increased ventilation appears to be the primary trigger of exercise induced   
    broncho spasm. 
2) The test is standardized for everyone and is highly quantifiable.  
3) It is safer than exercise. It is also possible to perform by children with cerebral 
palsy, for whom exercise might be difficult. 
 
Atopy needs to be excluded as a contributory factor and was assessed by using skin-
prick testing and the family history. Exhaled nitric oxide (FeNO), as a biomarker of 
eosinophillic infiltration, will be measured using an online method to assess the degree 
of underlying airway inflammation. High levels of endogenous nitric oxide (NO) in the 
exhaled breath have been found in children diagnosed with asthma when compared to 
healthy controls (Byrnes et al., 1997, Lundberg et al., 1996) and in adults suffering 
from COPD when compared to unaffected individuals.(Maziak et al., 1998) 
 
Lung volumes and the degree of hyperinflation will be assessed by plethysmography 
and helium dilution. Determining total lung capacity, functional residual capacity and 
residual volume will allow identification of the degree of restrictive lung disease or air 
trapping differences between the two groups of children assessed in this thesis.   
Plethysmographic measurements of lung volumes are based on Boyle’s Law, which 
states: when a constant mass of gas is compressed or decompressed, under 
isothermal conditions, the gas volume decreases or increases and gas pressure 
changes in a way that the product of volume and pressure at any given moment is 
constant. Helium dilution is a method for measuring lung volumes based on the 
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equilibration of gas in the lungs with a known volume of gas containing helium (Coates 
et al., 1997).  
 
The degree of alveo-capillary membrane damage, by measuring the total lung gas 
transfer, alveolar volume and gas transfer per unit volume, will be assessed by the 
single breath carbon monoxide uptake method, which has reference ranges for school 
age children. (Rosenthal et al., 1993b)  With the (CO) uptake single breath method the 
diffusing capacity of the lungs is measured. However, it is important to recognise that 
CO uptake will depend on number of processes. It will be affected by distribution of 
ventilation, determined by small and large airway obstruction, and the result of the 
test, calculated DLCO, will primarily reflect the properties of alveo-capillary membrane 
of the ventilated regions.(Macintyre et al., 2005) 
Maldistribution of the inspired volume due to small airway changes can significantly 
influence alveolar volume measurements obtained by single breath method, hence 
comparison of alveolar volume measurements obtained by gas transfer with total 
thoracic gas volume obtained by plethysmography will indicate the degree of small 
airway obstruction (Brusaco et al, 2005). 
 
There are a number of possible influences on lung function including passive/active 








School aged children, born extremely prematurely, who received high frequency 
oscillation rather than conventional ventilation in the neonatal period, would have 
better small airway function. 
 
Children born extremely preterm would have higher pulmonary pressures when 
compared with the term born children of the same age. 
 
Children born prematurely  would have worse lung function when compared with the 




1) To assess the difference in small airway function between the two 
ventilation groups of preterm children 
2) To assess the difference in large airway obstruction between the two 
ventilation groups 
3) To assess the differences between ventilation groups in alveo-capillary 
membrane function  
4) To assess differences in pulmonary pressures and the degree of pulmonary 
hypertension between the two ventilation groups. 
5) To compare the pulmonary pressures of preterm children with those of term 
children. 
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1) To compare the measurements of small airway function (FEF75 obtained by 
spirometry, R5Hz obtained by impulse oscillometry and LCI measurements), 
large airway function (FEV1, FEV1/FVC ratio obtained by spirometry and 
R20Hz obtained by impulse oscillometry) and measurements of the alveo-
capillary membrane function (the DLCO and KCO obtained by gas transfer) 
between the two ventilation groups. 
2) To compare the above listed lung function results between term and 
preterm children. 
3) To compare the peak and mean pulmonary pressures, obtained by 
echocardiography, between the two ventilation groups.  





















The UKOS follow up study was approved by National Research Ethics Service, South 
West London REC 3 on the 18th October 2010. The ethics committee additionally 
approved the echocardiography assessment of pulmonary hypertension in the preterm 
group of children as an amendment 1 (May 2011) and the term children control group 
recruitment as an amendment 2 (May 2013). (Appendix 2) Please also see 
declarations for protocol design acknowledgments.  
 
2.2. Protocol summary (in the order of assessments) 
 
1) Clinical History, targeted to assess if the child was fit to have lung function 
measurements. It was important to exclude on going or recent (within last 2 
weeks) lower respiratory tract infection.  Use of inhalers, beta-agonist and/or 
steroids and oral steroids, use of other medication, history of atopy were 
recorded. 
2) Measurements of oxygen saturation, haemoglobin, blood pressure, height and 
weight 
3) Lung function measurements were performed in the following order: 
1) Oscillometry  
2) Exhaled Nitric Oxide  
3) Spirometry  
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4) Multibreath washout technique  
5) Gas transfer  
6) He dilution  
7) Plethysmography  
8) ECHO 
9) Skin prick testing 
10) urine sample for level of cotinine 
11) Cold air challenge/bronchodilator  
12) Repeat spirometry to assess BHR  
Three types of questionnaires were given to the family: parental questionnaire, 
children’s questionnaire and teacher’s questionnaire. The parental and children’s 
questionnaires were posted back by the parents. The teacher’s questionnaires were 
posted back by the teachers. 
Term born children undertook the same assesments apart from : FeNo, LCI, cold air 
challenge and skin prick tests. This was due to the time constraints of the recruitment 
period for term children.  
 
Exclusion factors: children with significant lung and heart congenital abnormalities, 
malignancies and clinically significant scoliosis were excluded from the analysis. For 
detailed description of excluded cases please refer to the relevant results chapters. If 
a child had a current or recent (within two weeks) lower respiratory tract infection, lung 




Measurements of height, weight and blood pressure were done prior to lung function 
testing. The following equipment was used: 
Height: Marsden HM-250P Leicester Height Measure 
Weight: Seca 761 Class IIII Approved Weight Scale 
Blood pressure: WelchAllyn vital signs monitor with paediatric blood pressure cuff of 
appropriate size. 
Measurement of weight and height were performed with the child wearing light 
clothing, without shoes. All measurements (weight, height, blood pressure) were 
repeated twice, mean measurements were recorded and entered into the computer 
program. 
Gases used in the study were supplied by BOC (British Oxygen Company): 
• 10%He and air (Helium dilution) 
• 0.28% CO, 9%He, 19% O2 and N2 (single breath gas transfer) 
• 5%Co2 and dry air (cold air challenge) 
Innocor Rebreathing Gas - 94% O2, 5% N2O, 1% SF6 was used for LCI measurement 







Impulse oscillometry is a technique used to measure resistance of the bronchial tree 
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by superimposing small external pressure signals on the spontaneous breathing. 
It measures Zrs (respiratory impedance) as a function of frequency (f), allowing the 
recognition of characteristic respiratory responses at different oscillation 
frequencies.(Oostveen et al., 2003)  
Zrs is described as resistance (Rrs) and reactance (Xrs). The resistive component of 
respiratory impedance, Rrs, includes proximal and distal airways (central and 
peripheral), lung tissue and chest wall resistance. Resistance and Reactance are 
measured in cmH2O/L/s or KPa/L/s. The Resonant Frequency (Fres) is the point at 
which reactance is zero and is measured in Hertz (1/s). As a part of our protocol, Rrs 
was recorded at 5Hz and 20 Hz, representing the small and large airway resistance 
respectively. (Vink et al., 2003, Marotta et al., 2003) 
As it requires only stable tidal breathing, impulse oscillometry minimizes demands on 
the patient and requires only passive cooperation of the child (maintenance of an 
airtight seal of the lips around a mouthpiece and breathing normally through the 
measuring system with a nose-clip on and a parent providing the support for the 
cheeks if necessary). 
Oscillometry uses external multi-frequency forcing signals. The impulse oscillation 
method applies aperiodic waveforms using an impulse generator, producing pressure 
pulses of limited magnitude and 30–40 msec in duration.  A pressure–flow transducer 
measures inspiratory and expiratory flow and pressure, which are then separated from 
the breathing pattern by “signal filtering”. Measured Zrs is the sum of all the forces 
(Rrs and Xrs) opposing the pressure impulses (oscillations) and is calculated from the 
ratio of pressure and flow at each frequency. Therefore, IOS measures Rrs and Xrs 
from input Zrs measurements, made over a range of frequencies. 
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Aperiodic waveforms result in continuous spectrum after transformation of its time 
course into the frequency domain, using a Fourier integral in the fast Fourier 
transformer (FFT).  The IOS system records 5 impulses (5 impedance spectra) per 
second. Impulse power spectra of pressure and flow generated by the impulse 
oscillometry system (IOS) are shown over a frequency range of 0.1–35 Hz. The 
energy distribution provides practical assessment of low (5 Hz), as well as high (20 
Hz) frequency ranges.(Oostveen et al., 2003) 
Interpreting	the	results	from	impulse	oscillometry:	
 
The use of multiple oscillation frequencies during IOS permits a differentiation of large 
airway function from that of peripheral small airways. Sound waves at frequencies less 
than 15 Hz travel more distally and those of more than 20 Hz are damped out in the 
intermediate sized airways. 
The site of airway obstruction is inferred from the pattern of Rrs, as a function of 
oscillation frequency. Proximal airways obstruction elevates Rrs evenly independent of 
oscillation frequency (Figure 2.1). In distal airways obstruction, Rrs is highest at low 
oscillation frequencies and falls with increasing frequency. Therefore, the resistance at 
5 Hz (R5) will reflects resistance in the small airways, and the resistance at 20 Hz 
(R20) represents the resistance of the large airways. (Oostveen et al., 2003) 
In IOS, the quality assurance is measured by “coherence”, which is an index of the 
validity of the results. The coherence function is defined as the square of the cross-
power spectrum divided by the product of the auto-spectra of pressure and flow at any 
forcing frequency. It is a value between 0 and 1 that reflects the reproducibility of 
impedance measurements.(Oostveen et al., 2003) 
	118	
Miller and Pimmel (Miller and Pimmel, 1983) showed that estimated variance of 
calculated impedance is a function of coherence and the number of estimates 
averaged. Three replicate measures require coherence 0.9 to yield an estimated 
standard error of 10%. In contrast, IOS commonly includes the average of 100 
separate FFT analyses and, accordingly, requires less perfect coherence for the 
average data to provide an estimated standard error of 10%. For clinical purposes it is 
recommended to use a coherence value of 0.6 at 5 Hz for the acceptance threshold, 
provided that at least 100 FFT analyses are averaged, which is equal to minimum of 
20 seconds of recording. (Frei et al., 2005) 
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Figure 2.1. IOS recording from a study participant showing 3 separate recordings of 90 sec 
tidal breathing. The lower part of the figure is showing airway resistance over range of 
frequencies (5-35 Hz). The resistance is evenly elevated across the frequencies, consistent 
with large airway obstruction. 
 
Equipment: 
The Jaeger MasterScreen IOS system (Carefusion UK) was used which consists of 
the measuring-head and connectors: the loudspeaker enclosure is at the top, 
connected to a y-adaptor at one upper arm, an exit for flow with terminal resistor at the 
second upper arm and a lower arm connected to the pneumotachograph. A 
mouthpiece is connected to the open side of the pneumotachograph. Pulsatile flows 
are generated by the loudspeaker, part of it exits through the terminal resistor and part 
of it flows through the pneumotachograph and mouthpiece. The patient’s respiratory 
flow goes from the mouthpiece through the Y-connector, exiting through the terminal 
resistor. The resistance of the terminal resistor is 0.1 kPasL-1 and the dead space of 
the Y connector/pneumotachograph/mouthpiece is ~70 mL . 
Calibration of the IOS system:  
The IOS system was calibrated daily prior to testing using a three-litre calibrated 
syringe to deliver a spectra of flows between 0.5 and 12 L/s.   
The strokes were applied manually prior to starting of the tests each day. 
Volume accuracy within ±3.5% at each flow was considered appropriate.  The 
calibration syringe was stored in the same temperature and humidity conditions as the 
testing sight, kept close to the IOS but away from sunlight and other heat sources.  
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Leaks were checked for daily by applying a continuous positive pressure of 3.0cmH2O 
(0.3 KPa) with the outlet of the spirometer occluded (IOS measuring head). Any 
volume loss observed beyond 30mL after one minute was taken as an indication of a 
leak. 
Volume calibration over entire volume range of the spirometer (0-8 L), for the IOS 
measuring head, was performed every 3 months, using a calibrated syringe. The 
measured volume was accepted within 3.5% of the reading or 65 mL whichever was 
greater (Figure 2.2). This limit includes the 0.5% accuracy limit for a 3-L syringe.  
The calibration syringe was stored and used in the same temperature and humidity as 
the spirometer, on the testing site, out of direct sunlight and away from heat sources 
 
 
Figure 2.2, example of volume linearity of the IOS measuring head pneumotachometer, 
























Syringe volume (L) Measured volume (L) Error (L) Error (%) 
1 1.02 0.02 2.00 
2 2.02 0.02 1.00 
3 3.04 0.04 1.3 
4 4.05 0.05 1.25 
5 5.08 0.08 1.6 
6 6.04 0.04 0.67 
7 7.11 0.11 1.6 
 
Table 2.1, Measured volume versus syringe volume for the IOS system 
measuring head  
 
Measurement 
The measurement was performed as follows: while the patient spontaneously 
breathes ambient air via the tubing between mouthpiece and terminating resistor, the 
loudspeaker generator transmits brief pressure impulses via Y-adapter, 
pneumotachograph and mouthpiece into the respiratory tract; the pneumotachograph 
and pressure transducer register the composite signals containing breathing activities 
and the impulse signal for further processing.(Oostveen et al., 2003)  
 
Oscillometry was performed as the first test, to avoid any potential changes to airway 
resistance caused by forced respiratory manoeuvres.  
 
• The mouthpiece was supported at a position which ensures maintenance of a 
neutral relaxed head and neck posture, avoiding body postures that might 
affect Zrs.  
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• Children were seated in an appropriately sized chair, which comfortably 
supported their legs and were advised not to cross their legs, which requires 
abdominal muscle contraction that may lead to end-expiratory lung volumes 
below relaxation volume.  
 
• Children were talked through the whole length of the procedure to keep them 
comfortable and relaxed to maintain a constant body position without muscular 
effort.  
 
• Firm contraction of the facial muscles was necessary to support airtight closure 
of the lips around the mouthpiece and this was explained to the child. The 
parent supported cheeks if child needed help with maintaining the airtight seal 
around mouthpiece. 
 
• The tests were performed in a quiet examination room, to keep the subject 
relaxed and to facilitate normal tidal breathing.  
 
• The operator reviewed each test immediately to ensure adequate recording 
time free of artefacts (any deep breaths or leak); a minimum of 20 s of 






Minimum of three technically acceptable tests, of 20–30 s duration of stable tidal 
breathing or longer, were analysed.  
We used a coherence value of 0.6 at 5 Hz for the acceptance threshold. 
The results were recorded as percentage of predicted values for age and 
weight.(Nowowiejska et al., 2008) Two measurements within 10% were accepted as 
reproducible for resistance at each of 5Hz and 20 Hz, presuming that there was an 
acceptable coherence value of 0.6 and stable tidal breathing without interruption had 
been achieved for a minimum of 20 seconds.(Oostveen et al., 2003, Frei et al., 2005)  
 
2.3.2. Exhaled Nitric oxide measurement  
 
 
Online measurement refers to exhaled NO testing in real time, as opposed to offline 
testing which refers to collection of exhalate and delayed analysis. FENO is expressed 
in parts per billion (ppb), which is equivalent to nanoliters per liter (nl/L).  NO output 
represents the rate, that is the amount of NO exhaled per unit time, and it is denoted 
by VNO.  It is calculated from the product of NO concentration in nanolitres per litre and 
expiratory flow rate in litres per minute: 
VNO  = [NO] x airflow rate 
nl/min     nl/L x L/min 
 
Equipment:  
Fractional exhaled NO (FENO) was measured with an online method (Hypair FeNO, 
Medisoft Cardio-respiratory Instrumentation, Sorinnes, Belgium) using a computerised 
system and following the ATS recommendations (1999).  
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The system used a thermal mass flow meter with the On-Line NO Breath Kit for direct 
measurement of exhalation flow rate. 
Use of the On-Line NO Breath Kit accommodated flow rates from 30 to 250 mL/sec, to 
meet the American Thoracic Society’s (ATS) and the European Respiratory Society’s 




The calibration kit included an air filter, the calibration gas, and a low flow regulator. 
Cylinder of 45 ppm NO in N2 provided NO calibration gas for the upper point 
calibration. 
The air filter, that removed NO from ambient air, provided a clean (<1 ppb nitric oxide) 
air source for calibration. 
Accuracy	of	the	exhaled	NO	system	gas	analyser	
 
The accuracy of the electrochemical NO analyser cell was assessed using certified 
calibration gas cylinders with 4 different NO concentrations (0, 33, 66, and 112ppb).  
Each cylinder was connected to the analyser in turn using a dedicated calibration inlet 
valve and the measured values displayed.  In each case the error was less than 2ppb 
and the analyser was linear across the range (Figure 2.3). 
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Figure 2.3, accuracy of the exhaled NO gas analyser 
 
Cylinder NO concentration 
(ppb) 






0 0 0 0 
33 34.2 1.2 3.64 
67 68.6 1.6 2.39 
112 112.5 0.5 0.45 
 
Table 2.2, values measured during gas analyser calibration of the FeNO 
system 
Daily calibrations were performed, using the zero NO gas and one other concentration 
in the expected range of sample values. 
Ambient conditions were maintained stable and the equipment was kept in the same 
room, avoiding variations in temperature and humidity.  



























The accuracy of the Hypair FeNO system flow sensor was assessed by comparing the 
measured volume to the certified volume supplied by calibration syringes with a 
stroke-volume in the range of 1-7 litres.  Three strokes were applied manually from 
each syringe using a steady motion and the mean value plotted (Figure 2.4).  In each 
case the error was 2.8% or less and the device was linear across the range. 
 
 
Figure 2.4, volume calibration of the FeNO system using a calibrated syringe with a range of 
volumes 1-7 L 
	
Syringe volume (L) Measured volume (L) Error (L) Error (%) 
1 1.03 0.03 2.81 
2 1.99 -0.01 -0.71 
3 2.97 -0.03 -0.87 
4 4.01 0.01 0.15 
5 4.97 -0.03 -0.65 
6 5.94 -0.06 -0.94 
7 7.01 0.01 0.08 
	

























Exclusion of nasal nitric oxide 
 
Nasal NO levels are relatively high in comparison to the lower respiratory tract. This 
nasal NO can enter the oral expiratory air via the posterior nasopharynx. (Alving et al., 
1993, Kimberly et al., 1996) Closure of the velo-pharyngeal aperture during exhalation 
is one way to minimize nasal NO. Exclusion of nasal nitric oxide was achieved by 
exhaling against expiratory resistance with a positive mouthpiece pressure, which 
closed velo-pharyngeal aperture during exhalation. Constant expiratory flow rate was 
achieved by exhaling against a fixed resistor with real-time visual feedback, to 
maintain the expiratory flow within 10% of the desired value for duration of the 
measurement phase. Mouth pressure was maintained at 20 cmH2O throughout the 





Figure 2.5, picture showing an exhaled NO measurement being performed. Child is exhaling 
steadily into the breathing circuit against a fixed resistor with real-time visual feedback to 
maintain the expiratory flow within 10% of the desired value for duration of the measurement 
phase and following the animation shown on the screen. Child is not wearing the nose clip. 
(Picture shown with parental permission) 
 
Standardization of exhalation flow rate 
 
FENO result varied significantly with the flow rate due to variation of airway NO 
diffusion with transit time in the airway.(Silkoff et al., 1997, Högman et al., 1997) 
Therefore, standardization of exhalation flow is critical for obtaining reproducible 
measurements. Low flow rates (0.1 L/s) amplify the measured NO concentrations. 
However, lower flow rates result in longer exhalation times to reach an NO plateau 
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and the prolongation of the exhalation may be uncomfortable for some children. 
Therefore, the current ATS recommendation (American Thoracic Society guideline 
(1999)) were followed and target flow of 50 ml/sec for at least 2 sec was maintained 
using a software animation. 
 
Every effort was made to avoid the potential confounding factors that FENO level can 
be influenced by (1999): 
 
• Respiratory manoeuvres  (hence spirometry was not done before FENO 
measurements 
• Bronchodilatation  (timing of administration of a bronchodilator was 
documented and bronchodilator challenge was not given until the FENO 
measurements had been undertaken) 
• Certain food and beverages, such as green vegetables and lettuce can 
increase the level of exhaled NO.(Byrnes et al., 1997) Parents were advised to 
refrain from offering children food or drinks one hour before the test. Timing of 
last meal was noted and refreshments were only offered after FENO had been 
measured. 
• Smoking (urinary cotinine analysis was undertaken), as cigarette smoke can 
reduce level of NO in the exhaled breath (Robbins et al., 1997) 
• Infection (URTI and LRTI symptoms were recorded) 
• A nose clip was not used because this may allow nasal NO to accumulate 
• The child remained comfortably seated, breathing room temperature air    
      5 min before the test to acclimatize to laboratory conditions.  
• The child inserted the mouthpiece and inhaled NO free air through the     
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           mouth, to total lung capacity (TLC) over 2-3 sec 
• The child exhaled through an expiratory resistor at a constant rate of 50 ml/s 
until at least a 2-s NO plateau has been achieved and exhalation has lasted for 
at least 4 s. 
• Repeated exhalations were performed until three NO plateau values agreed at 
the 10% level and the mean of three performed NO values was recorded. 





Three technically satisfactory measurements within 10% of each other were obtained; 
the mean of the three was then recorded. 
 
 
2.3.3. Multibreath washout technique (MBW)    
 
Lung clearance index (LCI) is a physiological test that measures ventilation distribution 
in the lungs, and it is used as a marker of small airway disease. LCI reflects 
differences in small airway ventilation between well and poorly ventilated lung 
regions.(Horsley, 2009) 
Multiple breath inert gas wash-out technique (MBW) has been described as a 
sensitive measure of small airway disease in children with cystic fibrosis  
(Aurora et al., 2005). Spirometry is the commonest method of assessing lung function 
where diseases, such as cystic fibrosis, cause obstruction of larger airways and 
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eventually result in reduced expiratory flows and volumes. However, spirometry 
measurements are often normal in the early stages of peripheral airway disease, and 
therefore changes in the peripheral airways cannot be detected by spirometry until the 
disease has progressed considerably. Peripheral airway disease affects the way air 
mixes within the lungs and therefore leads to increased ventilation inhomogeneity. 
 
Description of equipment and technique 
 
In this study, Innocor (Innovision) Multi Breath Washout system was used. 
Ventilation inhomogeneity was assessed using the multiple-breath washout (MBW) 
test performed by washing out a previously washed-in tracer gas from the lungs, 
during tidal breathing of room air. From this test Functional Residual Capacity (FRC) 
was determined and the Lung Clearance Index (LCI) calculated.  
Composition of the gas used: Innocor Rebreathing Gas - 94% O2, 5% N2O, 1% SF6 
The gas used as the tracer gas (SF6) is an inert gas, with low water solubility, and 
zero lung tissue absorption is assumed.  
The LCI measurement has a wash-in and a wash-out phase. It starts with normal tidal 
breathing, for wash-in of a small amount of SF6. When an even concentration of SF6 is 
obtained in the lungs (inspiratory and expiratory SF6 concentrations differed by 
<0.004%), the child is disconnected from the bag (by the operator, who presses the 
wash out button on the screen) and the multiple-breath washout starts. The child 




Calculation of FRC: 
Calculation of the FRC with the SF6 MBW method is based on a single-alveolar lung 
model. 
The total systemic volume is defined as: 
 
Vs,tot = VL + Vds + Vds,rb + Vrb  
 
Vs,tot = Total systemic volume 
VL = Lung volume at the end of an expiration 
Vds = Dead space volume of rebreathing valve (RVU) 
Vds,rb = Residual volume of bag when empty 
Vrb = Volume of rebreathing bag 
 
During the rebreathing / wash-in period the concentration of insoluble gas (SF6) 
decreases from the initial value in the bag (F 0) to a final equilibrium (F) value 
practically obtained after approximately 10 breaths. Since the volume of the 
rebreathing bag is known, the total systemic volume can be determined from the 
dilution of the insoluble gas. 
The total systemic volume, is the volume at the time “zero”. Time “zero” is defined as 
the middle of the first inspiration. This volume is difficult to measure directly since the 
volume measurements require the insoluble gas to be perfectly mixed. At the time 
zero this is not the case. Therefore the volume is determined by back extrapolation by 
drawing a straight line through the expiratory points of the insoluble gas where 
adequate mixing is obtained. The insoluble gas concentration at time “zero” is then 
determined as the point where the extrapolated line crosses time “zero”. 




Vs,tot = Total systemic volume 
Fi 0 =  Initial concentration of insoluble gas in the rebreathing bag 
Fi,eq = Equilibrium concentration of insoluble gas (back extrapolated to t = 0) 
Vrb = Volume of rebreathing bag 
 
The Functional Residual Capacity (FRC) is defined as the gas volume in the lungs at 
the end of expiration. 
The FRC can be determined by the equation 
 
 
Functional residual capacity (FRC) is calculated from multiple breath washouts from 
the starting end-tidal fraction of tracer gas (CInit), the final fraction of tracer (CEnd), and 




LCI is then defined as the cumulative expired volume after performance of the test. 
(CEV), divided by the FRC:   
 
LCI=CEV/FRC 
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A typical SF6 curve from a rebreathing / wash-in manoeuvre is shown in figure 1.4.1-2. 
 
 
Figure 1.4.1-2 Insoluble gas concentration during rebreathing. 
 
 
The total systemic volume is not constant during a rebreathing and wash-in manoeuvre. Initially the 
volume increases due to a constant oxygen uptake and an increased excretion of carbon dioxide. 
As the carbon dioxide quickly builds up in the lungs and bag, the gradient between the alveolar and 
capillary (mixed venous) CO2 concentrations falls. This decreases the carbon dioxide excretion. 
The oxygen uptake is still constant. The result is therefore shrinkage in the total systemic volume. 
 
The total systemic volume, referred to in this document, is the volume at the time “zero”. Time 
“zero” is defined as the middle of the first inspiration. This volume is difficult to measure directly 
since the volume measurements require the insoluble gas to be perfectly mixed. At the time zero 
this is not the case. Therefore the volume is determined by back extrapolation by drawing a straight 
line through the expiratory points of the insoluble gas where adequate mixing is obtained. The 
insoluble gas concentration at time “zero” is then determined as the point where the extrapolated 
line crosses time “zero” - see figure 1.4.1-2 (Fi,eq). 
 







FV ⋅=  
where 
Vs,tot = Total systemic volume 
Fi0 = Initial concentration of insoluble gas in the rebreathing bag 












July 2013 COR-MAN-0000-008-IN, A/3 5 
 
Example: Total systemic volume 
 
How to calculate the total systemic volume from the data in figure 1.4.1-2: 
 
The following data is assumed: 
VRB = 1.0 l 
PB = 763 mmHg 
ta = 23 °C 
RH = 24% 
 
Data from figure 1.4.1-2: 
 
Initial concentration of SF6 in the rebreathing bag, Fi0 = 0.221% 
Equilibrium concentration of SF6, Fi,eq = 0.056% (back extrapolated to t = 0) 
  








tots, ⋅=  
 
where 





0.221(ATP)V tots, =⋅=  
 





























1.4.2 Functional Residual Capacity (FRC) 
 
The Functional Residual Capacity (FRC) is defined as the gas volume in the lungs at the end of 
expiration.  
 
The FRC can be determined by the equation from section 1.4.1: 
 
)(
,, dsrbdsrbtots VVVVFRC ++−=
 
 
When BTPS, STP and STPD conditions are used the equation becomes: 
 
 FRC(BTPS) = [Vs,tot(STPD) – (Vrb(ATP)+Vds,rb(ATP)) · C1] · C2 – Vds(BTPS) 
where 
 Vs,tot = Total systemic volume, STPD 
 Vrb = Volume of rebreathing bag, ATP 
Vds = Dead space volume of rebreathing valve (RVU), BTPS (containing expired air) 
Vds,bag = Residual volume of bag when empty, ATP 
 C1 = onversion from ATP to STPD, see section 1.6.3. 




Calibration of LCI (Innocor) system: 
 
All calibrations were performed once a day, before starting the tests. Ambient data 
were entered daily, prior to calibration. Equipment was kept in the Safe ambient 
operating temperature range from 18-23 °C and recommended humidity below 90%. 
The device was kept on a flat, horizontal and solid surface. Excessive heat, dust and 
direct sunlight was avoided. Calibrations included: flow-meter calibration, calibration of 
the flow-gas delay and oxygen calibration. 
Flow-meter calibration 
This was done by connecting a 1 liter calibrated syringe to the re-breathing valve and 
filling and emptying of the syringe through three different flow rates. Five strokes were 
done at slow, medium and fast flow rate in order to cover the physiological range of 
flows. New values were accepted if they were in the range of 0.9 to 1.1 L, otherwise 
the calibration was repeated.    
 Flow-gas delay calibration  
A gas cylinder was connected in order to close the RB port of the RB valve during the 
flow  calibration. 1 minute was aloud for warming up.  The operator, breathing in and 
out of the re-breathing valve, calibrated flow-gas delay. Slow expirations were followed 
by very fast inspirations until the calibration software determination of the flow-gas 
delay. If one or two breaths failed, the software automatically filtered those results. 
The delays did not vary more than 20-40 ms from day to day for the same gas sample 
inlet.   
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Performing the measurement: 
 
• The child was seated comfortably, with the mouthpiece adjusted at the level of 
child’s mouth 
• The child was asked to wear a nose clip and breathe evenly through the 
mouthpiece while keeping a tight mouth seal around it 
• The child was kept at ease and talked to until the end of the washout to achieve 
and maintain stable tidal breathing 
• The washout was deemed completed when the end-tidal tracer gas 




A maneuver was considered correctly performed when:  the deviation (x) between the 
inspiratory and expiratory concentration of the inert marker gas was less than 2% at 
the end of the wash-in.  
The end tidal concentration of the inert marker gas was below 1/40th of the starting 
concentration over three subsequent breaths. 
The results were considered reproducible if two LCI results were within 10% of each 
other.  
Maximum of three measurements were performed. Two measurements within 10% of 
each other were recorded. The mean of two measurements was used in the analysis: 
 
- The mean FRC of the two accepted maneuvers was recorded.  
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Spirometry assesses how an individual inhales or exhales volumes of air as a function 
of time. It is invaluable as a screening test of general respiratory health.(Miller et al., 
2005b) Spirometry measurements reflect large and small airway function and lung 
volumes.  Values we recorded from spirometry for each child were: 
FVC - maximal volume of air exhaled with maximally forced effort from  maximal 
inspiration, expressed in liters  
FEV1 -maximal volume of air exhaled in the first second of a forced  expiration from a 
position of full inspiration, expressed in liters  
FEF25-forced expiratory flow at the 25% of exhaled FVC 
FEF50- forced expiratory flow at the 50% of exhaled FVC 
FEF75- forced expiratory flow at the 75% of exhaled FVC 
FEF25-75 - The mean forced expiratory flow between 25% and 75% of the FVC   
PEF - maximum expiratory flow achieved from a maximum forced expiration,  starting 





The FVC manoeuvre is displayed as expiratory volume against time. 
There are three phases of the FVC manoeuvre: 1) maximal inspiration 2) a “blast” of 
exhalation 3) continued complete exhalation to the end of test. 
Flow volume curves were instructed by plotting flow against volume during forced 
inspiration and expiration, as shown on Figure 2.6. 
 
Figure 2.6, flow volume curves were instructed by plotting flow against volume during forced 
inspiration and expiration (original trace from a study participant) 
 
A Jaeger MS-PFT Analyzer Unit was used to measure FEV1, FVC, FEV1/FVC and 
MMEF. LabManager V5.3.0 software was used to encourage full expiration and the 
animations could be adjusted for a wide range of abilities.   
The following equipment requirements were adopted:  the spirometer was capable of 
accumulating volume for ≥15 s and measuring volumes of ≥8 L (BTPS) with an 
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accuracy of at least ±3% of reading or ±0.050 L, whichever is greater, with flows 
between 0 and 14 L/s and the total resistance to airflow at 14.0 Ls-1 was <1.5 
cmH2OL-1s-1 (0.15 kPaL-1s-1). (Miller et al., 2005b) 
The instrument display and graphical output satisfied the ERS/ATS criteria.  
BTPS corrections: 
All spirometry values were reported at BTPS conditions, with corrections made for 
room temperature and barometric pressure, measured at the time of testing with the 
software installed by the spirometer manufacturer.  
 
Calibration of the spirometry system:  
Volume 
The volume accuracy of the spirometer was measured daily, using a calibrated 
syringe with a single discharge of 3 L and a volume accuracy of ±15ml. Reading of 
±3.5% or ±65mL for the volume of the spirometer was considered appropriate, 
whichever was larger (this included the 0.5% accuracy limit for the 3L syringe). Daily 
calibration permitted immediate identification of equipment problems and the 
monitoring of daily variability.  
Leak: 
Leaks were checked for daily by applying a continuous positive pressure of 3.0cmH2O 
(0.3 KPa) with the outlet of the spirometer occluded; any volume loss observed 
beyond 30mL after one minute was taken as an indication of a leak.  
Volume linearity: 
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Volume calibration over entire volume range of the spirometer (0-8 L) was performed 
quarterly, using a calibrated syringe. The measured volume was accepted within 3.5% 
of the reading or 65 mL whichever was greater. This limit includes the 0.5% accuracy 
limit for a 3-L syringe. (Figure 2.7) 
The calibration syringe was stored and used in the same temperature and humidity as 
the spirometer, on the testing site, out of direct sunlight and away from heat sources. 
 
 
Figure 2.7, Example of the volume linearity calibration for the PFT measuring head 
pneumotachometer, showing linearity of expected and obtained measurements  
 
Syringe volume (L) Measured volume (L) Error (L) Error (%) 
1 0.99 0.01 1 
2 1.97 0.03 1.5 
3 3.0 0 0 
4 4.01 0.01 0.25 
5 5.03 0.03 0.6 
6 6.03 0.03 0.5 
























Table 2.4, showing the values obtained by the volume calibration of the PFT 




The child was instructed and the FVC manoeuvre demonstrated to the child. 
• Child assumed the correct posture 
• Attached nose clip, placed mouthpiece in the mouth and close lips around 
mouth piece 
• Inhaled completely and rapidly to TLC 
• Exhaled maximally until no more air can be expelled while maintaining the 
upright posture 




The assessments of the performed measurements were carried out such that a 
minimum of three manoeuvres within 6% of difference in measurements from each 
other were obtained, but no more than eight were usually required. The test 
repeatability was checked and more manoeuvres performed as necessary. Acceptable 
repeatability was achieved when the difference between the largest and the next 
largest FVC was ≤0.150 L and the difference between the largest and the next largest 
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FEV1 was ≤0.150 L. For those with an FVC of ≤1.0 L, both these values were 0.100 L. 
(Miller et al., 2005b) 
 “End of test” (EOT) criteria (1995, Aurora et al., 2004):  
To accurately measure the FVC and the parameters of the small and medium size 
airways (FEF75, FEF50, FEF75) that are extrapolated from the FVC, it is important for 
subjects to be verbally encouraged to continue to exhale the air at the end of the 
maneuver, to obtain maximal possible effort. 
Some young children may have difficulty meeting the ATS EOT criteria and care was 
taken not to cause discomfort to the child. 
EOT criteria we used to identify maximum FVC effort: 
1) If patient could or should not continue further exhalation 
2) If the volume-time curve showed no change in volume (<0.025 L) for ≥ 1 s, and 
the patient has tried to exhale for ≥ 6 s  
Achieving EOT criteria was used as a measure of maneuver acceptability. 
Maneuvers that did not meet EOT criteria were not used. 
 
The measurement was considered reproducible if three technically satisfactory 
volume-time loops were obtained with FEV1 and FVC measurements within 6% of 
each other.(Miller et al., 2005b) 
The results were expressed as the percentage predicted for height with the use of 
established reference ranges and were converted into z scores as 




2.3.5. Gas transfer (single breath method) 
 
Gas transfer single breath method was used to determine the capacity of the lung to 
exchange gases across alveo-capillary membrane. 
This technique measures the diffusing capacity (DLCO) of the alveo-capillary 
membrane. The DLCO measurement is based on a Roughton-Forster equation which 
divides diffusion capacity of the lung  into membrane and red cell diffusion capacities 
(Hughes, 2003): 
 
DL – diffusion capacity  
DM -  represents surface area and thickness 
Θ - represents rate of chemical reaction of CO with red cell  
Vc - micro capillary blood volume (volume of Hb) 
 
The total CO uptake from the lung (DLCO) is measured from the fall in the 
concentration of alveolar CO and alveolar volume. CO uptake depends on membrane 
conductivity (DM) and the binding of CO and haemoglobin (Hb).(Macintyre et al., 2005) 
When KCO (fall in concentration of alveolar CO per unit time per unit CO driving 








where DM is the diffusing capacity of the membranes separ-
ating the alveolar gas from the red cell itself; h is the rate of
reaction of CO with red cells (sometimes called the diffusing
capacity per ml of blood), and VC is the microvascular
(capillary) blood volume in contact with the inhaled CO.
Kruhoffer (1954), who worked in the same Department in
Copenhagen as did the Kroghs, had published a similar
equation 3 years earlier, but without giving a formal proof,
and with erroneous values for h.
The Roughton–Forster equation is the key to understanding
what the DL,CO is measuring. DL,CO is a conductance
(ml min)1 mmHg)1), and the reciprocals in equation (1) are
resistances. 1/hVC is the oxygen-dependent part of the
resistance, located in the pulm ary capillaries, and 1/DM
is what remains when 1/DL is back-extrapolated to zero PO2.
[1/DL – 1/DM]/[1/DL] is the ‘red cell’ fraction of the total
diffusion resistance. Roughton & Forster (1957) also showed,
from measurements of DL,CO at two or more alveolar PO2 levels
(ideally 150–200 and 500–600 mmHg and knowing hCO at
the appropriate PAO2, that DM and VC could be calculated by a
simple graphical method.
The membrane diffusing capacity
The DM is determined by the tissue diffusivity [solubility/
(mol. wt))2] of O2 or CO in lung tissue and the surface area/
thickness ratio of the epithelial, interstitial, endothelial and plasma
barriers. In physiological terms, DM is a function of the expansion
of the lung. With a doubling of the gas volume of the lung (from
50 to 100% TLC) DM increases by about 75%, but DL,CO by only
25% (VC does not change) (Stam et al., 1991). Increases of DM as
the lung expands are caused by a mixture of airspace spherical
expansion and unfolding of the surface. Unfortunately, the
measurement of DM is not independent of VC, because intracap-
illary Hb must be present for DM to be detected. Also, changes in
the dimensions of the VC component will alter DM.
The diffusing capacity of blood
In vivo, hCO is inversely proportional to PO2 . The original in vitro
measurements of Roughton & Forster (1957) were carried out at
pH 7.8–8.0. More recent estimates (Forster, 1987) at physio-
logical pH have resulted in significantly lower 1/h values at high
PO2s. If, in the Roughton–Forster equation, the 1987 1/h are
substituted for the 1957 ones, DM increases 2.5–3.5 times, and
VC decreases by 33% . Nearly all published DM and VC values
have used the 1957 hCO values, a notable exception being
Borland & Cox (1991) and Borland et al. (2001).
Pulmonary capillary volume
As measured by the Roughton–Forster technique, capillary
volumes (with 1957 1/h ) are in the range 80–100 ml
(females) and 100–120 ml (males) at rest, and 125–210 ml
(males and females) on exercise (Hsia et al., 1995). These
values would be about 33% lower if the 1987 1/h were to be
used. Morphometric values for VC at rest, from post-mortem
lungs, are about 200 ml (ranging from 120–280 ml depend-
ing on body weight) (Gehr et al., 1978). Because of the
Fa˚hreus–Lindqvist effect, whereby red cells accelerate relative
to mean plasma flow in their passage through the capillary
bed, capillary haematocrit (Hct ) is less than that in larger
vessels. In fact, pulmonary capillary Hct is about 67% of large
vessel Hct (Brudin et al., 1986). This effect does not change VC
estimates because there is an equal and opposite reduction in
hCO.
Diffusing capacity for nitric oxide
In the last 15 years, the alveolar uptake of nitric oxide (NO) has
been studied (Guenard et al., 1987; Borland & Higenbottam,
1989). The theory and technique for estimating DL,NO is
identical to that for DL,CO. DL,NO is four to five times greater than
DL,CO. T reason is that hNO is nearly seven times larger than
hCO (Carlsen & Comroe, 1958). From simultaneous inhalation
of NO and CO, DL,NO and DL,CO can be calculated, and the
Roughton–Forster equation solved on the basis of two values of
1/h (1/hNO and 1/hCO), instead of two values of 1/hCO at
different PAO2 s (Borland & Cox, 1991; Borland et al., 2001).
This has the effect of increasing DM,CO by three to four times,
and reducing the VC/DM ratio from about 2 to 0.35.
Red cell resistance fraction
As mentioned earlier, the general view, before the Roughton &
Forster (1957) paper, was that DL,CO%DM with no resistance to
diffusion attributable to the reaction of CO with haemoglobin.
When DL,CO was partitioned into DM and VC using the original
1957 hCO values, the red cell resistance fraction varied from
32–56% (Forster, 1957). With the morphometric analysis, the
red cell resistance fraction is in the range 50–80% (Gehr et al.,
1978). Using the 1987 hCO values and Borland & Cox (1991)
and Borland et al.’s (2001) hNO–hCO technique, this fraction has
risen to 80%, i.e. most of the diffusion resistance is intracap-
illary. Thus, DL,CO measurements may be heavily weighted
towards the numbers of red cells and/ or the number of
capillary vessels. This new perception supports the views of
clinicians who have maintained that DL,CO is a ‘window on the
pulmonary microcirculation’. Striking changes in DL,CO in severe
anaemia (fl) [Rankin et al., 1961], on exercise (›) [Hsia et al.,
1995], in intrapulmonary haemorrhage (›) [Ewan et al., 1976],
and in pulmonary vasculitis (fl) emphasize the pre-eminent role
of the capillary bed.
The ratio DL,O2/DL,CO in hypoxia is about 1.2 (Meyer et al.,
1981), the same as predicted (but for normoxia) by Krogh and
Krogh in 1909. If the DL,CO is measured in normoxia, the DL,O2
/ DL,CO ratio is 1.7, reflecting a combination of O2 /CO ratios
for DM (1.23) and h [c. 2.0; Forster, 1987).
Single breath T(L,CO) and KCO, J.M.B. Hughes
! 2003 Blackwell Publishing Ltd • Clinical Physiology and Functional Imaging 23, 2, 63–71
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(alveolar volume (VA)), the total uptake of CO by the lung (DLCO) per unit of time per 
unit driving pressure is obtained: 
 
DLCO=KCOxVA 
The product of the two measurements, KCOxVA, has been termed transfer factor of 
the lung for CO (DLCO). In this thesis, the ERS recommendations were followed and 
DLCO was expressed in mmol min-1kPa1. The measurements were corrected for BTPS 
factors (ambient pressure, temperature and humidity).(Macintyre et al., 2005)          
   
Description	of	equipment	and	technique:	
 
The system contained a source of test gas, a pneumotachometer for measuring the 
inspired and expired volume over time and a gas analyser with a display of volume 
over time.  
The equipment used in this study, Jaeger MS-PFT Analyzer Unit, complied with the 
following specifications: 
 
• Volume accuracy:  for measurements according to the ATS/ERS standards 
for spirometry (3.5% accuracy over an 8-L volume using test gases, with a 
testing syringe accuracy of 0.5%) 
• Gas analysers accuracy:  Linear from zero to full span within ±0.5% of full 
span. Stable over the duration of the test with drift  <±0.5% of a measured 
gas 
• Circuit resistance <1.5 cmH2OL-1s-1 at a flow of 6 Ls-1 
• Timer should be accurate to within ±1.0% over 10 s (100 ms) 
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• Dead space volume (valve, filter and mouthpiece) was  <0.350 L 
• System should be leak free. 
 
As the diffusion capacity of the lung partially depends on the level of Hb in the 
capillary blood, we needed to determine the Hb level in each study participant. 
We have obtained the Hb level by non-invasive method, pulse CO-oximetry that has 
acceptable accuracy when compared with the invasive laboratory measurements. In a 
large study by Macknet and co-workers that analysed 335 paired samples, pulse 
oximetry based measurements were found to be accurate within 1.0 g/dL (1 SD) when 
compared with standard laboratory measurements. (Frasca et al., 2011, Macknet et 
al., 2010) We have used Masimo Rainbow (Radical 7) pulse oximeter in our study, to 




The volume accuracy of the spirometer (PFT measuring system) was measured daily, 
using a calibrated syringe with a single discharge of 3 L and a volume accuracy of 
±15ml; a reading ±3.5% or ±65mL for the volume of the spirometer was considered 
appropriate, whichever was larger (this included the 0.5% accuracy limit for the 3 L 
syringe).  Daily calibration testing permitted immediate identification of equipment 
problems and the monitoring of daily variability.  
Leaks were identified by applying a continuous positive pressure of 3.0cmH2O (0.3 
KPa) with the outlet of the spirometer occluded; any volume loss observed beyond 
30mL after one minute was taken to indicate a leak.  
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The gas analyser was zeroed daily to account for drift. Linearity of the gas analyser 
was assessed through measuring intermediate dilutions of the tested gas. All 
equipment checks were documented.  
 
 
Figure 2.8, Inspired gas composition: the mixture used in the study contained 0.28% CO, 




Figure 2.9, Single breath method manoeuvre. After unforced exhalation to residual volume, 
the mouthpiece was connected to a source of test gas and the child inhaled rapidly to TLC. 
Child maintained full inspiration for minimum of 8 sec followed by rapid exhalation to the RV 
(an actual anonymised trace from a study participant). 
Performing	the	manoeuvre	
 
• Before beginning the test, Hb measured by Massimo spectrometer was 
recorded and entered into computer programme. 
• The manoeuvres were demonstrated to the child and the child was carefully 
instructed. 
• The child was seated comfortably throughout the test procedure. 
• Once the mouthpiece and nose clip were in place, tidal breathing was carried 
out for a sufficient time to assure that the child was comfortable with the 
mouthpiece. 
Deep inspirations were avoided during this period as they can increase 
subsequent CO uptake 
 
• The DLCO manoeuvre begun with unforced exhalation to residual volume.  
• At RV, the mouthpiece was connected to a source of test gas and the child 
inhaled rapidly to TLC.(Figure 2.9) 
• The child maintained full inspiration (breath hold) using only the minimal 
effort necessary, for minimum of 8 sec. (Figure 2.9) 







Potential problems encountered with the single-breath diffusing capacity of the lung for 
carbon monoxide breathing manoeuvre that can lead to measurement errors are: 
 
- Stepwise inhalation or exhalation 
- Exhaled gas leak 
- Inhalation too slow 
- Exhaled volume larger than inhaled volume 
- Transient overshoot from high flows and changing gas temperatures 
 
Every time-volume curve was inspected for potential artefacts reflecting above listed 
problems and if any occurred, measurement was excluded from analysis. 
Four minutes break was made between tests to allow an adequate elimination of test 
gas from the lungs. The child remained seated during that interval and several deep 
inspirations helped to clear test gases more effectively. 
  
Valsalva (expiratory efforts against a closed airway) and Muller manoeuvres 
(inspiratory efforts against a closed airway) during the breath-hold were avoided. By 
decreasing and increasing thoracic blood volume, they might decrease and increase 
DLCO, respectively.   
Inspiratory volume (VI) target was 90% of the largest known VC (previously obtained 
by spirometry). 
A sub maximal inspired volume (less than the 90% of the known VC) can affect CO 
uptake, depending upon whether it is a result of an initial suboptimal exhalation to RV 
(test performed at TLC) or whether it is due to a suboptimal inhalation from RV (test 
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performed below TLC). In the former case, the calculated VA and DLCO will accurately 
reflect lung volume and the CO uptake properties of the lung at TLC. In the latter case, 
the VA will be reduced and DLCO measurement will be affected. Due to these effects, it 
was important that the VI was as close to the known VC as possible. 
 
A rapid inspiration was encouraged, since the DLCO calculations assume 
‘‘instantaneous’’ lung filling. 85% of VI should be inspired in <4.0 sec 
 
The DLCO calculation assumes instantaneous lung emptying as well.  
Therefore, expiratory manoeuvre was accepted if smooth, unforced, without hesitation 
or interruption, and total exhalation time did not exceed 4 s, with sample collection 
time <3 s. 
Reproducibility		
 
At least two test results within 10% of each other were reported. For the test to be 
acceptable, the inspired volume of gas (VIN) during the breath holding manoeuvre 
was within 90% of the FVC obtained by spirometry.  
More than five tests were however not undertaken as five tests will increase COHb by 
~3.5%, which will decrease the measured DLCO by ~3–3.5%.  
 
The results include measured DLCO, adjusted for Hb, the predicted and per cent 
predicted DLCO, and the predicted and per cent predicted DLCO/VA (KCO). Any 
adjustments are reported with the data used to make the adjustment. The average VA 
is reported along with the predicted VA (the predicted TLC minus predicted VD, dead 




2.3.6. Lung volume measurements  
 
He dilution method 
 
This method for measuring FRC is based on the equilibration of gas in the lungs with a 




The system contained: the spirometer (PFT measuring head), a mixing fan, CO2 
absorber, O2 and helium supply, a gas inlet and outlet and a water vapour absorber in 
the line to the helium analyser.  The gas mixture used contained 10% He, with added 
room air and O2. Gas was supplied by the BOC (British Oxygen Company). 
The helium analyser had a range of 0–10% helium, a resolution of ≤0.01% helium 
over the entire range, and a 95% response time of <15 s to a 2% step change in 
helium concentration in the breathing circuit. The meter was stable with a drift of 
≤0.02% for measurement periods of up to 10 min (Wanger et al., 2005). 
The lung volume is calculated from the helium fraction at the time of equilibration. The 
measurements are corrected for BTPS condition (ambient pressure, temperature and 
humidity). 
 
The breathing-circuit CO2 level during testing was kept below 0.5% to avoid patient 
discomfort and hyperventilation. (Wanger et al., 2005) This was achieved with a CO2 
absorber connected within the circuit. The activity of the CO2 absorber was checked 
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before each test and absorber was changed when indicated by colour change on 
visual inspection. The capacity and the specifications of the spirometer were 
described previously (see spirometry). 
Calibration	of	the	He	dilution	system:	
 
PFT measuring head pneumotachograph was volume calibrated daily with a 3L 
syringe, as previously described (see spirometry). The gas analyser was zeroed daily 
to account for drift.   
Linearity of the gas analyser was assessed through measuring intermediate dilutions 




• The test was explained to the child 
• The child wore a nose clip and started breathing through the mouth piece with 
an adequate seal, avoiding any leaks 
• Tidal breathing for 30-60 sec was allowed to ensure stable end tidal expiratory 
level 
• After 30 sec, the patient was connected to the test gas  
• He concentration was noted every 15 seconds 
• He concentration was considered to be complete when the change in the 
concentration was <0.02% for 30 sec. 
• When the helium equilibration was complete, as indicated on the display from 
the He concentration measurement of the exhaled air, the child was 




Figure 2.10, He concentration measurement (anonymised trace from a study participant) 
Reproducibility:	
	
At least two satisfactory measurements were performed, with results agreeing within 




















































The changes in thoracic volume that accompany compression or decompression of 
the gas in the lungs during respiratory manoeuvres can be obtained using a body 




Measurements were done using a transducer capable of measuring the mouth 
pressure  ≥± 5kPa (≥±50cmH2O), with a flat frequency response in excess of 8 Hz, 
meeting published standards for the accuracy and frequency response of spirometric 
devices.  
FRCpleth refers to the volume of intra thoracic gas measured when airflow occlusion 
occurs at FRC.(Wanger et al., 2005, Miller et al., 2005a, Coates et al., 1997) 
 
A Jaeger MasterScreen Body plethysmograph was used in this study, which complied 




Pneumotacograph was calibrated daily using a 3 L syringe, in accordance with the 
manufacturer’s instructions.  
The plethysmograph signal was also calibrated each day, using a volume signal of 
comparable frequency and magnitude to the respiratory manoeuvres. The accuracy of 
volume measurements was required to be ±3% or ±50mL whichever was larger.  
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The volume linearity of the measuring head (BodyBox) was checked quarterly, with 
the range of volumes 0-7 L, using a calibrated Syringe. (Figure 2.11) 
 
Figure 2.11, volume linearity of the BodyBox measuring head pneumotachometer, showing 




Syringe volume (L) Measured volume (L) Error (L) Error (%) 
1 1 0 0 
2 2.05 0.05 2.5 
3 3.08 0.08 2.7 
4 4.06 0.06 1.5 
5 5.01 0.01 0.2 
6 6.02 0.02 0.33 
7 7.14 0.14 2 
 
Table 2.5, values obtained during calibration of the plethysmography 

























1 The child was seated comfortably in the plethysmograph 
2 The test was explained and demonstrated to the child. 
3 The door of the plethysmograph was closed and time was allowed for the thermal 
transients to stabilise (2 min) 
4 The patient was instructed to attach to the mouthpiece and breathe quietly until a 
stable end-expiratory level was achieved (3-10 tidal breaths)  
5 When the patient was at the FRC, the shutter was closed at end-expiration for 3 
sec, and the patient was instructed to perform a series of gentle pants. Minimum 
of 3 panting manoeuvres were recorded and visually inspected. Satisfactory 
panting maneuvers were recorded as a series of almost superimposed straight 
lines separated by only a small thermal drift on the pressure–volume (Figure 
2.12) 
6 After a panting maneuver, the shutter is opened and the patient performs an ERV    












Figure 2.12, display of properly performed panting manoeuvre, smooth lines (red, green and 




At least three FRCpleth values that agreed within 5% were obtained and the mean 
value reported, together with TLC and RV. The values were reported as percentage 
predicted and z-score (Wanger et al., 2005, Rosenthal et al., 1993b)   
All measurements of the FVC measured by plethysmography (Vmax) were compared 
and cross checked with the FVC measured by spirometry.  Measurements were 
considered reproducible if they were within 5% agreement. In very few cases when 
Vmax was lower than FVC measured by spirometry by >5%, RV was manually 
recalculated, entered onto the database and included into the analysis.  
15/08/13
12:32:39PM
0.22 0.62 0.51 0.62 0.60 269.1 5.06
0.22 0.52 0.46 0.51 0.51 227.4 3.81
0.45 0.27 0.54 0.48
0.77 0.67 0.80 0.79
0.30 0.30 0.43 0.41
0.66 0.67 0.61 0.63
0.51 1.23 1.01 1.23 1.19 234.6
0.51 1.03 0.92 1.02 1.01 198.3
0.48 0.69 0.68 0.56 0.67 139.2 1.51
1.97 1.97 1.97
2.74 3.31 2.74 2.83
88.91 90.65 82.04 80.90 80.90 91.0 -1.85
3.84 1.61 1.97 1.61 1.67 43.5 -2.19
3.84 1.94 2.17 1.95 1.98 51.5 -1.88
0.81 0.99 0.81 0.84
0.97 1.09 0.98 0.99
ECCS+ROSEN
1.97 1.65 1.65 1.65 83.9 -0.95
1.00 0.87 0.81 0.81 81.0 -0.68
3.79 3.94 4.02 4.02 106.0 0.50
24.29 22.12 20.08 20.08 82.7 -0.88
48.18 41.94 41.04 41.04 85.2 -1.46
3.07 3.07 3.21 3.21 104.8 0.35
0.96 0.78 0.84 0.84 87.8 -0.58
1.98 2.29 2.37 2.37 119.8 1.21
5.64 3.98 4.31 4.23 4.23 74.9 -1.23


































2.3.7.Cold Air Bronchial Provocation (Isocapnic Hyperventilation 
Cold Air Challenge (IHCACh))  
 
Children with an FEV1 more than 70% underwent a cold air challenge. This involved 
the child breathing through a face mask sub-freezing air (-15 degrees) for 4 minutes at 
60% of their maximum voluntary ventilation, as measured by a target ventilation meter 
(1992). 
 
The test consists of patients hyperventilating dry sub frigid air (-20 C) at 
predetermined target ventilation for a fixed period of time, at rest. During the 
procedure, the end-tidal carbon dioxide (PetCO2) levels are kept constant by adding 
carbon dioxide (5% CO2) to the breathing mixture, which allows the subject to 
hyperventilate without becoming dizzy or lightheaded. 
Gas was supplied by BOC (British Oxygen Company) as the 5% CO2 and air (large 
cylinder).  
 
The TAC-1-0092 target ventilation device (Equilibrated Bio Systems) was used in this 
study. The target ventilation system was connected to a tank of gas, mixture of air and 
5% CO2. 
The test was undertaken by children with initial FEV1> 70% predicted.  
• For children undertaking the cold air challenge, target ventilation was obtained 
by measuring the patient’s FEV1 (spirometry) and multiplying it by 17.5 which 





• Sub frigid dry air (-20 C) was administered while the patient hyperventilated at 
approximately 60% of their Maximal Voluntary Ventilation (MVV) for a minimum 
of three minutes, without exercise. 
 
• To avoid hypocapnia, an isocapnic technique (where the end tidal CO2  was 
maintained in the normal range of approximately 40 mmHg)  was employed  by 
the patient breathing a mixture of 5% CO2 and balance air. 
 
• The mixture was dry, since the tank was guaranteed to contain only trace 
amounts of water.  
 
• In addition, chilling the air to approximately -20ºC caused any remaining water 
vapour to condense and freeze before reaching the patient. 
  
• After the cold air exposure, spirometry testing was performed at five minute 
intervals over a 20-minute period. 
 
If the FEV1 was significantly reduced (more than 10% of the baseline), the test was 
considered positive. 
 
Performing the test: 
 
• Beta 2 agonist (Salbutamol, Salmeterol) were withheld for 24 hours prior to the 
test (1992) 
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• The procedure was explained to the child 
• The TAC (Turboaire Challenger) with the mouth piece attached was adjusted 
for the child’s seating height and the child seated comfortably while breathing 
through the mouth piece 
• The child was breathing normally on the TAC for 1 minute, connected to the air 
from the cylinder with 5% CO2 and air mixture, to acclimate to the cold air and 
for the temperature to go down to -20 C. 
• After 1 minute, the child begun to hyperventilate, at the target ventilation, 
continuously following the target meter 
• The target ventilation be achieved by breathing faster or deeper, or combination 
of both 
• Once the target ventilation was reached, the clock was started and ventilation 
continued for 3 minutes. 
• After the child was removed from the TAC, the clock was started for the waiting 




The minimum of three reproducible baseline flow-volume loops needed to be obtained 
by spirometry prior to the child undertaking the cold air challenge. If the patient was 
incapable of this due to a lack of coordination or effort, the test was not continued 
because there was no valid means of comparing the pre- and post-challenge 
performance. If the loops were acceptable but appeared smaller with each successive 
effort, resulting in a drop in the FEV1 of 10% or more, this usually indicated highly 
sensitive airways and was considered the equivalent of a positive test. Hence, if that 






All patients with FEV1<70% on initial spirometry received bronchodilator and their 
FEV1 was re-measured. The baseline spirometry had to be reproducible, with three 
acceptable tests of FEV1, FVC and PEF recorded. 
 
Standardised dose of salbutamol, 500 mcg (5 inhalations of 100 mcg each) via a 
spacer device and inhaler was administered, to test for the reversibility of the large 
airway obstruction. Spirometry was repeated 10 min after bronchodilator 
administration.  
Significant post bronchodilator response was defined as an improvement of at least 
12% increase in the FEV1 and a minimum of a 200ml increase in the FVC. (Miller et 








Pulmonary hypertension was defined as the mean pulmonary artery pressure (mPAP) 
>25 mmHg and systolic pulmonary pressure (SPAP) >36 mmHg (TRvmax >2.9 
m/s)(Galiè et al., 2009). Echocardiography was performed using a Phillips iE33 
ultrasound device, equipped with a standard 5 and 8 MHz transducer.  
Multiple views were recorded including subxiphoid, apical, short parasternal, long 
parasternal and suprasternal view. Reproducibility was established on 20 scans, 
performed independently by a paediatric cardiology consultant and myself. The scans 
were analysed by two different clinicians blinded two each other’s findings. 
The ECHO assessments were also used to exclude secondary pulmonary 
hypertension caused by potential LVOT (left outflow tract obstruction). This included 
ruling out left atrium (LA) enlargement and mitral stenosis, assessing whether mitral 
inflow is normal and assessing LV (left ventricle) systolic and diastolic function. 
We have reported: 
• LA dimensions at the end of ventricular systole in apical 4 chamber view   
• E:A ratio ( Absolute E: A velocities) 
• LVEDD (mm)(left ventricle end diastolic diameter) 
• LVEF (%)(left ventricle ejection fraction) 
• End diastolic IVS (mm)(interventricular septum) 
TAPSE (mm)(tricuspid annular plane systolic excursion) was recorded as a measure 
of right ventricular systolic function. 
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Pulmonary end diastolic pressure estimated from pulmonary regurgitation jet and 
PAAT (pulmonary artery acceleration time) were recorded as an additional measure of 
pulmonary pressure, independent of TR measurements.  
Right atrial pressure was estimated by measuring the IVC diameter and it’s change 
with respiration. IVC diameter was measured 2 cm from IVC-RA junction, 
perpendicular to the long axis of the vessel, at the moment of maximum expansion, in 
the subxiphoid short axis view (Lopez et al., 2010). Patients were asked to perform 
brief rapid inspiration and additional loops were recorded, as shown on Figure 2.13. 
Value of 5 mmHg was taken for collapse of ≥50%, 15 mmHg for ≤50%  (10 mmHg 
range is needed to have sufficient predictive accuracy). IVC size of 2 cm was taken as 
a cut off for RAP >10 mmHg (Arcasoy et al., 2003).  
In other words:  when IVC was less than 20 mm and the collapsibility greater than 
50% RAP was estimated as 5 mmHg versus 10 mmHg when the collapsibility was 
less than 50%. When the IVC was greater than 20 mm, RAP was estimated as 15 
mmHg when the collapsibility was greater than 50% and as 20 mmHg when the 








Figure 2.13, IVC diameter was measured 2 cm from IVC-RA junction, perpendicular to the 
long axis of the vessel, at the moment of maximum expansion, in the subxiphoid short axis 
view. Patients were asked to perform brief rapid inspiration and additional loops were 




Continuous wave Doppler was used to determine the peak velocity jet of the tricuspid 
regurgitation (TR) in the apical four-chamber view and parasternal long axis view 
angulated for TR (Figure 2.14).  Time velocity integral was traced to obtain the mean 
RV-RA gradient. Mean pulmonary artery pressure (mPAP) has been found to be 
highly accurate for initial diagnosis of pulmonary hypertension (Er et al., 2010).  
Patents were excluded when TR jet was not available. The highest TR velocity was 
measured and traced to obtain the peak and mean systolic right-ventricular-right-atrial 
(RV-RA) gradient, with the use of the modified Bernoulli equation (Quiñones et al., 
2002). 
The TR time velocity integral was traced if Doppler envelope had full spade shape and 
optimal visualisation, with exactly detectable peak. The mPAP was calculated as 
mean RV-RA gradient pressure plus estimated RA pressure (Aduen et al., 2009). 
The parasternal short axis views were inspected and recorded at the level of mitral 







Figure 2.14, Continuous wave Doppler was used to determine the peak velocity jet of the 
tricuspid regurgitation (TR) in the apical four-chamber view and parasternal long axis view 





Figure 2.15, the normal shape of the RV and LV on the parasternal short axis view. (ECHO 
from the study participant). Short parasternal axis view has been inspected in all participants 
who had ECHO. 
The exclusion of confounding factors included reporting left atrium (LA) dimensions at 
the end of ventricular systole, mitral valve (MV) inflow velocities, ratio of the early 
filling and atrial filling velocity of the left ventricle (E:A wave ratio), end diastolic 
diameter of the left ventricle (LVEDD), left ventricle ejection fraction (LVEF), end-
diastolic diameter of the inter ventricular septum (EDIVS). LA diameter was measured 






Figure 2.16, showing left atrium (LA) dimensions at the end of ventricular systole in the four-
chamber view. Inter ventricular septum and LV internal dimensions were measured from the 
recordings made from the parasternal long axis acoustic window, using M Mode 
measurements at the mitral valve leaflet tips (ECHO from our study participant) 
	
Mitral valve inflow velocities were measured by Pulsed-wave Doppler (PW) at the tips 
of the valve leaflets (Lindqvist et al., 2008). 
Inter ventricular septum and LV internal dimensions were measured from the 
recordings made from the parasternal long axis acoustic window, using M Mode 
measurements at the mitral valve leaflet tips. The RV systolic function was estimated 
by calculating tricuspid annular plane systolic excursion (TAPSE), using the M-mode 
measurement of systolic long axis motion of the RV free wall (Figure 2.17) in the 
apical four chamber view(Lindqvist et al., 2008). We have used published references 
to derive the z scores for M-mode values of the left ventricle and TAPSE. (Pettersen et 




Figure 2.17, measurements of tricuspid annular systolic plane excursion (TAPSE). Original 
trace from the study participant. 
Additional measurements of the pulmonary valve were undertaken to compare the 
pressure gradients between the two groups and exclude pulmonary stenosis. PW 
Doppler measurements of the peak velocity at the level of pulmonary valve were 
recorded in the parasternal short axis view (Lopez et al., 2010). End diastolic 
pulmonary regurgitation velocity was recorded, when present. Pulmonary artery 
acceleration time (PAAT) was measured as an interval between the onset of the flow 
and the peak flow of the pulmonary valve velocity measured by PW. (Yared et al., 
2011) 
 
Echo analysis reproducibility: 
Reproducibility was achieved by agreement on measurements of TR peak velocity 






Figure 2.18, showing the maximum TR velocity obtained individually by the two sonographers 
on the same patients, blinded to each other’s findings 
1) Bland-Altman plot ECHO agreement 
 
(15 children, with 5 no TR thus considered missing for the plot) 
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Figure 2.19, Bland-Altman plot ECHO agreement for TR velocity, mean difference: 0.009, 
SD=0.21, 95% limits of agreement: (-0.40, 0.42) 
 
2) Kappa statistics = 0.69 with p-value 0.0006 
(TR peak vs no TR peak, 20 children) 
*P=0.0006 means we can reject the hypothesis that the two assessors are making 
their assessment randomly. 




Skin prick testing was done to test for hypersensitivity to a range of common 







1.5 2 2.5 3
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dander, Dermathophagoides pteronyssimus, Dermathophagoides pharinae and 
Aspergillus fumigatus.(Chan et al., 2005, Sporik et al., 1990) 
The technique used for skin prick testing involves puncturing the skin with a calibrated 
lancet (1 mm) held vertically, through a drop of diluted allergen. 
All patients undergoing skin prick testing also had a positive histamine control and 
negative diluent (saline) control test included. The negative control excludes the 
presence of dermographism, which if present makes the tests difficult to interpret. 
(Berger, 2002) 
The maximum diameter of the wheals to various allergens was read at 15minutes. A 
weal of 3mm or more was considered to represent a positive response. Positive 







We have used the following questionnaires to assess the health-related quality of life, 
behavioral outcomes and academic achievement , that were incorporated into 3 
separate questionnaires (parental questionnaire, children’s questionnaire and 
teacher’s questionnaire)(Goodman, 1997): 
1. Strengths and Difficulties Questionnaire (SDQ; completed separately by the 
child, the parents, and the teacher; total scores from the five sub-scales range 
from 0 to 40, with higher scores indicating a greater degree of difficulty), 
2. Health Utilities Index Mark 3 (HUI3; completed separately by the parents and the 
child; scores range from −0.36 to 1, with lower scores indicating more severe 
health problems)  
3. Questions regarding respiratory health, symptoms, medicine use, hospital 
admissions, and neurologic illness (seizures) were also included in the parents 
questionnaire.  
4. Teacher Academic Attainment Scale (completed by the teachers in mainstream 
schools; scores range from 1 to 5 for each school subject, with higher scores 
indicating better performance).  
5. Questions regarding pubertal development (Tanner staging) were included in the 
children’s questionnaire 
 
The questionnaires are attached as Appendix 1 (parental questionnaire), Appendix 2 







A urine sample for the detection of cotinine was obtained from the children at the time 
of assessment. 
Urinary cotinine is a highly specific and highly sensitive measure of cigarette smoke 
exposure. The test has high sensitivity and high specificity. (Berny et al., 2002, Jacob 
et al., 2005b) It can differentiate between passive and active smoke exposure. It is 
stable in the urine and it can accurately identify amount of nicotine exposure within 24 
hours. (Berny et al., 2002, Jacob et al., 2005b)            
Urine samples were taken to the biochemistry lab and kept in the fridge until analysis. 
A laboratory technician blinded to the child’s history and smoke exposure performed 





Lung function data and echocardiographic data of two ventilation groups were 
compared as two independent samples. Statistical analysis of the lung function and 
the questionnaires results between two ventilation groups for the NJEM paper 
(Zivanovic et al., 2014), was done by the study statisticians (please see declarations). 
For the main analysis of outcomes, including the FEF75 z score (primary outcome), 
mixed model analysis was used, with the mother or the pregnancy as the random 
	174	
effect to allow for clustering due to multiple births. Skewed lung-function data were 
log-transformed. Imbalances in baseline factors were adjusted for by including those 
factors as fixed effects in the models. In sensitivity analyses, each lung-function 
outcome was also adjusted for, BPD, pubertal stage, and cotinine level. The primary 
outcome, FEF75, and 19 secondary lung-function outcomes were pre specified. To 
adjust for multiple testing, sensitivity analysis was performed using the Bonferroni 
adjustment: if any comparison had a p value of less than 0.05÷19 (i.e., <0.0026), the 
composite hypothesis would be rejected. 
Differences in means between two groups can be difficult to interpret clinically, so 
differences between groups were calculated as the proportion of children in each 
group with an FEF75 value below the 10th percentile (z score less than −1.28). Stata 
software, version 12.1 (StataCorp) was used for this analysis. 
When preterm lung function and echocardiographic measurements were compared to 
term children, two ventilation groups (CV and HFOV) were pulled to represent the 
preterm group of children. Term and preterm group were than compared as two 
independent samples.  All variables were assessed for normal distribution by visual 
inspection of normality curves and tested with the Kolmogorov-Smirnov test. 
Continuous variables are expressed as means with standard deviation (SD). 
Comparison of means was performed with the independent sample t test for normally 
distributed variables and the Mann-Whitney U test for non-Gaussian variables. Chi-
square test or Fisher’s exact test was used for nonparametric comparisons. P value of 
0.05 was considered statistically significant. Adjusted analysis was performed for 
baseline demographic differences. Sensitivity analysis was performed for birth weight 
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and gestational age, as there was incomplete data set on gestational age and birth 
weight of term children. 
To examine the differences in proportions of abnormal lung function between term and 
preterm children, a z-score of +/- 2 was taken as abnormal and differences expressed 
as odds ratio. This analysis was performed by using SPSS 22 version (SPSS GmbH 
Software – IBM Company, USA).  
 
Sample size calculation 
 
Initial sample size for the UKOS follow up recruitment was calculated for the lung 
function outcomes.(Zivanovic et al., 2014) Assessment of 320 children allowed a 
difference of 0.36 SD in lung function results to be detected with power of 90% and a 
significance level of 5%. Differences in lung function of 1.0 SD or greater have been 
demonstrated in children with or without adverse respiratory outcomes, thus the 
sample size allowed detection of a clinically important difference in lung function 














The sequelae of premature birth are well documented as abnormalities of large 
airways, increased airway hyper responsiveness, small airway abnormalities and 
abnormalities of alveo-capillary membrane.  Longitudinal studies have shown a 
degree of normalization of lung volumes and pulmonary mechanics with somatic and 
lung growth. Small airway abnormalities, however, persist.(Broström et al., 2010, 
Gross et al., 1998) 
In a small, non randomised study, using the tidal volume RTC technique and raised 
volume RTC technique measure forced vital capacity (FVC) and forced expiratory 
flows between 25 and 75% of FVC (FEF25-75) were measured in 36 infants with CLD, 
VmaxFRC was evaluated at 6 and 12 months corrected age, and the relationship 
between perinatal factors and lung function was studied. Vmax FRC (maximal flow at 
FRC) mainly represents function of smaller, more peripheral airways. The results have 
shown that very low birth weight infants with CLD have decreased VmaxFRC that 
worsen during the first year of life. Initial treatment with HFOV was associated with a 
more favorable outcome of VmaxFRC at 12 months corrected age.(Hofhuis et al., 
2002) 
The original United Kingdom Oscillation Study (UKOS) uniquely tested the hypothesis 
that the mode of ventilation in the first hour after birth in extremely prematurely born 
infants would affect outcome. The initial results, however, showed no difference in 
mortality or incidence of BPD when assessed at 28 days of life and 36 weeks of 
corrected gestational age(Johnson et al., 2002). There was no difference in lung 
function when measured at 11-14 months in a subgroup of 76 infants.(Thomas et al., 
2004) 
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It is possible to obtain more reproducible measurements of small airway function at 
school age. Small airway function can be assessed by spirometry forced expiratory 
flows (FEF25-75), the forced oscillation technique and the multiple breath washout 
technique assessing ventilation maldistribution (lung clearance index)(Skloot et al., 
2004, Pellegrino et al., 2005, Horsley, 2009). 
It was important to assess whether oscillated children have more preserved small 
airway function at school age, as a primary aim of the UKOS follow up study. 
Secondly, we aimed to assess whether large airway function and the diffusion 
capacity of the alveo-capillary membrane would differ according to the ventilation 
mode at birth.  
3.2.	Methods 
Seven hundred and ninety seven infants born at 23-28 weeks of gestation were 
recruited in the UKOS study; Out of those, 521 children survived and at the time of the 
follow up study were 11 to 14 years of age. Children able to travel were invited to 
King’s College Hospital Foundation Trust, London (KCH) for detailed respiratory and 
pulmonary hypertension assessment and to complete respiratory, health status and 
educational questionnaires.  Children, who were unable to come to KCH, were invited 
to participate in a detailed postal survey, completing the same respiratory, health 
status and educational questionnaires. 
Ethics: The UKOS follow up study was approved by National Research Ethics Service, 
South West London REC 3 on the 18th October 2010. REC reference number: 
10/H0803/105. 
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Small airway function was assessed by spirometry as an indirect measure of airway 
resistance. Spirometry also measured the degree of large airway obstruction and 
forced vital capacity and as part of a bronchial hyper responsivness testing.  
Inhomogeneity of ventilation distribution, which reflects small airway function, was 
assessed by the multiple breath technique to determine lung clearance index (LCI). 
LCI reflects abnormalities of the smaller airways(Horsley, 2009).  
Large airway function was assessed by spirometry and by impulse oscillometry.  
Airway hyperactivity was assessed by bronchial challenge tailored to the child’s 
baseline lung function. Children with a baseline FEV1 of less than 70%, received a 
bronchodilator and their FEV1 was re-measured. Children with an FEV1 more than 
70% underwent a cold air challenge.. Forced expiratory volume in one second was 
measured prior to, and then every 5 minutes, for 15 minutes after the cold air 
challenge.(Steinbrugger et al., 1995, Eliasson et al., 1992) 
 
Atopy needed to be excluded as a contributory factor and was assessed by using 
skin-prick testing. Exhaled nitric oxide (FeNO) using an online method was measured 
to assess the degree of underlying airway inflammation. 
 
Lung volumes and the degree of hyperinflation were assessed by plethysmography 
and helium dilution.  
The degree of alveo-capillary membrane damage by measuring the total lung gas 
transfer, alveolar volume and gas transfer per unit volume was assessed by the single 
breath carbon monoxide uptake method, which has reference ranges for school age 
children.(Rosenthal et al., 1993b)  
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There are a number of possible influences on lung function including passive/active 
smoking and pollution exposure, hence urine samples were obtained to assess 
cotinine levels.(Berny et al., 2002, Jacob et al., 2005a) 
Respiratory health was additionally assessed through the parental questionnaire, 
including the family history of smoking, damp in the house, use of chest 
medicine/inhalers and symptoms over the last 12 months (Appendix 1). 
Sample size 
Assessment of 320 children allowed for a difference of 0.36 SD in lung function results 
to be detected with power of 90% and a significance level of 5%. Differences in lung 
function of 1.0 SD or greater have been demonstrated in children with or without 
adverse respiratory outcomes, thus the sample size allowed detection of a clinically 
























Recruited for follow-up and analysed 
N=159 
Completed assessment and questionnaires 
(123) 
Completed questionnaires only (33) 
Completed assessment only (3)	
Lost to follow-up (N=133): 
Died (4) 
Overseas centre (26) 
Declined to participate (6) 
Moved overseas (2) 
Non-contactable (95)  
 
Allocated to Conventional Ventilation (CV) 
(n=397) 
 
1. Survived to hospital discharge 
Lost to follow-up (N=140): 
2. Died (11) 
3. Overseas centre (28) 
4. Declined to participate (4) 
5. Non-contactable (97) 
	




Recruited for follow-up and analysed 
N=160 
Completed assessment and questionnaire 
(133) 
 
Completed questionnaire only (26) 
 
















The original UKOS study design was followed and respiratory outcomes data were 
analysed as a two parallel-group study, in keeping with the randomization at birth. 
To determine whether the follow up sample was representative of the original 
UKOS study population, neonatal baseline data were compared for the children 
recruited and not recruited at age 11-14 years. Neonatal baseline characteristics 
and characteristics at follow-up data were compared by ventilation group.  
All variables were assessed for normal distribution by visual inspection of normality 
curves and tested with the Kolmogorov-Smirnov test. Continuous variables are 
expressed as means with standard deviation (SD). Comparison of means was 
performed with the independent sample t test for normally distributed variables and 
the Mann-Whitney U test for non-Gaussian variables. Additionally, skewed 
outcomes data were log-transformed. Adjusted analysis was performed for birth 
weight, gestational age groups and weather child was given surfactant at birth. 
Sensitivity analysis was performed for BPD, puberty and cotinine. Chi-square test 
was used for nonparametric comparisons. P value of 0.05 was considered 
statistically significant. Statistical analysis was performed using SPSS 22 version 
(SPSS GmbH Software – IBM Company).  
Mixed model analysis was used for the main lung function outcomes by the study 
statisticians, as previously described (please also see declarations). This statistical 
analysis was performed with the use of Stata software, version 12.1 




Respiratory outcomes were compared in 319 preterm children, 160 children from 
the HFOV group and 158 children from the CV group. When neonatal 
characteristics of two ventilation groups were compared, the conventional 
ventilation (CV) group had a higher mean birth weight (923 vs 867g, p 0.016), had 
higher gestational age (27.0 vs 26.7 weeks, p 0.048), a greater proportion were 
born at 26 to 28 weeks of gestation (81% versus 68%, p 0.006), and a greater 
proportion in CV group received surfactant (99% versus 95%, p 0.036), (Table 3.1).   
Comparison of baseline characteristics of those who were and were not recruited 
for follow-up demonstrated few significant differences. Children who were recruited 
were more likely to have a white mother and were less likely to have a mother who 
smoked during pregnancy (24% versus 38%)(Table 3.2). 
There were no significant differences found between the two ventilation groups 
when the baseline characteristics were compared at the time of assessment, at 11 







Table 3.1, Baseline characteristics according to ventilation group, values 
under ventilation groups are mean (SD) or number/total number (%) unless 
specified 
Characteristics 






Male gender (%) 84/158 (53%) 77/160 (48%) 0.37 
Mother’s race   Overall 0.88 
white 142/157 (90%) 143/160(89%)  
black 10/157 (6.4%) 10/160 (6.3%)  
other 5/157 (3.2%) 7/160 (4.4%)  
Birth weight (g) 923 (207) 867 (209) 0.016 
Birth weight z 
score (range) 
-0.55 (-2.94, 1.73) -0.62 (-3.45, 2.41) 0.51 
Gestational age, 
weeks 
27.0 (1.18) 26.7 (1.45) 0.048 
Gestational group    
      23-25 w 30/158 (19%) 52/160 (33%) 0.006 
      26-28 w 128/158 (81%) 108/160 (68%)  
    
Multiple birth 39/158 (25%) 37/160 (23%) 0.75 
Received 
surfactant 
157/158 (99%) 152/160 (95%) 0.036 
Mother smoked 
during pregnancy 
31/145) (21% 38/146 (26%) 0.35 
Postnatal steroids 36/156 (23%) 48/157 (31%) 0.14 
O2 dependency at 
36 weeks 
gestational age 
95/158 (60%) 88/160 (55%) 0.36 
O2 dependency at 
28 days of life 
130/158 (83%) 131/160 (82%) 0.93 
O2 dependency at 
discharge 
34/155 (22%) 37/159 (23%) 0.78 
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Table 3.2, Differences between children that were recruited for follow up and 
those that did not respond, baseline characteristics in the neonatal period 














Mother’s race    
white 285/317 (90%) 149/204 (73%) Overall <0.001 
black 20/317 (6.3%) 36/204 (18%)  
other 112/317 (3.8%) 19/204 (9.3%)  
Birth weight (g) 895 (209) 914 (204) 0.3 
Birth weight z 
score (range) 
-0.52 (-3.45, 2.41) -0.42 (-3.28, 2.17) 0.056 
Gestational age, 
weeks 
26.9 (1.33) 26.7 (1.39) 0.39 




























O2 dependency at 
36 weeks of 
gestation 
183/318 (58%) 121/205 (59%) 0.74 
O2 at 28 days  261/318 (82%) 165/205 (80%) 0.65 
O2 dependency at 
discharge 
71/314 (23%) 44/205 (21%) 0.76 
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Table 3.3, Baseline characteristics of children at the time of assessment, 11-
14 years of age, according to ventilation groups (248 children included into 
analysis) 
 
Characteristic CV HFOV p-value 
 
 
Age (range), years  
 
12.5 (11.2- 14.4) 
 




Weight (range), kg 
 
44.4 (23.4 -102) 
 




             boy 
 
45.4 (25 – 102) 
 
 
43.3 (19 – 86.7) 
 
0.65 
             girl 43.1 (23.4 – 57)  46.5 (29 – 72) 0.10 
Height (range), cm  
153 (129 – 173) 
 
151 (124 – 172) 
 
0.26 
              
            boy 
 
153 (138 – 173) 
 
151 (124 – 172) 
 
0.12 
             
            girl 
 
152 (129 – 169) 
 






17.8 (12.8 – 34.5) 
 






17.7 (12.8 – 34.5) 
 






19 (14.1 – 23.6) 
 






Table 3.4, cotinine measurements, puberty status from children’s 
questionnaire and social circumstances  as described by the parental 
questionnaire, 11-14 years of age, according to ventilation groups (248 
children included into analysis) 
 
 CV HFOV p-value 
 












3/92 (3.3%) 3/102 (2.9%)  
active smoking 
>15 ng/ml 
14/92 (15%) 18/102 (18%)  












damp or mold* 
10/150 (6.7%) 13/154 (8.4%) 0.56 
 

















^Reached Tanner stage 3 in hair or physical development. Data from self assessed 
questionnaire  
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*data from parents questionnaire, 305 returned, 49% from CV group 
 
Comparison of the primary outcome showed a significant difference in FEF75 z 
score. The FEF75 z score was higher in the HFO group (-1.19 versus -0.97) (Table 
3.5). Both the unadjusted difference and the adjusted analysis for the baseline 
neonatal factors showed significant difference between the ventilation groups. The 
adjusted difference in mean z-scores was 0.23 (95% CI: 0.02 to 0.45).  
There were significant differences between the ventilation groups in favour of 
HFOV in several other measurements obtained by spirometry, including FEV1, 
FEV1:FVC, FEF25, FEF50 and PEF.  (Table 3.5) 
There were significant differences in the measurement of small airway function 
obtained by impulse oscillometry. Measure of resistance of small airways, R5Hz, 





Table 3.5, results of spirometry according to ventilation groups, conventional 
ventilation versus high frequency ventilation, presented as mean (SD) 
Lung function CV 
Mean 
(SD) or % 
HFOV 
Mean 











(%predicted)   


















FEV1 z score   

















FVC z score 








FEF25 z score 








FEF50 z score 








FEF75 z score 




























*log transformed values,  ^adjusted for birth weight, gestational age groups and 
weather given surfactant at birth 
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There were no significant differences in the amount of air trapping, measured by 
plethysmography (FRCpleth and RV), Table 3.6.  
There were no significant differences in lung volumes measured by spirometry 
(FVC), plethysmography (TLC) and gas transfer single breath method (VA).(Table 
3.6) 
Measurement of alveo-capillary membrane diffusion capacity, DLCO, was 
significantly better for HFOV group (mean z score for CV group -1.10 vs mean z 
score for HFOV group -0.81). (Table 3.6.) 
Sensitivity analyses for pubertal stage and cotinine levels showed similar significant 
differences in the primary outcome and the above secondary outcomes of the lung 




Table 3.6, results of plethysmography, He dilution and gas-transfer 
according to ventilation groups, conventional ventilation versus high 
frequency ventilation, presented as mean (SD) 














FRC pleth z 
score 








RV z score 








TLC z score 








VCmax z score 








FRC He z score 








DLCO z score 


























*log transformed values 




Table 3.7, sensitivity analysis for puberty and cotinine, on lung function 
results (adjusted for gestational age, birth weight and surfactant) 
 




FEV1 z score 0.32 (0.04, 0.61) 0.027 
FVC z score 0.10 (-0.16, 0.36) 0.46 
FEV1/FVC z score 0.45 (0.018, 0.88) 0.041 
FEF25 z score 0.29 (0.05, 0.52) 0.017 
FEF50 z score 0.30 (0.06, 0.53) 0.013 
FEF75 z score 0.25 (0.02, 0.49) 0.034 
FEF25-75 z score 0.17 (-0.11, 0.45) 0.24 
PEF% predicted 6.88 (2.77, 11.0) 0.001 
DLCO z score 0.35 (0.04, 0.65) 0.028 
VA (L) -0.07 (-0.21, 0.08) 0.36 
DLCO/VA  0.03 (-0.03, 0.08) 0.33 
FRC He z score -0.22 (-0.51, 0.08) 0.15 
FRC pleth z score -0.09 (-0.44, 0.26) 0.62 
RV z score -0.03 (-0.37, 0.31) 0.85 
TLC z score 0.18 (-0.12, 0.48) 0.25 
VC max z score 0.31 (0.02, 0.60) 0.037 
FENO ppb 0.94 (0.78, 1.14)  0.55 
LCI 0.13 (-0.33, 0.58) 0.58 
FRC SF6 (L) -0.06 (-0.18, 0.07) 0.37 
R5Hz % predicted -7.45 (-13.4, -1.50) 0.014 
R20Hz% predicted -5.42 (-11.3, 0.43) 0.069 
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Table 3.8, results of exhaled NO, multi-breath washout test and broncho-
provocation with cold air, according to ventilation group 
Lung function CV 
Mean 
(SD) or % 
HFOV 
Mean 





























































1.56 (0.41, 5.95) 
0.55 0.47 
 
*log transformed values 




There were no significant differences between the two groups of ventilation in the 
proportions of children with airway hyper-reactivity and in their exhaled nitric oxide 





Figure 3.2, box plot diagrams showing differences in medians of z scores of large airway 










Figure 3.3, box plot diagrams showing differences in medians in z scores of medium and 





Table 3.9, respiratory morbidity in the past 12 months according to 
ventilation group, odds ratio unadjusted and adjusted for birth weight, 
gestational age and weather given surfactant at birth 
Respiratory  
morbidity  
CV HFOV Unadjusted 













     
Daily 1/22 (4.6%) 5/23 (22%)    
Weekly 1/22 (4.6%) 2/23 (8.7%)    
Monthly 4/22 (18%) 4/23 (17.4%)    
Less than 
monthly 
16/22(73%) 11/23 (48)    
Antibiotics for 
chest problems 





yes 22/150 (15%) 18/154 (12%)    
No 123/150 (82%) 132/154 (86%)    










Table  3.10, chest medicines (other than antibiotics) and hospital 
admissions over last 12 months, according to ventilation group 
Respiratory  
morbidity  
CV HFOV Unadjusted 












Yes 24/150 (16%) 21/152 (14%)    
No 125/150 (83%) 129/152 (85%)    
Don’t know 1/150 (0.67%) 2/152 (1.3%)    
The type of chest 
medicine 
     
Prednisolone 1 2    
Oxygen 3 0    
Ventolin 20 20    
Bricanyl 2 2    
Atrovent 1 0    
Salmeterol 0 1    
Other inhaler 
reliever 
3 2    
Becotide 6 5    
Pulmicort 2 1    
Other inhaler 
preventer 
5 7    
Seretide 3 5    
Admission to 
hospital 







3 0    
surgery 6 9    
Other* 16 17    
	




With regards to respiratory morbidity in the last 12 months, there were no 
significant differences between ventilation groups in respiratory symptoms over last 
12 months (number of wheeze episodes and the use of antibiotics for chest 
problems), as documented by the completed parent’s questionnaire (Table 3.9). 
There was no difference in the use of any other chest medicine between the two 
ventilation groups, when reported by parental questionnaire (Table 3.10). 
There was no difference in the number of hospital admissions due to any cause 
(Table 3.10). 
There was difference in any other major prematurity related morbidity, including 
epilepsy, cerebral palsy, hydrocephalus with a VP shunt or gastrostomy between 
the two groups of ventilation (as shown in Table 3.11). 
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Table 3.11, other morbidity according to ventilation group 
	
 Other health 
problems 
CV HFOV Unadjusted 











Not on prescribed 
medication for 
seizures 
5 10    
On medication 
and seizure free 
3 2    
On medication 
with <1 seizure 
per month 
0 2    
On medication 
with >1 seizure 
per month 
2 1    
Diabetes 0 0    
Cerebral palsy 12 18    
Hydrocephalus 
with a shunt 
2 3    
gastrostomy 2 1    
Other bowel 
stoma 
3 2    
Any other  
problem under 
the care of a 
doctor** 











Two hundered and twenty five teachers returned the questionnaires.   
 
With regards to the educational attainment  according to ventilation group,  
there were statistically significant differences in three subjects (IT, Design & 
Technology, Art and Design), with higher scores in the HFOV group. (Table 
3.12). 
 
With regards to the children’s educational provision, there was no difference 
in the type of educational provision between the two ventilation groups (Table 
3.13). 
There was no difference in the area of special educational need (Table 3.13). 
 
However, proportion of children receiving SEN support in school was smaller 












Table  3.12 , educational attainment according to ventilation group, 
scores 1-4, results presented as mean (SD) for ventilation group 
 
* Rating scale for area of study: 1: very below average; 2: below average; 3: 
average; 4: above average; 5: very above average. Average score is the 
mean of all available subject scores 
 
Area of Study * N CV HFO 
Difference  
(95% CI) p-value  
      
English/Literacy 219 2.81 (1.04) 2.92 (0.91) 0.07 (-0.17, 0.32) 0.35 
 
Mathematics 218 2.76 (1.03) 2.76 (1.01) 0.00 (-0.27, 0.26) 0.75 
 
Art & Design 208 2.76 (0.89) 3.00 (0.79) 0.24 (0.01, 0.47) 0.006 
 
Geography 206 2.79 (0.91) 2.88 (0.77) 0.07 (-0.13, 0.27) 0.27 
 
History 205 2.81 (0.89) 2.92 (0.84) 0.10 (-0.13, 0.33) 0.14 
 
I.T. 204 2.82 (0.80) 3.00 (0.78) 0.18 (-0.03, 0.39) 0.023 
 
Science 215 2.83 (0.99) 2.96 (0.83) 0.12 (-0.12, 0.36) 0.12 
 
Design & 
Technology 197 2.80 (0.88) 3.04 (0.75) 0.24 (0.02, 0.46) 0.017 
 
Average subject 
score 221 2.79 (0.79) 2.93 (0.70) 0.12 (-0.07, 0.30) 0.076 
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Special school or 











0   
Other 1/148 
(0.68%) 










Area of need: **** 
 
    
Specific learning 
difficulty (SpLD) 





difficulty (MLD) 19 19 
0.89 (0.44, 
1.77) ** 0.74  
Severe learning  













 Behaviour, emotional 









and  communication 
needs (SLCN) 



















0 0   
Physical Disability 
(PD) 










Table  3.14, details of children’s special educational needs provision, 
CV vs HFOV ventilation group 
Educational 
provision 

















Stage of special needs 
register: 
    
School Action 21/52 (40%) 18/56 (32%)   
School Action Plus 14/52 (27%) 15/56 (27%)   
Statement of Special 
Education Needs 
17/52 (33%) 24/56 (43%)   
Receives SEN support in 











23 24   
Median hours/wk 
(range) 
5 (1 to 40) 20 (1 to 30)   
One-to-one special 
needs provision 
17 22   
Median hours/wk 
(range) 
1.5 (1 to 20) 4 (1 to 40)   
Small group special 
needs provision 
44 34   
Median hours/wk 
(range) 
3 (1 to 33) 3 (1 to 30)   
Seeing the following 
professionals in school: 
**** 
    
Outreach Teacher 7 4   
Educational 
Psychologist 
19 12   
Clinical Psychologist 2 1   
Physiotherapist 6 11   
Speech/Language 
Therapist 
16 16   
Occupational Therapist 14 13   
Child require extra 











** All non-responses were assumed to not have the particular area of need 
*** P-value unadjusted due to small numbers; all non-responses were 
assumed to not have the particular area of need 
****Some children require more than one area of special educational needs, 
SEN support or professional help in school (responders could tick more than 
one box).  
All data derived from teacher’s questionnaire except for school type and support, 
which comes from parental questionnaire. There were 225 returned teacher’s 
questionnaires , one teacher for every child (109 in CV group and 116 in HFOV 
group) and 305 parental questionnaires returned (150 in CV group and 155 in 
HFOV group).  
 
3.5.	Discussion	
The analysis of lung function measurements showed better small airway function in 
extremely preterm children who were supported with high frequency oscillation 
immediately after birth, thus proving the primary hypothesis of this thesis.  
There were significant differences found in the baseline characteristics of two 
ventilation groups. Conventionally ventilated children had higher birth weight (923g 
vs 867g, p 0.016), had higher gestational age (27w vs 26.7w, p 0.048) and more of 
them received surfactant (99% vs 95%, p 0.036).  After adjusting for those 
characteristics result remained significant, in favour of HFOV.   The adjusted 
analysis also did not change the significant difference in the large airway function, 
FEV1 z score and FEV1/FVC, in favour of HFOV group. 
Surprisingly, there was no difference in the LCI measurements between the two 
ventilation groups, although there was a significant difference measured in the 
small airway function by spirometry (z score FEF75) and impulse oscillometry 
(R5Hz). Also, there was no difference in the amount of air trapping, as measured 
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by plethysmography derived RV. There are several possible explanations for this. 
LCI is a test with high sensitivity and useful in detection of early airways disease. 
However, it is less useful with significant large and small airway obstruction, such 
as found in extremely preterm children.(Horsley, 2009) The significant large airway 
obstruction differences encountered in our study population of preterm children 
could have influenced the SF6 washout results. Additionally, we found LCI 
measurements were significantly longer then previously described in the literature 
(significantly longer than 5 min per measurement). It was the longest lung function 
test in our protocol, lasting over 30 minutes for three attempts. Children found it 
difficult to maintain the seal on the mouthpiece for that amount of time. 
There were no significant differences in respiratory symptoms at follow up, as 
obtained by the results of respiratory questionnaires analysis, although lung 
function differences for small and large airway function were significant between 
the two groups of ventilation in preterm children. Other studies have found 
asymptomatic bronco-obstruction in preterm population of children. (Fawke et al., 
2010) Furthermore, because the differences in respiratory symptoms were not 
present in our study population at school age, further respiratory follow up would be 
difficult just on the basis of respiratory symptoms.  It is difficult to predict the rate of 
decline in the lung function and the potential respiratory vulnerability in the 
adulthood is worrying. As the respiratory symptoms are not relevant and not a good 
indicator of decline, longitudinal measurements of lung function will be of 
paramount importance. 
The lung function differences found in this study are the first published data 
comparing the two modes of ventilation suggesting that oscillated preterm children 
might have more preserved lung function than conventionally ventilated children at 
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school age. (Gerstmann et al., 2001, Courtney et al., 2002, Van Reempts et al., 
2003) 
There were concerns in previous studies regarding association of HFOV and 
increased incidence of IVH (inter ventricular haemorrhage) and PVL (periventricular 
leukomalacia).(1989, Moriette et al., 2001).   However, study has shown no 
significant difference between the two ventilation groups in the majority of 
functional outcomes. Furthermore, with regards to educational attainment, 
oscillated children seem to have better visual spatial skills as they had significantly 
better performance in Art and design, IT and Design and technology. Additionally, 
there was a trend towards more SEN support in the CV group. 
There are limitations in this study.  References for lung function result z scores that 
were used in this study did not account for ethnic origin. New reference ranges, 
showing differences in spirometry results between ethnic groups, have been 
published recently. (Quanjer et al., 2012) The majority of the children in the study, 
however, are of white ethnic origin and for the consistency with other lung function 
tests (plethysmography, helium dilution, gas transfer) the same reference source 
was used (Rosenthal et al., 1993a). 
The power of the study was calculated for the sample of 320 children. This target 
was achieved (n = 319) for the completed questionnaires (parental and children’s). 
However, only 248 children had full assessment with the lung function 
measurements.  
Conclusion 
There are long-term benefits on lung function from using HFOV with a high volume 
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lung strategy in extremely preterm babies. Although the difference was small, it 
was statistically significant and consistent across a range of different lung function 
tests. Longitudinal study of lung function would add significantly to this body of 
evidence, to assess the impact of the ventilation mode in neonatal period on the 
aging lung later in life. High frequency oscillation does not cause more functional 











Pulmonary hypertension has been defined as an increase in mean pulmonary 
arterial pressure (PAP) >25 mmHg at rest as assessed by right heart 
catheterization (RHC). (Galiè et al., 2009) 
Available published data from several RCT’s, on 1,187 individuals from 47 studies 
in 13 countries, have shown that the normal mean PAP at rest is 14±3 mmHg, with 
an upper limit of normal being 20 mmHg. Normal systolic PAP for population is 
found to be at 20.8±4.4 mmHg.  The significance of a mean PAP between 21 and 
24 mmHg is unclear. Patients presenting with PAP in this range need further 
evaluation.(Kovacs et al., 2009) 
Studies of the lungs of infants who died and had had BPD have found an increase 
in pulmonary arterial medial thickness, reduced number of alveoli and significantly 
reduced total number of arteries (Hislop and Haworth, 1990). Those findings 
suggest that infants who recover from RDS might have significant vascular 
abnormalities.  
Angiogenesis is necessary for alveolarization and growth of the small pulmonary 
arteries is significantly interrupted due to premature birth. Several angiogenic 
factors, such as vascular endothelial growth factor (VEGF) have been implicated in 
vascular development. Decreased VEGF mRNA and a decreased number of 
angiogenic receptors were found in infants who were born below 27 weeks of GA, 
had BPD and died.(Bhatt et al., 2001) 
One study assessed 29 patients with BPD who had an ECHO in the first years after 
birth and subsequently underwent cardiac catheterisation. Tricuspid regurgitation 
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was detectable in 19 children, allowing estimation of the systolic pulmonary artery 
pressure (SPAP) in 61% of the patients. Cardiac catheterisation confirmed PH in 
23 patients (74%). Although examination by ECHO can underestimate and 
overestimate SPAP in comparison with the gold standard cardiac catheterisation 
nevertheless, it is advised as a valuable screening tool.(Mourani et al., 2008) 
We aimed to assess pulmonary pressures in very prematurely born infants at 
school age and assess the potential influence of ventilation mode at birth on 
pulmonary pressures.   
We have also aimed to assess any potential correlation between the small airway 
changes previously measured with spirometry (Chapter 3) and the pulmonary 




Doppler echocardiography is a non-invasive method that is commonly used to 
screen for pulmonary hypertension (PH). It can simultaneously provide information 
of the right ventricular systolic pressure (RVSP), functional and morphologic 
sequelae of PH and identify possible cardiac causes of PH (Abbas et al., 2003, 
Arcasoy et al., 2003).  
The estimation of pulmonary artery pressure (PAP) is based on the peak velocity of 
the jet of tricuspid regurgitation. The simplified Bernoulli equation describes the 




Max RV-RA gradient= 4 x vmax2 
Max RV-RA gradient -  peak pressure gradient between right ventricle (RV) and 
right atrium (RA) 
vmax  -   peak systolic velocity of the tricuspid regurgitation jet 
This equation allows for estimation of systolic pulmonary artery pressure (sPAP), 
taking into account right atrial pressure (RAP):  
sPAP = RAP + maxRV-RA gradient 
Right atrial pressure can be estimated based on the diameter and respiratory 
variation of the inferior vena cava although often a fixed value of 5 or 10 mmHg is 
assumed.(Fisher et al., 2009) 
 
Continuous wave Doppler was used to determine the peak velocity of the tricuspid 
regurgitation and time velocity integral was traced to obtain the mean RV-RA 
gradient. Ultrasound system Phillips iE33 was used for all scans. The following 
views were used to take measurements: subcostal long axis, apical 4 chamber, 
parasternal long axis, parasternal long axis angulated for TV, parasternal short 
axis. 
	
Pulmonary hypertension was defined as the mean pulmonary artery pressure 
(mPAP)>25 mmHg. The mPAP(mean pulmonary artery pressure)  was calculated 
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as the mean RV-RA pressure (right ventricule/right atrium gradient) plus estimated 
RA pressure. The RA (right atrial) pressure was estimated by measuring the IVC 
(inferior vena cava) diameter and change with respiration. The IVC diameter was 
measured 2 cm from IVC-RA junction.  
SPAP (systolic pulmonary artery pressure) was calculated by adding a minimal 
right atrial pressure of 5 mmHg to the maximal RV-RA pressure gradient, to avoid 
potential variations in IVC measurements. 
The child was asked to perform a brief rapid inspiration and IVC collapse was 
visualised and recorded.  The RA pressure was recorded as a value of 5 mmHg for 
collapse of ≥50%, 15 mmHg for ≤50%. IVC size of 2 cm was taken as a cut off for 
RAP >10 mmHg.  That is when IVC was less than 20 mm and the collapsibility 
greater than 50%, RAP was estimated as 5 mmHg versus 10 mmHg when the 
collapsibility was less than 50%. When the IVC was greater than 20 mm, RAP was 
estimated as 15 mmHg when the collapsibility was greater than 50% and as 20 
mmHg when the collapsibility was less than 50%. 
Children with TR velocity of equal or greater to 2.7 m/s were referred to their local 
paediatric cardiology team for further assessment and follow up.  
The ECHO assessments were also used to assess for left atrium (LA) enlargement, 
to exclude mitral stenosis, to assess whether mitral inflow was normal and whether 
LV(left ventricle) function was normal.  Following measurements were reported : 
LA dimensions at the end of ventricular systole on apical 4 chamber view   
E:A ratio ( absolute E: A velocities) 
LVEDD (mm)(left ventricle end diastolic diameter) 
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LVEF (%)(left ventricle ejection fraction) 
 
To assess the right ventricular function the following were reported: 
End diastolic IVS (inter-ventricular septum) diameter (mm) 
TAPSE (mm)(tricuspid annular plane systolic excursion) 
Pulmonary end diastolic pressure estimated from pulmonary regurgitation jet and 
pulmonary artery acceleration time (PAAT), as additional measurements of 
pulmonary pressure independent of tricuspid regurgitation velocity(Yared et al., 




Post hoc power calculation for the differences in pulmonary pressures was done for 
the peak velocity of the tricuspid regurgitation (TR vmax (m/s)), assessed by 
continuous wave Doppler as the primary outcome. The achieved sample size of 
110 children in each group allowed a difference of one standard deviation to be 
detected with 90% power at the 5% significance level. Difference in pulmonary 
pressure of 3 mmHg (equal to difference in velocity of 0.9 m/s) is considered 
significant in predicting the clinical outcome.(Galiè et al., 2009) 
All variables were tested for normal distribution with the Kolmogorov-Smirnov test. 
T test for normally distributed variables and the Mann-Whitney U test for 
nonparametric comparisons. P value of 0.05 was considered statistically significant. 
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Sensitivity analysis was performed for birth weight and gestational age, for all echo 
parameters. 
Statistical analysis was performed using SPSS 22 version (SPSS GmbH Software 
– IBM Company).  
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Recruited for follow-up and analysed 
N=159 
Attended assessment at KCH N=126 
Questionnaires only N=33 
	
Allocated to Conventional Ventilation 
(CV) (n=397) 
 
2. Survived to hospital discharge 
Allocated to high frequency 
oscillation (HFO) (n=400) 
	
•
Recruited for follow-up and analysed 
N=160 
Attended assessment at KCH, N=134 
 













- ASD N=1 
- PDA N=1 
- HOCM N=1 
- Scoliosis N=2 
- Poor window N=2 
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4.4.	Results	
Two hundred scans were obtained. Seven scans were excluded from the analysis: 
one child had a large atrial septum defect, one child had a significant persistent 
ductus arteriosus, one child was diagnosed with hypertrophic cardiomyopathy at 
the time of the screening. Scans of 2 children were excluded from analysis due to 
severe scoliosis and 2 scans from preterm children were excluded due to poor 
window quality. 
There was no significant difference in demographics and baseline measurements 
of children in two ventilation groups (Table 4.1). 
There was no significant difference in left atrial dimensions, intra-ventricular septum 
diameter, left ventricular systolic and diastolic function or right ventricular systolic 
function. (Table 4.2)  
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Table 4.1, demographics and baseline measurements of children in two 
ventilation groups 
 CV  







GA (weeks) 27.0 (1.2) 26.8 (1.4) 0.2 (-0.2, 0.6) 0.34 
Birth weight (g) 898 (193) 890 (213) 8 (-50, 65) 0.80 
Weight (kg) 44.0 (12.7) 45.0 (11.4) -1.0 (-4.4, 2.5) 0.56 
Height (cm) 152.4 (9.2) 151.3 (8.1) 1.1 (-1.4, 3.6) 0.39 
Hb 12.6 (1.3) 12.54 (1.1) 0.16 (-0.22,0.59) 0.42 
O2 saturation (%) 98.3 (1.1) 98.3 (1.2) 0.03 (-0.3, 0.37) 0.98 
BP systolic (mmHg) 118 (9.4) 117 (11.0) 0.59 (-2.5, 3.7) 0.71 
BP diastolic (mmHg) 74.3 (8.9) 74.1 (9.5) 0.19 (-2.64, 3.02) 0.89 
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Table 4.2, difference in left atrial dimensions, intra-ventricular septum 
diameter, left ventricular systolic and diastolic function and right 












































































































 (-0.30, 0.84) 
0.35 
	
&comparison of means based on independent samples the t-test, normal 
distribution  
* number of children included into analysis 
	 219	
Abbreviations: left atrium diameter (LA), ratio of left ventricle inflow velocities (E/A), 
left ventricle end diastolic diameter z score (LVEDD), left ventricle ejection fraction 
(LVEF), intra-ventricular septum end diastolic diameter z score (EDIVS) and 
tricuspid plane systolic excursion z score (TAPSE) 
Comparison of echocardiographic parameters, including pulmonary pressure 
measurements from tricuspid regurgitation, inferior vena cava measurements, 
pulmonary pressure measurements from pulmonary regurgitation and pulmonary 
artery acceleration time, showed no statistical differences between the CV and 
HFOV group. (Table 4.3 and Table 4.4.) 
Three children from the total study population were found to have peak TR velocity 
>2.7 m/s and they were referred to their local paediatric cardiology team for further 




Table 4.3, echocardiographic measurements of the tricuspid regurgitation 





























































































































0.25 (-0.98, 1.49) 
-0.3 (-1.5, 1.0) 
0.69 
 
&comparison of means based on independent samples the t-test, normal 
distribution  
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*SPAP calculated as peak RV-RA gradient plus minimal RAP of 5 mmHg for all 
**MPAP calculated as mean RV-RA gradient plus minimal RAP of 5 mmHg for all 
^number of children included into analysis 
Abbreviations: tricuspid regurgitation velocity (TR), RV-RA gradient, inferior vena 
cava (IVC) diameter and estimated right atrium pressure (RAP), systolic pulmonary 
artery pressure (SPAP) 
 
Table 4.4, measurements of pulmonary regurgitation and pulmonary artery 


































































&comparison of means based on independent samples the t-test, normal 
distribution  
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* number of children included into analysis 
Abbreviations: pulmonary outflow velocity (PV), maximum gradient across 
pulmonary valve (PV max PG), end diastolic velocity of the pulmonary regurgitation 




The correlation coefficient  -0.28 (p-value <0.001) 
Figure 4.2, Scatter plot of FEF75 z-score and TR peak velocity in preterm children, both 
ventilation groups combined 
 
The Pearson correlation between main outcome of the small airway (FEF75 z 
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the preterm group of children has shown mild to moderate correlation (correlation 
coefficient -0.28, p<0.001), Figure 4.2. Additionally, DLCO z score has shown mild  










Figure 4.3, scatter plot of DLCO z score and TR peak velocity, Pearson correlation 






The feasibility of the TR measurement was consistent with the literature, which 
shows that TR is measurable in approximately 2/3 of the population.(Mourani et al., 
2008) TR velocity was measurable in 68% of conventionally ventilated children and 
76% of the oscillated children. 
Comparison of echocardiographic parameters, including pulmonary pressure 
measurements from two different sites, tricuspid regurgitation and pulmonary 
pressure measurements from pulmonary regurgitation and pulmonary artery 
acceleration time, has shown no statistical difference between the CV and HFOV 
group.   There were also no significant differences found in left atrial dimensions, 
intra-ventricular septum diameter, left ventricular systolic and diastolic function or 
right ventricular systolic function between the ventilation groups. 
The striking finding of echocardiographic measurements was the consistency 
across the pulmonary pressure parameters, left and right ventricle measurements 
within the preterm group, independent of the ventilation mode.  
Furthermore, there was a mild to moderate correlation between the small airway 
changes measured by spirometry (FEF75) and the pulmonary pressures measured 
by tricuspid regurgitation (TRvmax) and a mild correlation between z DLCO and 
tricuspid regurgitation. This could, perhaps, suggest similar underlying mechanism 
of injury of the small airways, alveo-capillary membrane and small pulmonary 
arteries, such as underlying inflammatory process, including perivascular and 
interstitial inflammation(Stacher et al., 2012). Lung function abnormalities have 
been described in patients with pulmonary hypertension of different origin.(Meyer et 
al., 2002) Abnormal pulmonary vessels could potentially affect the function of their 
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adjacent airways, as described in a review by Low and co-workers. (Low et al., 
2015) 
The proportion of children in the whole preterm study population that had 
pulmonary pressures on the higher side of normal was worrying. Maximum RV-RA 
gradient was equal or higher than 25 mmHg in 11.9% of preterm children (both 
ventilation groups combined).  
With added minimal RA pressure of 5 mmHg, this makes the calculated systolic 
mean pulmonary artery pressure equal or higher then 30 mmHg in almost 12% of 
the preterm children assessed. Therefore, it was important to compare the 
pulmonary pressures and cardiac parameters of preterm children to children born 
at term, which was done as the second part of this thesis (please see Chapter 6). 
 
Limitations	
Only 200 children, out of 248 children that came for assessment to King’s College 
Hospital, had ECHO. This was due to delay in obtaining the equipment after the 
recruitment already started. 
Echocardiographic estimates of systolic and mean pulmonary artery pressure are 
less sensitive than cardiac catheterisation measurements. Therefore, the severity 
of pulmonary hypertension is difficult to determine by ECHO.(Er et al., 2010, Abbas 
et al., 2003, Janda et al., 2011) Twenty-nine studies were included in the meta-
analysis published in 2011 by Janda and co-workers. The summary correlation 
coefficient between systolic pulmonary arterial pressure estimated from 
echocardiography versus measured by right heart catheterization was 0.70 (95% 
CI 0.67 to 0.73). The summary sensitivity and specificity for echocardiography for 
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diagnosing pulmonary hypertension was 83% (95% CI 73 to 90) and 72% (95% CI 
53 to 85), respectively. 
 
Conclusion 
Preterm children at school age have higher mean pulmonary pressure than the 
estimated general population mean.  
Pulmonary pressures at school age are independent of ventilation mode at birth in 












Studies have shown that premature birth, independent of BPD, is associated with 
lung function abnormalities. Babies diagnosed with BPD, however, have worse 
lung function during infancy than children without BPD. (Sanchez-Solis et al., 2012)   
Several studies have found small airway abnormalities in children born 
prematurely. Robin and co-workers measured lung function of 28 infants less than 
three years of age, who had BPD.  They used the raised-volume rapid thoracic 
abdominal compression (RVRTC) to measure forced expiratory flows and 
demonstrated significantly decreased FEF75-25 in the children who had BPD 
compared to normal controls healthy infants born at term(Robin et al., 2004).  
Gross and co-workers measured the lung function of 125 children aged seven 
years who were born between 24 and 31 weeks of gestation. They found 
significantly worse pulmonary function in the prematurely born children compared 
to controls, with particularly reduced forced expiratory flows, 25%-75% of vital 
capacity (FEF25-75). (Gross et al., 1998)   
Widespread small airway changes on thoracic high resolution computed 
tomography were described in eight year old children who had BPD. Those findings 
of wide spread peripheral airway changes suggest an increased risk of chronic 
obstructive pulmonary disease (COPD) later on in life.(Broström et al., 2010) 
Large airway obstruction in children born prematurely has been documented in 
several studies. Lum and co-workers demonstrated a high prevalence of lung 
function abnormalities in fifty 11 year old children born below 25 weeks of gestation 
compared to age matched controls born at term. Twenty-one of the extremely 
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premature children exhibited an obstructive pattern, while only 5 had evidence of 
restrictive lung disease (45 vs 11%). While 29% of the preterm children had 
previously diagnosed asthma, there was no increased prevalence of atopy or level 
of FeNO, suggesting a different underlying pathophysiology. (Lum et al., 2011) 
Premature birth at 25 weeks of gestation coincides with the saccular stage of lung 
development.  Histology findings in lung parenchyma of infants born between 24 
and 30 weeks of gestation have shown marked simplification of acinar structure 
with reduced alveolar number and decreased internal surface area. Those findings 
are consistent with the reduced pulmonary diffusing capacity (DLCO) 
demonstrating alveolar involvement in both BPD and non-BPD prematurely born 
children when compared to term controls.(Hakulinen et al., 1996)   
Balinotti and co-workers measured DLCO and alveolar volume, using a single 
breath-hold manoeuvre at elevated lung volume, in 39 infants born prior to 29 
weeks of gestation and at a mean of 11.6 months corrected age at the time of 
testing. They found decreased diffusing capacity in comparison with term born 
controls, consistent with impaired alveolar development after premature birth. 
(Balinotti et al., 2010) 
The children assessed in this thesis were all born between 23 and 28 weeks of 
gestation, hence it was very important to determine how their lung function 
measurements compared with term born children and which parts of the respiratory 




The lung function assessments of the preterm children are previously described 
(see Chapter 3).   
Lung function protocol in the term group, although initially designed to match the 
preterm group protocol, was not able to assess the degree of broncho-reactivity 
(cold air challenge test) due to time constrain. 
Term born children had small airway function assessed by spirometry. Spirometry 
also measured the degree of large airway obstruction and forced vital capacity. 
Direct assessment of small airway resistance was done by impulse oscillometry. 
Large airway function was assessed by spirometry and by impulse oscillometry.  
Lung volumes and the degree of hyperinflation were assessed by plethysmography 
and helium dilution.  The degree of alveo-capillary membrane damage by 
measuring the total lung gas transfer, alveolar volume and gas transfer per unit 
volume was assessed by the single breath carbon monoxide uptake method. 
The same reference ranges for all lung function measurements were used in the 
term born controls as for the prematurely born subjects. 
To exclude possible influences on lung function including passive/active smoking 
and pollution exposure, urine samples were obtained to assess cotinine 
levels.(Berny et al., 2002, Jacob et al., 2005a) 
Respiratory health was additionally assessed through the same parental 
questionnaire, including the family history of smoking, damp in the house, use of 




A sample size of 249 children in the preterm group and 110 children in the term 
group provided us with 90% power at 5% significance level to identify a difference 
of one SD in the primary outcome (FEF75). Differences of one SD or greater have 
been previously found when lung function have been compared in term and 
extremely preterm children.(Lum et al., 2011) 
Statistical	analysis  
Lung function data of two ventilation groups (CV and HFOV) were pulled together 
to represent the preterm group of children. All variables were assessed for normal 
distribution with the Kolmogorov-Smirnov test. For normally distributed variables t 
test was used to calculate the difference in the means between two groups, and the 
Mann-Whitney U test was used for non-parametric data. Chi-square test was used 
for categorical data. Sensitivity analysis was performed for birth weight and 
gestational age. All lung function outcomes between the two groups were adjusted 
for observed baseline imbalances at the time of assessment, pubertal status, 
height and level of cotinine in the urine, by performing analysis of covariance 
(ANCOVA) and statistically controlling for these variables. 
To examine the differences in proportions of abnormal lung function between term 
and preterm children, a z-score of +/- 2 was taken as abnormal and differences 
expressed as odds ratio. Published z- scores were used for all lung function 
measurements.(Rosenthal et al., 1993a, Rosenthal et al., 1993b) 
Statistical analysis was performed using SPSS 22 version (SPSS GmbH Software 
– IBM Company).  
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  Figure 5.1, UKOS recruitment flow diagram for lung function analysis between gestation 


















Recruited for follow-up and analysed 
N=319 
Attended assessment at KCH N=260 
Questionnaires only N=59 
	
UKOS trial 1998-2000,  

























Two hundred and sixty preterm children attended lung function assessment. 
However, 11 children needed to be excluded due to severe scoliosis (N=2) or 
inability to perform any lung function test (N=9). Therefore, 249 preterm children 
and one hundred and ten term children were included in the lung function tests 
analysis. 
Comparison of baseline characteristics of term and preterm children demonstrate 
that the term children were significantly taller (p<0.001). Preterm children had 
higher haemoglobin (p<0.001), lower oxygen saturation (p 0.027) and lower 
diastolic blood pressure (p<0.001). There were no significant differences in 
children’s age at follow up, proportion of boys, weight or systolic blood pressure 
(Table 5.1). 
Cotinine analysis showed that term children had higher proportion of urine samples 
with undetectable cotinine and lower proportion of samples with cotinine of >15 
ng/ml (lower proportion of active smokers detected), p<0.001. (Table 5.2)   A higher 





Table 5.1, Baseline neonatal characteristics and follow up 
characteristics of preterm and term children participating in the lung 
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Table 5.2, urine cotinine measurements and pubertal status, differences 



















































































*Independent sample t-test, chi square test for independence as appropriate, ^ 
Puberty defined as Tanner stage 3 reached, large difference in the proportion of 
missing data 
 
Oscillometry and spirometry measurements (Table 5.3) showed significant 
differences in all parameters measured, with more large and small airway 
obstruction in preterm children. Analysis of oscillometry measurements has shown 
that there was an increased resistance of small airways (measured at 5 Hz p = 
0.001) and large airways (measured at 20 Hz, p<0.001) in the preterm group of 
children.  
 Preterm children had worse large airway function measured by spirometry. The 
mean difference in FEV1 z score of 0.62 SD was found between term and preterm 
group, p<0.001. There was also significantly reduced FEV1/FVC z score in preterm 
children (mean difference 1.04 SD, p<0.001) and reduced PEF % predicted (mean 
difference 10%, p<0.001).       (Table 5.3) 
Preterm children had worse small and medium airway function measured by 
spirometry, with significant difference in FEF25 z score, FEF50 z score, FEF 75 z 
score and FEF2575 z score (mean difference in FEF2575 z score 0.9 SD, 
p<0.001), (Table 5.3). 
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Table 5.3, oscillometry and spirometry measurements, comparison of 
means between term and preterm children  
LF 
measurement 
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^sensitivity analysis performed for patients with gestational age at birth and birth 
weight 
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*Number of children participating in the analysis, & comparison of means based on 
independent samples the t-test, normal distribution 
 
Gas transfer measurements have shown better diffusion capacity of the lungs 
(DLCO) in the term group of children, with a mean difference of 0.78 SD, p<0.001. 
Mean alveolar volume (VA) was higher in the term group of children, mean 
difference 0.32 SD, p<0.001. 
 
Plethysmography measurements have shown significantly higher total lung 
capacity, mean TLC z score, in the preterm group of children prior to sensitivity 
analysis (p<0.001) and when non parametric statistics was used (p 0.039). 
Furthermore, there was higher mean residual volume (RV) z score in the preterm 
group, mean difference 0.68 SD, p<0.001. (Table 5.4)   
There was no difference between term and preterm children in the functional 
residual capacity measured by plethysmography (FRC pleth) z score (p 0.681), or 
VCmax z score (p 0.768).  There was no difference between the term and preterm 
group in the mean functional residual capacity measured by helium dilution (FRC 
He) z score, p 0.189. (Table 5.4) 
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Table 5.4, Comparison of gas-transfer, plethysmography and helium dilution 
measurements between term and preterm children 
Lung function 
measurement 
































































































































   
FENO >20 ppm  N/A 60/207    
 
	240	
*based on independent samples t-test 
^sensitivity analysis performed for patients with gestational age at birth and birth 
weight 




Table 5.5, adjusted analysis for baseline differences in spirometry and 
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* adjusted analysis for baseline differences in pubertal status, height and cotinine 







Table 5.6, adjusted analysis for baseline differences, result of gas-transfer 



































































































       
 
*Adjusted differences for pubertal status, height and cotinine level  
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Sensitivity analysis done on all the lung function parameters for gestational age 
and birth weight showed significant difference for all the main lung function 
parameters apart from the TLC z score. TLC z score difference also remained 
positive when non parametric test was used. (Table 5.5, Table 5.6) 
Adjusting additionally for baseline imbalances, pubertal status, height at school age 
and cotinine level, produced  similar significant difference in the small airway 
function, in favour of term children (Table 5.5). Difference remained significant in all 
other lung function parameters including large airway function (Table 5.5), diffusion 
capacity of the alveo-capillary membrane and the amount of air trapping (Table 
5.6). 
Comparison of proportions of children with abnormal lung function (z score < -2 or 
<80% predicted) has shown significantly higher proportion of abnormal FEV1 z 
score in the preterm group (11.7% in preterm vs 1.8% in term children, OR 7.08, 
95%CI 1.65, 30.3). There were significantly higher proportions of abnormal FVC z 
score (6% in preterm vs 1.8% in term children, OR 3.44, 95%CI 0.77, 15.3), 
FEV1/FVC z score (34.3% in preterm vs 10.1% in term children, OR 4.65, 95%CI 
2.36, 9.1), FEF25 z score (14.2% in preterm vs 3.7% in term children, OR 4.33, 
95%CI 1.5, 12.5), FEF50 z score (24% in preterm vs 3.7% in term children, OR 
8.28, 95%CI 2.9, 23.4) and FEF75 z score (13.3% in preterm vs 4.5% in term 





Table 5.7, Differences in proportions of abnormal lung function 
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0.95 (0.41, 2.20) 
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When parental questionnaires were analysed, preterm children did not have 
significantly more wheeze episodes over last 12 months (14.8% in preterm vs 9.8% 
in term, p 0.132). 
However, preterm children had significantly more antibiotics prescribed for chest 
problems over last 12 months (13.2% in preterm vs 2.9% in term, p 0.001). (Table 
5.8) 
There was no difference in the use of other chest medicine (14.8% in preterm vs 
10.8% in term, p 0.517) or in the number of hospital admissions over last 12 
months (10.9% in pretrm vs 9.8% in term, p 0.678). (Table 5.8) 
There was no significant difference in the number of seizure episodes between 
term and preterm children (7.9% in preterm vs 2.9% in term, p 0.106). However, 
preterm children were receiving significantly more SEN support in school (36.8% in 
preterm vs 6.9% in term, p<0.001). (Table 5.8)  
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Table 5.8, comparison of respiratory symptoms between gestation groups, 
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We have demonstrated that preterm children born below 29 weeks of gestation 
have significantly worse lung function when compared to term born children of the 
same age. 
This group of preterm infants was born and treated at the time of routine use of 
antenatal steroids and postnatal surfactant. However, lung function abnormalities 
are still widespread and severe, including small airway function, large airway 
function and the capacity of the alveo-capillary membrane.  
We found significant differences in the baseline measurements between the two 
groups. Preterm children in our study were significantly shorter than term born 
children of the same age. There was a significantly higher proportion of term 
children that reached puberty at the time of assessment. However, the difference in 
all lung function parameters remained significant even after adjusting for these 
differences. 
The difference in proximal airway function was large, measuring a whole standard 
deviation for FEV1FVC ratio z score, in favour of term children.  
The difference in small airway function was significant, although smaller. There was 
a difference of 8% in R5 percentage predicted between gestation groups and a 
difference of 0.55 of SD in FEF75 z score. 
Considering the differences in lung volumes, we found higher residual volume in 
the preterm group, consistent with air trapping as a consequence of large and small 
airway obstruction. There was no difference in functional residual capacity between 
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the groups, as obtained by two different methods, plethysmography and helium 
dilution. 
Some of the previous studies have shown similar differences in small and large 
airway function, on a smaller number of children. Fillipone and co-workers 
undertook a longitudinal study of pulmonary function at 24 months and school age 
involving 18 children with moderate to severe BPD. They found that FEV1 and 
FEF25-75 were lower than normal in 15 of the 18 children at school age with a 
significant positive correlation with VmaxFRC at 24 months. The large airway 
obstruction was unresponsive to salbutamol in 10 of the 15 children. There was no 
increase in FENO in any of the children.(Filippone	et	al.,	2003)	
Mean difference between the groups in the alveo-capillary membrane function, as 
expressed by diffusing capacity for carbon monoxide, DLCO z score, was also 
significant, favouring term children.  
A study by Vrijlandt and co-workers investigated lung function of 42 preterm infants 
in a prospective cohort study. Children were born with a gestational age of less 
than 32 wk and a birth weight under 1,500 g and followed up for 19 yr. They 
compared the lung function to healthy term control subjects (n = 48). The diffusion 
capacity of the lungs was significantly reduced in preterm children (88% predicted 
vs. 96% predicted, p 0.003).  No differences between the groups were found in 
TLC measured by plethysmography. No significant differences in lung function and 
exercise parameters were found between preterm children with and without 
broncho-pulmonary dysplasia.(Vrijlandt et al., 2006) 
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Preterm children in our study were 7 times more likely to have an abnormal FEV1 z 
score (<-2) than children born at term. Therefore, it was surprising to find that there 
was no difference in respiratory symptoms between gestation groups, in particular 
the incidence of wheeze, as obtained by the parent’s questionnaire.  
There was, however, significantly higher proportion of preterm children that was 
prescribed antibiotics for chest problems in the last year. There are potentially 
significant clinical implications of these findings. It is difficult to depict whether there 
is an increased incidence of chest infections among preterm children at school age, 
or are those symptoms of different aetiology, potentially unrecognised broncho-




Term group of children was not recruited at birth, as this was not possible in the 
original UKOS study. Therefore, the perinatal data of the term children were 
incomplete, as they were dependent on the parent’s recollection. However, 
sensitivity analysis on these data did not make a difference to the main lung 
function findings. 
Full lung function protocol, which was performed by preterm children, was not 
possible in term children group, due to time constraints. Therefore, it was not 
possible to compare the bronco-reactivity and the degree of inflammation 




There are significant, worrying lung function abnormalities in extremely preterm 
born children at school age, despite of routine use of antenatal steroids and 
postnatal surfactant. 
Clinical diagnosis of broncho-obstruction in preterm children could be difficult 
without lung function testing, as common respiratory symptoms are frequently 









The diagnosis of pulmonary hypertension (PH) is often difficult because the 
symptoms may be subtle and masked by coexisting respiratory problems (Galiè et 
al., 2009).  To determine the role of pulmonary vascular tone in pulmonary 
hypertension, Mourani and co-workers studied 10 patients with BPD who 
underwent cardiac catheterisation for evaluation of pulmonary pressures and found 
that high pulmonary vascular tone contributed to pulmonary vascular disease in 
children with BPD(Mourani et al., 2004). Pulmonary hypertension persisted into 
adolescence and, in addition to structural changes, vascular tone continued to 
contribute to hypertension and remained responsive to oxygen and NO.  
The clinical utility of echocardiography (ECHO) in the diagnosis of pulmonary 
vascular disease in children with BPD has been described in the literature.(Mourani 
et al., 2008)  
 
6.2. Methods 
Same echocardiography assessment protocol was undertaken for the term group 
of children, as described previously for the preterm group (please see Chapter 4). 
Continuous wave Doppler was used to determine the peak velocity of the tricuspid 
regurgitation and time velocity integral was traced to obtain the mean RV-RA 
gradient. Ultrasound system Phillips iE33 was used for all scans.  
Pulmonary hypertension was defined as the mean pulmonary artery pressure 
(mPAP)>25 mmHg and systolic pulmonary artry pressure greater than 36 mmHg. 
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The mPAP(mean pulmonary artery pressure)  was calculated as the mean RV-RA 
pressure (right ventricule/right atrium gradient) plus estimated RA pressure. The 
RA (right atrial) pressure was estimated by measuring the IVC (inferior vena cava) 
diameter and change with respiration. SPAP (systolic pulmonary artery pressure) 
was calculated by adding a minimal right atrial pressure of 5 mmHg, to avoid 
potential variations in IVC measurements.  
Additional measurements of the pulmonary artery pressure, independent of 
tricuspid regurgitation velocity, were undertaken and reported: pulmonary end 
diastolic pressure estimated from pulmonary regurgitation jet and pulmonary artery 




  Figure 6.1, UKOS recruitment flow diagram for ECHO analysis between gestation groups 
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- ASD N=1 
- PDA N=1 
- HOCM N=1 
- Scoliosis N=2 




6.3 Analysis  
 
Sample size  
The sample size for the prematurely born cohort was fixed as the children were 
followed up at age 11-14 years from the UKOS trial.  We aimed for balanced 
numbers, that is to assess the same number of term born children as the number of 
prematurely born children in each of the ventilation groups.  Approximately 100 
children in each ventilation group had pulmonary artery assessments. Since peak 
velocity of the tricuspid regurgitation, TR vmax (m/s), was the primary outcome and 
these data were continuous, the sample was able to detect small differences 
between groups: specifically comparison of the preterm (n=2x100) and term born 
children (n=100) allowed detection of a difference of 0.40 standard deviations 
(SDs) between prematurely and term born children and by comparison by mode of 
ventilation to detect a difference of 0.46 SD both with power 90% and two-side 
significant of 5%.  
Analysis 
All variables were tested for normal distribution with the Kolmogorov-Smirnov test. 
Continuous variables were expressed as means with standard deviation (SD). 
Comparisons of 2 means were performed with the t test for normally distributed 
variables and the Mann-Whitney U test for non-Gaussian variables. Chi-square test 
was used for categorical variables. Sensitivity analysis was performed for birth 
weight and gestational age, for all echocardiographic parameters. All 
echocardiographic outcomes were adjusted for observed baseline imbalances at 
	256	
the time of assessment, age and height, between the two gestation groups by 
performing an analysis of covariance and statistically controlling for these two 
variables (ANCOVA). To show the differences in proportions of low, moderate and 
high maximum RV-RA gradient, RV-RA gradient derived from peak TR velocity was 
divided into three categories: 1) less than 20 mmHg, 2) 20-25 mmHg, 3) more than 
25 mmHg.  The analysis was performed using SPSS 22 version (SPSS GmbH 
Software – IBM Company). 
Additionally, Bland Altman analysis was undertaken to establish agreement of 
mean pulmonary pressures measurements by two different methods: TR (mean PG 
gradients obtained by tracing the TR envelope) and PR (early, peak, velocity of the 
pulmonary regurgitation jet with added RA pressure).  
P value of 0.05 was considered statistically significant.  
Statistical analysis was performed using SPSS 22 version (SPSS GmbH Software 
– IBM Company).  
 
6.4 Results  
Three of the term children were excluded from analysis: one child had had a 
congenital diaphragmatic hernia, one child had severe nephrotic syndrome with 
pericardial effusion and the third child was found to be preterm (at 32 weeks of 
gestation) during assessments. Comparisons of the neonatal demographics of the 
term and preterm group, (Table 6.1), have shown equal gender distribution 
between term and preterm infants (p 0.316) but significant differences in 
gestational age and birth weight (p<0.001), (Table 6.1). Baseline measurements at 
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the time of the echocardiogram (Table 6.2) showed significant differences in age (p 
0.046) and in height (p<0.001) but no differences in weight at follow up (p 0.181).  
Hemoglobin measured by spectroscopy was higher in the preterm children (p 
0.002) and there was a small but significant difference in oxygen saturation, being 
higher in term children (p 0.008). Diastolic blood pressure was significantly lower in 
the preterm children, but no differences in systolic blood pressure were found. 
(Table 6.2) 
Table 6.1, baseline neonatal characteristics of preterm and term 
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Table 6.2, Follow up characteristics and baseline measurements of preterm 



























46.4 (11.4) 44.9 (11.9) -1.88 (-4.6, 0.88) 0.181 
 
Height (cm) 












































Overall, TR velocity jet was measurable in 68% of preterm and 76% of term 
children. The maximum RV-RA gradient was equal or higher than 25 mmHg in 
11.9% of preterm children and none of the term children. (Table 6.3) 
Peak TR velocity was significantly higher in preterm group (p<0.001), (Table 6.3). 
The mean RV-RA gradient obtained by tracing of the TR jet time velocity integral 





Figure 6.2, boxplots of RV-RA gradient calculated from maximum TR velocity, according to 
gestation group (term vs preterm) 
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Table 6.3, Comparison of measurements of tricuspid valve velocity by 



















































































































































<0.001 <0.001 <0.001 
&comparison of means based on independent samples the t-test, normal 
distribution  
* number of children included into analysis 
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^sensitivity analysis performed for patients with gestational age at birth and birth 
weight 
abbreviations: tricuspid regurgitation velocity (TR), RV-RA gradient , inferior vena 
cava (IVC) diameter and estimated right atrium pressure (RAP), systolic pulmonary 
artery pressure (SPAP)  
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Results of inferior vena cava diameter (mean 1.79 cm preterm vs 1.69 cm term, p 
0.009) and estimated RAP (mean 7.82 mmHg in preterm vs 5.75 in term, p<0.001) 
were higher in preterm children (Table 6.3). 
 
 
Figure 6.3, scatterplot showing linear relationship between peak tricuspid velocity and 
mean RV-RA gradient derived by tracing the time velocity integral of the TR Doppler trace, 
according to gestation group. Proportion of preterm children (blue dots) have both mean 
and peak pulmonary gradient measured at the higher velocities. 
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There were no significant differences in left atrial size, left ventricle end diastolic 
diameter (LVEDD z score) or the diastolic function of the left ventricle (E/A ratio), 
(Table 6.4).  
There was a significant difference in the systolic function of the left ventricle 
(LVEF%), 68.7% in preterm vs 64.8 in term group, adjusted p 0.001 (Table 6.4). 
There was a significant difference in the systolic function of the right ventricle as 
assessed by TAPSE z score (mean 0.03 in preterm vs mean 0.98 in term, p 0.004), 
Table 6.4. 
The end diastolic diameter of the intra-ventricular septum was significantly lower in 






Table 6.4, Comparisons of left atrial size, diastolic and systolic function of 
the left ventricle, left ventricle and inter-ventricular septum diameter and 
systolic function of the right ventricle between term and preterm children  
 














































































































































Abbreviations: left atrium diameter (LA), ratio of left ventricle inflow velocities (E/A), left 
ventricle end diastolic diameter z score (LVEDD), left ventricle ejection fraction (LVEF), 
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intra-ventricular septum end diastolic diameter z score (EDIVS) and tricuspid plane systolic 
excursion z score (TAPSE) 
^sensitivity analysis performed for patients with gestational age at birth and birth weight 
Assessments of the pulmonary gradients measured by pulmonary regurgitation jet 
end diastolic velocity and pulmonary artery acceleration time, showed significant 
differences between the term and preterm group (Table 6.5). 
PI end diastolic velocity of the pulmonary regurgitation jet was significantly higher in 
preterm children (mean 89.6 m/s preterm vs 78.8 m/s in term, adjusted p <0.001). 
Adjusting for baseline imbalances in age and height at assessment produced the 
same difference in the primary outcome, TR peak velocity (Table 6.3). The 
difference remained significant in all other echocardiographic parameters apart 





Table 6.5, Comparisons of pulmonary pressures based on the Doppler 






































































































































*based on independent samples t-test 




Abbreviations: pulmonary outflow velocity (PV), maximum gradient across 
pulmonary valve (PV max PG), end diastolic velocity of the pulmonary regurgitation 






Figure 6.4, showing significant differences in proportions of low, moderate and high 
maximum RV-RA gradient. RV-RA gradient derived from peak TR velocity was divided into 




To show the differences in proportions of low, moderate and high maximum RV-RA 
gradient, the RV-RA gradient derived from peak TR velocity was divided into three 
categories: 1) less than 20 mmHg, 2) 20-25 mmHg, 3) more than 25 mmHg. There 
were significant differences in proportions of term and preterm children in the first 
group (50.7% vs 86.9%), the second group (40.4% vs 13.1%) and the third 




Figure 6.5, scatterplot of RV-RA gradient calculated from maximum TR velocity , 
according to birth weight. Proportion of preterm children  (lower group) have maximum 
















Figure 6.6, Bland-Altman plot, agreement of measurements of MPAP*, mean difference: 























Figure 6.7, showing linear correlation of the measurements of MPAP, by TR (mean 
gradient obtained by tracing of the TR envelope) and PR (peak velocity with added RA 









Figure 6.8, showing that there was no relationship between maximum pulmonary gradient 
measured by TR peak velocity and cotinine level. Pearson Correlation 0.027, p=0.772 
	
Discussion			
We have demonstrated that at 11-14 years of age, the mean pulmonary pressures 
of extremely preterm children were higher than those born at term.  Only one of the 
children born prematurely, however, had a systolic pulmonary pressure of 36 
mmHg, measured by SPAP and, therefore, fulfilled the diagnosis of pulmonary 
hypertension according to ERS guidelines (Galiè et al., 2009)  
In addition to the pulmonary pressures being higher in premature children, lower 
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systolic function of the right ventricle measured by TAPSE and thinner end diastolic 
inter ventricular septum diameter was found in the preterm group.  
Term group of children was found to be significantly older and taller when baseline 
characteristics were compared. As both age and height could potentially influence 
the calculated z scores, adjusted analysis was performed. The differences in z 
scores remained significant even after adjusting for baseline differences, thus 
excluding the possibility of the difference in z scores being related to differences in 
age or height. 
Interestingly, higher pulmonary artery pressure and right ventricular after load did 
not cause an increase in ventricular septal wall thickness.  Indeed, the prematurely 
born children had a thinner septum, although still within normal z score range.  A 
possible explanation is the lower blood pressures of the prematurely born children.  
In addition, the systolic after load of the left ventricle is a more important 
determinant of septal thickness.   
Our results contrast with those of Joshi et al (Joshi et al., 2014).  At 8-12 years they 
found no difference between echocardiographic markers of left and right ventricular 
function, they were similar in term born controls and those born preterm who did 
and did not develop BPD. The total population studied was ninety children and they 
did not undertake a similar extensive suite of echo assessments.   
There is recent evidence that preterm birth is associated with global myocardial 
structural and functional differences in adult life, with potentially clinically significant 
impairment in right ventricular systolic function. (Lewandowski et al., 2013b, 
Lewandowski et al., 2013a) It is possible that the structural changes detected later 
on in adulthood could be consequence of an increase in the resistance in the 
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pulmonary arterial vasculature. 
It is important to recognize that reduced right ventricular function and size of the 
right ventricle can potentially indicate the severity and chronicity of increased 
pulmonary pressure. In adult patients with pulmonary arterial hypertension, right 
ventricular function is the most important determinant of the life span. Specific 
mechanism underlying the decrease in systolic function of the right ventricle 
secondary to increased pulmonary artery pressure is unclear. When the right 
ventricle is exposed to pressure overload, it will initially show adaptive myocardial 
hypertrophy, subsequently followed by progressive contractile dysfunction. 
Subsequently, chamber dilatation could follow, to allow compensatory preload and 
maintain stroke volume. If contractile weakness progresses, clinical evidence of 
decompensated right ventricular failure can occur, characterized by diastolic 
dysfunction and decreasing cardiac output(Haddad et al., 2008, Voelkel et al., 
2006, Gladwin et al., 2004).   
This study has a number of strengths and some limitations.  
One of the strengths of the study is that we have measured pulmonary pressures 
by three different echocardiographic methods, TR regurgitation jet velocity (peak 
and mean), pulmonary regurgitation end diastolic velocity and pulmonary artery 
acceleration time. All three methods have shown similar results.  The study was 
adequately powered and presents largest study measuring cardiac parameters of 
very preterm children in school age to date. 
Qualitative echocardiographic findings may be less accurate than cardiac 
catheterization, and therefore underestimate or overestimate the degree of 
pulmonary hypertension. Echocardiographic estimates of systolic and mean 
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pulmonary artery pressure are relatively sensitive as a screening tool (up to 83%), 
however the severity of pulmonary hypertension is difficult to determine.(Er et al., 
2010, Abbas et al., 2003, Janda et al., 2011)  
 
Conclusion 
Children born very prematurely had significantly higher pulmonary pressures at 
school age when compared to term children. This was accompanied by lower 
systolic function of the right ventricle and thinner inter ventricular septum. 













The comparison of lung function measurements showed better small airway 
function in extremely preterm children who were treated with high frequency 
oscillation after birth, thus proving the primary hypothesis of the study.   
Children born extremely preterm had higher pulmonary pressures when compared 
with the term born children of the same age. 
Children born prematurely  had worse lung function when compared with the term 




There were significant differences between the ventilation groups in favour of 
HFOV in the results of several other measurements obtained by spirometry, 
including FEV1, FEV1:FVC, FEF25, FEF50 and PEF.   There were significant 
differences in the measurement of small airway function obtained by impulse 
oscillometry, as well as spirometry, showing that resistance of small airway function 
was significantly higher in the CV group. This is an important evidence of 
differences in small airway function between the ventilation groups obtained by 
both volitional (spirometry) and non-volitional (impulse oscillometry) lung function 
tests. 
Measurement of alveolar-capillary membrane diffusion capacity, DLCO, was 
significantly better for HFOV group which would suggest that the gas exchange 
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area is better preserved in those children who were supported by HFOV in infancy.  
There were significant differences found in the baseline characteristics of the two 
ventilation groups. Conventionally ventilated children had a higher birth weight, 
higher gestational ages and more had received surfactant. After adjusting for those 
characteristics, the results remained significant, in favour of HFOV for small airway 
results assessed by spirometry (FEF75) and oscillometry (R5Hz).   High frequency 
oscillation did not contribute to poorer educational outcomes at school age.   There 
were no significant differences found in pulmonary pressures or parameters of left 




Comparison of the outcomes of term and preterm born children demonstrated 
significant differences between the two groups, with preterm children having 
significantly worse lung function. At follow up, the preterm children were 
significantly shorter and a significantly higher proportion of term children had 
reached puberty.  There were significant differences found in large airway function, 
with a mean difference of 15% for R20 percentage predicted, between the groups. 
For FEV1 z score, the mean difference between the groups was 0.6 of standard 
deviation and a standard deviation in FEV1FVC ratio.    The difference in small 
airway function was significant, although smaller. There was a difference of 8% in 
R5 percentage predicted between gestation groups and a difference of 0.55 of SD 
in FEF75 z score.  The mean difference between the groups in the alveo-capillary 
membrane function, (as expressed by diffusing capacity for carbon monoxide, 
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DLCO z score), was also significant favouring term children.  Considering the 
differences in lung volumes, the higher residual volumes in the preterm group were 
consistent with air trapping as a consequence of large and small airway 
obstruction. There was no difference in functional residual capacity between the 
groups, as obtained by two different methods, plethysmography and helium 
dilution.  
Comparison of the respiratory symptoms and medication use demonstrated that a 
significantly higher proportion of preterm children were prescribed antibiotics for 
chest problems in the previous year. From those data it is difficult to conclude that 
there was an increased incidence of chest infections among preterm children at 
school age as the antibiotics may have been prescribed for symptoms of different 
aetiology, potentially unrecognised broncho-obstruction.  
Interestingly, another study has shown high incidence of asymptomatic broncho-
obstruction in preterm children when compared to term. Fawke and co-workers 
(2011) demonstrated significantly more respiratory symptoms such as wheeze in 
preterm children born below 25 weeks of gestation when compared to term children 
at 11 years of age. However, among the 65% of extremely preterm children who 
had been asymptomatic over the previous 12 months, 48% had abnormal baseline 
spirometry, showing a high incidence of asymptomatic broncho-obstruction in 
extremely preterm children at school age.(Fawke et al., 2010) 
Worryingly, a significant proportion (16.8%) of the preterm children examined in this 
thesis were found to be actively smoking, as diagnosed on cotinine sample at the 
time of assessment. High prevalence of active smoking in preterm young adults 
has been previously shown in the literature.(Narang et al., 2008) This could further 
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worsen already impaired lung function, as several studies have provided evidence 
that lung function abnormalities persist into late childhood and early adulthood in 
preterm children, and some studies have observed a gradual decline in the lung 
function.(Hofhuis et al., 2002, Kotecha et al., 2012, Kotecha et al., 2013) A 
prospective study by Guerra and co-workers, published since the start of this 
thesis, produced further evidence on synergistic effect of parental and active 
smoking on early lung function deficits in young adulthood. Maternal and paternal 
smoking was assessed via questionnaires completed by the parents at the time of 
the participant’s birth. Active smoking by participants was assessed via personal 
questionnaires completed at ages 16, 22 and 26 years. Lung function was 
measured by spirometry at 11, 16, 22 and 26 years. Subjects who were only 
exposed to active smoking or only exposed to parental smoking did not differ from 
those who were not exposed to either. Participants with exposure to both parental 
and active smoking had the steepest decline in FEV1/FVC, FEV1, FEF25–75 z 
scores between 11 and 26 years of life.(Guerra et al., 2013) 
In this thesis, the pulmonary pressures of extremely preterm children were 
significantly higher than in term children, at school age. However, only one preterm 
child had systolic pulmonary pressure >36 mmHg, defined as pulmonary 






Preterm children in our study were found to be significantly shorter than age 
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matched controls. Other studies have shown that preterm children are shorter than 
controls throughout childhood, remaining below their genetic height potential. 
Preterm birth appears to alter the endocrine regulation of postnatal growth in 
childhood and adolescence, so growth is no longer associated with its normal 
endocrine regulators. Furthermore, a study by Cutfield and co-workers found an 
alteration in insulin-like growth factor (IGF)-IGF binding protein axis that influences 
growth in premature children.(Cutfield et al., 2004, Rowe et al., 2011) 
Influence of preterm birth on lung function 
 
In a study by Cazzato and co-workers, lung function results of 48 children born 
below 32 weeks of gestation were compared to 46 term children at a mean age of 
8.5 years. They found similar differences in large airway (FEV1 z score), small 
airway (FEF25-75 z score), alveo-capillary membrane (DLCO z score) and higher 
degree of air trapping (RV z score)(Cazzato et al., 2013). 
In another study, Gibson and co-workers reported lung function data (spirometry 
and lung volumes) in adulthood of VLBW (<1501 g) survivors compared with 
normal birth weight controls (>2499 g), and in those who had bronchopulmonary 
dysplasia (BPD) compared with those without BPD, should that VLBW survivors 
continue to have airways obstruction in their mid-20s compared with controls, 
particularly those previously diagnosed with BPD (oxygen requirement at 28 days 
of life). Both subgroups with birth weight <1501 g had significant reductions in 
airflow compared with controls. Within the VLBW cohort, those with BPD had 
reductions in airflow, including the z-score for the forced expired volume in 1 sec 
(FEV1), compared with those without BPD. Within the VLBW cohort, there were 
positive relationships between FEV1 measurements earlier in childhood with those 
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obtained at 25 years of age.(Gibson et al., 2015) 
In a recent longitudinal study by Lange and co-workers, they have shown 
relationship between reduced FEV1 earlier on in life and development of COPD. 
They stratified 657 participants according to lung function (FEV1 ≥80% or <80% of 
the predicted value) at a mean age of approximately 40 years and the presence or 
absence of COPD at the last study visit. They determined the rate of decline in 
FEV1 over time among the participants according to their FEV1 at cohort inception 
and COPD status at study end. Among 657 persons who had an FEV1 of less than 
80% of the predicted value before 40 years of age, 174 (26%) had COPD after 22 
years of observation, whereas among 2207 persons who had a baseline FEV1 of at 
least 80% of the predicted value before 40 years of age, 158 (7%) had COPD after 
22 years of observation (P<0.001). Approximately half of the 332 participants with 
COPD at the end of the observation period had had a normal FEV1 before 40 
years of age and had a rapid decline in FEV1 thereafter, with a mean decline of 53 
ml per year. The remaining half had had a low FEV1 in early adulthood and a 
subsequent mean decline in FEV1 of 27 ml per year (p<0.001), despite similar 
smoking exposure. Therefore, low FEV1 in early adulthood is important in the 
genesis of COPD and accelerated decline in FEV1 is not an obligate feature of 
COPD.(Lange et al., 2015) It is important to point out in the context of these 
findings that in our cohort of preterm children, a significant proportion of them had 
an FEV1<80% predicted (11.7% in preterm vs 1.8% in term children, OR 7.08, 
95%CI 1.65, 30.3), therefore increasing their risk of COPD later on in adulthood.   
 
Preterm birth and cardiovascular abnormalities 
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Recently published data have shown significant proportion of extremely preterm 
infants have high pulmonary pressures in the neonatal period. In a study of 145 
infants born at a median gestational age of 26 weeks were screened by 
echocardiography over a three-year period. Overall, 17.9% were diagnosed with 
pulmonary hypertension during hospital stay. Additionally, infants diagnosed with 
pulmonary hypertension were more likely to be diagnosed with broncho-pulmonary 
dysplasia, diagnosed as oxygen requirement at 28 days of life, and they were more 
likely to be small for gestational age (SGA).(Bhat et al., 2012)  
This is consistent with our study findings, which showed that children born 
prematurely have higher pulmonary pressures at school age than term born 
children. The maximum RV-RA gradient was equal or higher than 25 mmHg in 
11.9% of preterm children and none of the term children. It is important to point out 
that only one of the preterm children had pulmonary hypertension, as defined by 
ERS (systolic pulmonary pressure>36 mmHg, diagnosed by tricuspid velocity jet on 
ECHO).(Galiè et al., 2009) It is difficult to decide how much clinical significance 
those findings carry or whether any of the children have symptoms due to their 
pulmonary pressures, such as shortness of breath on exercise. 
Additionally, our study has shown reduced systolic function of the right ventricle, 
measured by tricuspid annular plane systolic excursion (TAPSE) in children born 
very preterm.  
Longitudinal progression of these findings seems plausible, as another recent study 
has provided evidence of differences in global myocardial structure and function in 
an older cohort of preterm born young adults, when compared to term born 
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individuals.(Lewandowski et al., 2013b) In particular, they had clinically significant 
impairment in right ventricular systolic function. In a study of 102 young adults born 
prematurely, smaller right ventricular size and greater mass of the right ventricle 
was found on cardiovascular magnetic resonance, when compared to term 
individuals. Furthermore, 21% of young adults born preterm had ejection fraction of 
the right ventricle below the lower limit observed in adults born at term. 
(Lewandowski et al., 2013b). The changes observed in the right ventricle were than 
subsequently observed in the left ventricle.(Lewandowski et al., 2013a) 
Unfortunately, the above study could not provide simultaneous data on the 
pulmonary pressures. However, it is possible that the structural changes detected 
later on in adulthood are consequence of an increase in the resistance in the 
pulmonary arterial vasculature, as indicated by pulmonary pressure measurements 
in preterm children in our study. 
Another study has investigated the association between impaired lung function and 
cardiovascular physiology. As a part of the Epicure study, the relationship between 
altered lung function and large-artery hemodynamics in school-age children born 
extremely preterm at 25 weeks of gestation or less was investigated. (Bolton et al., 
2012b) Spirometry and hemodynamic assessments were performed in a subgroup 
of 66 preterm children and 86 term children. Hemodynamic assessments included 
measuring augmentation index (AIx), a composite vascular parameter of arterial 
stiffness, used as an independent predictor of cardiovascular disease in adulthood. 
They found an independent association between impaired lung function and arterial 
stiffness in early adolescence, implying higher cardiovascular risk for children born 
preterm.   AIx values were on average 5% higher in the preterm infants, remaining 
significant after adjustment for potential confounders. Neonatal BPD status was not 
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related to AIx. Lung function and maternal smoking were independently associated 
with Alx. AIx increased by 2.7% per z-score reduction in FEV1 and by 4.9% in 
those whose mothers smoked during pregnancy.  These findings suggested 
independent association between impaired lung function and cardiovascular 
physiology in early adolescence, with higher cardiovascular risk for children born 
preterm. Similarly, our study has shown mild to moderate correlation between 
mane outcome of the small airway function (FEF75 z score) and main ECHO 







The lung function differences found in this study are the first among published data 
(Gerstmann et al., 2001, Courtney et al., 2002, Van Reempts et al., 2003) 
comparing the two modes of ventilation suggesting that oscillated preterm children 
have more preserved lung function than conventionally ventilated children at school 
age (11-14 years).   The adjusted analysis also did not change the significant 
differences in the large airway function, FEV1 z score and FEV1/FVC, in favour of 
HFOV group. 
The distribution of the primary outcomes (FEF75 z scores) for the entire CV group 
was shifted downwards, suggesting there was a small effect of the ventilation mode 
across the group. 
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Concerns were raised in previous studies regarding association of HFOV and 
increased incidence of IVH (inter ventricular haemorrhage) and PVL (periventricular 
leukomalacia).(1989, Moriette et al., 2001)  The results, however, reported in this  
study have provided reassuring evidence regarding the neurodevelopment of 
oscillated children. It has shown no significant difference between the two 
ventilation groups in the majority of functional outcomes. Furthermore, with regards 
to educational attainment, children supported by HFOV seem to have better visual 
spatial skills as they had significantly better performance in Art and design, IT and 
Design and technology. Additionally, there was a trend towards more SEN support 
in the CV group. 
Both spirometry and oscillometry, as two different methods of measuring airway 
function, have shown worse large and small airway obstruction in preterm children 
when compared to those born at term. Large airway function was consistently 
worse in preterm children when expressed as FEV1 z score, FEV1FVC ratio z 
score or R20 percentage predicted. In addition, small airway function was 
significantly worse in preterm children when expressed as FEF75 measured by 
spirometry and as R5Hz when measured by oscillometry.  Measurements of lung 
volumes have also shown high degree of internal consistency. Lung volumes 
obtained by plethysmography and by Helium dilution have shown similar results. 
Furthermore, our study has uniquely assessed influence of ventilation mode at birth 
on the pulmonary pressures at school age. It has also provided evidence of raised 
pulmonary pressures in school aged preterm children in comparison to term. The 
pulmonary pressures were measured by three different echocardiographic 
methods, TR regurgitation jet velocity (peak and mean), pulmonary regurgitation 
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end diastolic velocity and pulmonary artery acceleration time, showing similar 
results. 
The correlation between the lung function of small airway (FEF75 z score), and TR 
peak velocity in preterm children has shown a mild to moderate correlation 
(correlation coefficient -0.28, p<0.001). This finding raises further questions 
regarding the aetiology of the high pulmonary pressures in preterm children and 
whether there is a common underlying mechanism affecting the small airways and 
small pulmonary arteries or whether they are independent consequence of the 
arrested vasculogenesis. Very few studies have investigated relationship of the 
pulmonary hypertension and airway obstruction. Rastogi and co-workers (2004) 
investigated the relationship between primary pulmonary hypertension (PPH) and 
lower airway obstruction in term born children between 5 and 18 years of 
age.(Rastogi et al., 2004) They found that in 39 children tested with spirometry, the 
obstructive pattern was present in 59% of the children, particularly in the small 
airways (FEF25-75). Mean pulmonary artery pressure showed a significant positive 
correlation with the TLC, RV, and RV/TLC, but a negative one with the ratio 
FEV1/FVC. Reversible airway obstruction was the most common lung function 
abnormality among their patients with PPH, however whether airway reactivity is a 







References for lung function result z scores that were used in this study did not 
consider ethnic origin. New reference ranges, showing differences in spirometry 
results between ethnic groups, have been published recently. (Quanjer et al., 2012) 
However, the majority of the children in the study were of white ethnic origin and for 
the consistency with other lung function tests (plethysmography, helium dilution, 
gas transfer) we used the same reference source (Rosenthal et al., 1993a). 
7.3.2.	Volume	guarantee	
	
New modes of conventional ventilation have been developed over the last decade, 
which aim to deliver a consistent tidal volume. With the development of the flow 
sensor placed at the piece between the ventilator circuit and the endotracheal tube, 
and the use of appropriate software, it is nowadays possible to target the delivered 
tidal volume (VT) and reduce the VT delivery variability. This should prevent both 
atelectasis and volutrauma at the same time. Meta-analysis of 12 randomised 
controlled trials, in the Cochrane review published in 2010 (Wheeler et al., 2010), 
has shown that there is a statistically significant reduction in the combined outcome 
of death and broncho-pulmonary dysplasia (RR 0.73 (95% CI 0.57 to 0.93) when 
using the volume targeted ventilation. Conventional ventilation used in the UKOS 
study did not include the volume guarantee modes. Infants in the CV group 
received time-cycled, pressure-limited ventilation. (Johnson et al., 2002) This could 
have impaired the outcomes of the conventionally ventilated group. Comparing the 
HFOV to volume-targeted ventilation (VTV) might potentially produce different 
outcome, as both of these modes provide stable alveolar volume, limiting the 
atelectasis and over distension. (Wheeler et al., 2010) However, during VTV the 
volume levels achieved (5-7 ml/kg) are still much higher than tidal volumes during 
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HFOV (1-2 ml/kg), which will produce more lung stretch and subsequent volume 
induced trauma than during HFOV.(Kneyber et al., 2012) 
7.3.3.	Echocardiography	
	
Echocardiographic estimates of systolic and mean pulmonary artery pressure are a 
useful screening tool, however the severity of pulmonary hypertension is difficult to 
determine, and qualitative echocardiographic findings may be less accurate than 
cardiac catheterization, and therefore underestimate or overestimate the degree of 
pulmonary hypertension. Cardiac catheterisation, although able to accurately 
measure pulmonary pressures, is an invasive procedure with potential significant 




When appropriately used, high frequency oscillation can optimise the tidal volume 
and minimise atelectasis during ventilation of extremely premature babies, without 
an increased risk of long-term neuro-developmental impairment.  
Minimising the volutrauma is an important component of lung protective neonatal 
ventilation. At present, there is no evidence whether compared with volume 
targeted mode of ventilation, comparison of HFOV and CV would have a different 
long term outcome.  
Children born extremely preterm may have abnormalities of lung function that are 
not accompanied by classical symptoms of broncho-obstruction. Respiratory 
symptoms are not a good indicator of airway obstruction in preterm children and 
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low threshold should be kept for lung function testing in this specific population. 
(Fawke et al., 2010) 
To be able to investigate the respiratory symptoms in school age and later on in 
adulthood, clinicians need to be aware of gestational age at birth and perinatal 
history should be asked beyond childhood. (Bolton et al., 2015) 
Pulmonary hypertension should be kept in mind in the differential diagnosis of 




As lung function of extremely preterm children is significantly impaired in 
comparison to term born children, it would be important to assess if there is a 
further decline in lung function parameters after onset of puberty and in early 
adulthood and whether the ventilation strategy at birth has further implications on 
preservation of small airway function in early adulthood. Evidence on the degree 
and best way of management of broncho-obstruction in preterm born adults is still 
lacking.(Bolton et al., 2012a) 
Higher pulmonary pressures, lower systolic function of the right ventricle and 
thinner inter ventricular septum, accompany extremely preterm birth. Longitudinal 
studies are needed to assess the progression of these changes and wether they 





Comparison of ventilation groups 
 
There are long-term benefits on lung function from using HFOV with open lung 
strategy in extremely preterm babies.  
High frequency oscillation does not cause more functional impairment or worse 
educational outcomes at school age. 
Pulmonary pressures at school age are independent of ventilation mode at birth in 
extremely preterm children. 
Comparison of preterm and term children 
 
There are significant, worrying lung function abnormalities in extremely preterm 
born children at school age, despite of routine use of antenatal steroids and 
postnatal surfactant. 
Clinical diagnosis of broncho-obstruction in preterm children could be difficult 
without lung function testing, as common respiratory symptoms are frequently 
lacking in the history. 
Children born very prematurely have higher pulmonary pressures at school age 
when compared to term children. This is accompanied by lower systolic function of 






















Please tell us your name: 
 
What is your relationship to the child: 
 
The questions in this form ask about your child’s usual health and usual ability to 
do things. Please do not report temporary or occasional problems. For example we 
are interested in how well your child is usually able to get around, talk and see. We 
will be asking about other things too, like emotions, and ability to learn and 
remember as well as questions about your child’s health. 
 
You may think that some of the things we ask don’t apply to your child, but we are 
interested in the overall health of a large group of children. Therefore we need to 
ask the same questions for each child. If you need any help filling this in do ring us 
on 020 329 3037 or email queries to ukos@kcl.ac.uk 
 
There are no right and wrong answers! All we want is your opinion about your 
child’s health. 









Part One: Your child’s ability 
1*. Which one of the following best describes your child’s usual ability to see well 
enough to read ordinary newsprint? 
Able to see well enough without glasses or contact lenses  
Able to see well enough with glasses or contact lenses  
Unable to see well enough with glasses or contact lenses  
Unable to see at all 
If your child has a problem with seeing, do you know the cause?  
Yes                      No 
If yes, can you please tell us what it is? 
  
 
2*. Which one of the following best describes your child’s usual ability to see 
well enough to recognize a friend on the other side of the street? 
Able to see well enough without glasses or contact lenses  
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Able to see well enough with glasses or contact lenses  
Unable to see well enough with glasses or contact lenses  
Unable to see at all 
 
 
3*. Which one of the following best describes your child’s usual ability to 
hear what is said in a group conversation with at least three other 
people? 
Able to hear what is said without a hearing aid  
Able to hear what is said with a hearing aid  
Unable to hear what is said even with a hearing aid  
Unable to hear what is said, but do not wear a hearing aid  
Unable to hear at all 
If your child has a problem with hearing, do you know the cause?  
Yes                      No 





4*. Which one of the following best describes your child’s usual ability to 
hear what is said in a conversation with one other person in a quiet room? 
Able to hear what is said without a hearing aid  
Able to hear what is said with a hearing aid  
Unable to hear what is said even with a heating aid  
Unable to hear what is said, but do not wear a hearing aid  
Unable to hear at all 
 
 
5*. Which one of the following best describes your child’s usual ability to 
be understood when speaking his/her own language with people who do 
not know them? 
Able to be understood completely  
Able to be understood partially  
Unable to be understood  
Unable to speak at all 
 
6*. Which one of the following best describes your child’s usual ability to 
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be understood when speaking with people who know him/her well? 
Able to be understood completely  
Able to be understood partially  
Unable to be understood  
Unable to speak at all 
 
7*. Which one of the following best describes how your child usually 
feels? 
Happy and interested in life  
Somewhat happy  
Somewhat unhappy  
Very unhappy 
So unhappy that life is not worthwhile 
 
8*. Which one of the following best describes your child’s usual level of 
pain and discomfort? 
Free of pain and discomfort  
Mild to moderate pain or discomfort that prevents no activities  
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Moderate pain or discomfort that prevents a few activities  
Moderate to severe pain or discomfort that prevents some activities 
Severe pain or discomfort that prevents most activities 
 
 
9*. Which one of the following best describes your child’s usual ability to 
walk? 
Note: Walking equipment refers to mechanical supports such as braces, a cane, 
crutches or a walker. 
a) Able to walk around the neighborhood without difficulty, and without equipment 
b) Able to walk around the neighborhood with difficulty, but does not require 
walking equipment or the help of another person 
c) Able to walk around the neighborhood with walking equipment, but without the 
help of another person 
d) Able to walk only short distances with walking equipment, and requires a wheel 
chair to get around the neighborhood 
e) Unable to walk alone, even with walking equipment. Able to walk short 
distance with the help of another person, and requires a wheelchair to get around 
neighborhood 
d) Unable to walk at all  
If your child has a problem with getting around, do you know the cause? 
Yes                            No  
If yes, can you please tell us what it is? 
  
 
10*. Which one of the following best describes your child’s usual ability to 
use hands and fingers? 
Note: Special tools refers to hooks for buttoning clothes, gripping devices for 
opening jars or lifting small items, and other devices to compensate for limitations 
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of hands or fingers. 
 
a) Full use of two hands and ten fingers 
b) Limitations in the use of hands or fingers, but does not require special tools or 
the help of another person 
c) Limitations in the use of hands or fingers, independent with use of special tools 
(do not require the help of another person) 
d) Limitations in the use of hands and fingers, requires the help of another person 
for some tasks (not independent even with use of special tools) 
e) Limitations in the use of hands or fingers, requires the help of another person 
for most tasks (not independent even with use of special tools) 
f) Limitations in the use of hands or fingers, requires the help of another person 
for all tasks (not independent even with use of special tools) 
 
11*. Which one of the following best describes your child’s usual ability to 
remember things? 
Able to remember most things  
Somewhat forgetful  
Very forgetful  
Unable to remember anything at all 
 
	
12*. Which one of the following best describes your child’s usual ability to think 
and solve day to day problems? 
Able to think clearly and solve day to day problems  
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Has a little difficulty when trying to think and solve day to day problems 
Has some difficulty when trying to think and solve day to day problems 
Has great difficulty when trying to think and solve day to day problems 
Unable to think or solve day to day problems 
 
13*. Which one of the following best describes your child’s usual ability to 
perform basic activities? 
Eats, bathes, dresses and uses the toilet normally  
Eats, bathes, dresses and uses the toilet independently with difficulty 
Requires mechanical equipment to eat, bathe, dress or use the toilet 
independently 
Requires the help of another person to eat, bathe, dress or use the toilet 
 
14*. Which one of the following best describes how your child usually feels? 
Generally happy and free from worry  
Occasionally fretful, angry, irritable, anxious or depressed 
Often fretful, angry, irritable, anxious or depressed  
Almost always fretful, angry, irritable, anxious or depressed 
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Extremely fretful, angry, irritable, anxious or depressed; to the point of needing 
professional help 
 
15*. Which one of the following best describes your child’s usual level of 
pain or discomfort? 
a)	Free of pain and discomfort 
b) Occasional pain or discomfort. Discomfort relieved by non-prescription drugs 
or self-control activity without disruption of normal activities 
c) Frequent pain or discomfort. Discomfort relieved by oral medicines with 
occasional disruption of normal activities 
d) Frequent pain or discomfort; frequent disruption of normal activities. 
Discomfort requires prescription narcotics for relief. 
e) Severe pain or discomfort. Pain not relieved by drugs and constantly disrupts 
normal activities 
	
Part Two: Your child’s general development 
16*. For each item, please mark the box for Not True, Somewhat True or 
Certainly True. It would help us if you answered all items as best you can 
even if you are not absolutely certain or the item seems daft! Please give 












 Not True        Somewhat True    Certainly 
True 
Considerate of other people’s feelings 
Restless, overactive, cannot stay still for 
long 
Often complains of headaches, 
stomach-aches or sickness  
Shares readily with other children 
(treats, toys, pencils etc.)  
Often has temper tantrums or hot 
tempers  
Rather solitary, tends to play alone 
Generally obedient, usually does what 
adults request 
Many worries, often seems worried 
	
                                                                
																																		 																																			 	
                                                                          
 
 
                                                                 
 
 
                                                                 
 
                                                                 
 
                                                                
	
																																		 																																				 	
Helpful if someone is hurt, upset or 
feeling ill 
Constantly fidgeting or squirming 
Has at least one good friend 
Often fights with other children or bullies 
them  
Often unhappy, down-hearted or tearful  
Generally liked by other children  
Easily distracted, concentration wanders 
Nervous or clingy in new situations, 
easily loses confidence 
	
                                                                
																																		 																																			 	
                                                                          
 
 
                                                                 
 
 
                                                                 
 
                                                                 
 
                                                                
	
																																		 																																				 	
Kind to younger children 
Often lies or cheats 
Picked on or bullied by other children 
Often volunteers to help others (parents, 
                                                                
																																		 																																			 	




teachers, other children) 
Thinks things out before acting 
Steals from home, school or elsewhere 
Gets on better with adults than with 
other children 
Has many fears, easily scared 
  
Sees tasks through to the end, good 
attention span 
	
                                                                 
 
 
                                                                 
 
                                                                 
 









18*. Over the last month, has your child had difficulties in one or more of the 
following areas: emotions, concentration, behaviour or being able to get on 
with other people? 
No  
Yes, minor difficulties  
Yes, definite difficulties  
Yes, severe difficulties 
	
 
If you have answered “yes”, please answer the following questions about 
these difficulties. If “no” then go to question 19. 
a*. Do the difficulties upset or distress your child? 
Not at all  
Only a little  
Quite a lot  
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A great deal 
 
b*. Do the difficulties interfere with your child’s everyday life in the 
following areas? 
 Not at all         Only a little              Quite a lot      A 
great deal 
 
Home life  
Friendships  
Classroom learning  
Leisure activities 
 
                                                                                   
 
                                                                                   
 
                                                                                   
 
                                                                                   
 
 
c*. Do the difficulties put a burden on you or the family as a whole? 
Not at all  
Only a little  
Quite a lot 
 A great deal 
 
19. Your child’s school. 
 Which of the following best describes the sort of school your child is in and 
type of support they receive?  
My child is in a main stream school 
My child is in a main stream school with some learning support or additional help 
My child is in a special class or unit  
My child is in a special school or pupil referral unit (PRU)  
My child has home or hospital tution  
None of these 
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Please can you describe what best describes the sort of school your child is in: 
	
Part Three: Your child’s health 
This part asks particularly about whether your child has any wheezing/asthma, 
hospital admissions, seizures and some particular problems your child may have. 
Don’t be alarmed by any of these questions. The likelihood is that your child will not 
have or develop any of these serious problems. 
 
20. In the last 12 months, has your child had any attacks of wheezing? 
Yes     No 
 If no, go to question 22 




Less than monthly 
 
21. In the last 12 months, has your child’s sleep been disturbed due to 
wheezing? 
Never woken with wheezing  
Seldom wakes (less than one night per week)  
Frequently wakes (one or more nights per week) 
22. In the last 12 months has your child been given any courses of antibiotics 
for chest problems? 
Yes  
Don’t know  
No 






23. In the last 12 months has your child been given any other medicines (not 
antibiotics) for chest problems? 
Yes  
Don’t know  
No  
 
If no go to question 24 





Ventolin (blue)  
Bricanyl (blue)  
Atrovent (green)  
Salmeterol (green)  
Others 





Pulmicort (brown)  
Flixotide (orange)  
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Others 





In the last 12 months has your child been admitted to hospital for any 
reason? 
Yes     No 
If no go to question 25 
 
If yes, can you tell us the reason and number of admissions?  
Reason                                                Number of admissions  
Chest problems  
Surgery 
Anything else 
Can you tell us briefly what these were for? 
25. Has your child ever had any fits, seizures and convulsions? 
Yes    No  
 
If no go to question 26 
Please tick one answer which best describes your child’s 
seizures/convulsions now: 
Not on prescribed medicines for seizures  
On prescribed treatment with no seizures  
Has less than 1 seizure/month on prescribed treatment  
Has more than 1 seizure/month on prescribed treatment 
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26. Please tick if your child has any of the following conditions? 
Diabetes 
Cerebral palsy  
Hydrocephalus with shunt  
Gastrostomy  





27. Any other problem for which he/she is under the care of a doctor? 
Yes       No 
 
If yes, can you tell us about this problem and give us the diagnosis if you 
know it? 
 
Part Four: You and home environment 
We need to know a little about you and your circumstances and have taken some 
of these questions from the 2001 census. You may need to tick more than one box. 
Home environment 
These questions apply to the family at home; by this we mean mum (or partner), or 
dad (or partner) and brothers and sisters. 
 
28. Does anyone in the family smoke? 
 
Yes     No 
29. Does your house have problems with damp or mould? 
 
Yes     No 
30. Has a doctor ever said that any member of your family has asthma? 
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Yes     No 
 
Your Home 
31*. Do you rent or own your accommodation? 
Owner (mortgage)  
Council rented 
 Private rented (furnished)  
Private rented (unfurnished)  
Housing society or co-operative  
Tied to occupation 
Other (please describe below)  
Reason: 
 
32*. What is your ethnic group? 
Choose ONE section from A to E, then tick the appropriate box to indicate 
your cultural background. 
A  White   
British 
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 Irish  
B  Mixed   
White and Black Caribbean  
White and Black African  
White and Asian  
Any other Mixed background 




Any other Asian background: 
 




Any other Black background: 
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If there is anything you would like to tell us about your child’s health, please 







Thank you very much for completing the questionnaire. 
Please can you check carefully that you have completed every section. 
 
 







Please return it in the prepaid envelope provided to: 
NIHR United Kingdom Oscillation Study (UKOS) 
King's College Hospital 
King’s College London 












Questionnaire for boys 
About my body 
 
 
There are important changes to a boy’s body that can start as 
early as 6 years for some boys but can start much later in others, 
up to 16 years of age. In this questionnaire we ask you to describe 
what changes you have noticed up to now. We would like you to 
complete the questionnaire yourself but you might want to ask 
your parents for help if you have difficulty answering any of the 
questions 
All the information in this questionnaire will be treated in the 
strictest confidence. This means that we will not show it to 
anyone outside the study, and the questionnaire will be 
destroyed when we have finished with it. Your name is not 
anywhere on the questionnaire so no one outside the study 
will know who this questionnaire belongs to. 
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1. Firstly, could you tell us how active you are. In the last 
month, how often have you taken part in strong physical 
activity (such as running, football, swimming, athletics)? 
None  
Less than once a week 
1-3 times a week 
4-6 times a week 
Daily 
 
2. Has your voice changed at all? 
No, it is the same 
Yes, sometimes it is a lot lower 
Yes, it has now changed totally 
Not sure 
 






We would now like to know about the changes that are 
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happening to your body. The pictures on the next 2 
pages show different stages of development that are 
often used by doctors to assess boy’s growth and 
development. Please answer questions 4 and 5 by 
reading the instructions and looking at the pictures 
carefully. 
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4. Boys go through the different stages of physical 
development at different ages. Some start as early as 6 
years of age, others not until they are 16. We need your 
help in letting us know the stage of physical 
development you are going through at the moment. 
Look at each of the pictures below and read the 
descriptions carefully. Please put a tick in the box that 
is closest to your stage of development at the moment. 
 
Stage 1. At this stage the size and shape of the testes, 
scrotum (the sac holding the testes) and penis are about the 
same as w 
 
 
Stage 2. At this stage the penis is a little bit bigger. The 
scrotum has dropped and the skin of the scrotum has 
changed. The testes are also bigger. 
 
UKOS2:  Boy’s questionnaire v1, 14.03.11 3
4.  Boys go through the different stages of physical development at different ages.  Some 
start as early as 6 years of age, others not until they are 16.  We need your help in letting us 
know the stage of physical development you are going through at the moment.  Look at each 
of the pictures below and read the descriptions carefully.  Please put a tick in the box that is 
closest to your stage of development at the moment. 
 
                
 
              
 
              
 
              
 






Stage 1.  At this stage the size and shape of the testes, 
scrotum (the sac holding the testes) and penis are 
about the same as when you were younger. 
 
Stage 4.  At this stage the penis is longer and wider.  
The head of the penis is bigger, and the scrotum is a 
darker colour and bigger. The testes are also bigger. 
Stage 2.  At this stage the penis is a little bit bigger. 
The scrotum has dropped and the skin of the 
scrotum has changed. The testes are also bigger.
Stage 3.  At this stage the penis has grown longer, and 
the testes have grown and dropped lower. 
 
Stage 5.  At this stage the penis, scrotum and testes 
are the size and shape of a man’s. 
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Stage 3. At this stage the penis has grown longer, and the 
testes have grown and dropped lower. 
 
Stage 4. At this stage the penis is longer and wider. The 
head of the penis is bigger, and the scrotum is a darker 
colour and bigger. The testes are also bigger. 
 
 
Stage 5. At this stage the penis, scrotum and testes are the 
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4.  Boys go through the different stages of physical development at different ages.  Some 
start as early as 6 years of age, others not until they are 16.  We need your help in letting us 
know the stage of physical development you are going through at the moment.  Look at each 
of the pictures below and read the descriptions carefully.  Please put a tick in the box that is 
closest to your stage of development at the moment. 
 
                
 
              
 
              
 
              
 






Stage 1.  At this stage the size and shape of the testes, 
scrotum (the sac holding the testes) and penis are 
about the same as when you were younger. 
 
Stage 4.  At this stage the penis is longer and wider.  
The head of the penis is bigger, and the scrotum is a 
darker colour and bigger. The testes are also bigger. 
Stage 2.  At this stage the penis is a little bit bigger. 
The scrotum has dropped and the skin of the 
scrotum has changed. The testes are also bigger.
Stage 3.  At this stage the penis has grown longer, and 
the testes have grown and dropped lower. 
 
Stage 5.  At this stage the penis, scrotum and testes 
are the size and shape of a man’s. 
 
Please tick this box if you are not sure. 
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4.  Boys go through the different stages of physical development at different ages.  Some 
start as early as 6 years of age, others not until they are 16.  We need your help in letting us 
know the stage of physical development you are going through at the moment.  Look at each 
of the pictures below and read the descriptions carefully.  Please put a tick in the box that is 
closest to your stage of development at the moment. 
 
                
 
             
 
              
 
              
 






Stage 1.  At this stage the size and shape of the testes, 
scrotum (the sac holding the testes) and penis are 
about the same as when you were younger. 
 
Stage 4.  At this stage the penis is longer and wider.  
The head of the penis is bigger, and the scrotum is a 
darker c lour and bigger. The testes are also bigger. 
Stage 2.  At this stage the penis is a little bit bigger. 
The scrotum has dropped and the skin of the 
scrotum has changed. The testes are also bigger.
Stage 3.  At this tage the penis has grown longer, and 
the testes have grown and dropped lower. 
 
Stage 5.  At this stage the penis, scrotum and testes 
are the size and shape of a man’s. 
 
Please tick this box if you are not sure. 
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4.  Boys go through the differe t stages of physical development a  different ages.  S me 
start as early as 6 years of age, others not until they are 16.  We need your h lp i  letti g us 
know the stage of physical development you re going through at the moment.  Look at each 
of the pictures below and read the descriptions carefully.  Please put a tick in the box that is 
closest to your stage of development at the moment. 
 
    
              
              
 
              
 






Stage 1.  At this stage the size and shape of the testes, 
scrotum (the sac holding the testes) and penis are 
about the same as when you were younger. 
 
Stage 4.  At this stage the penis is longer and wider.  
The head of the penis is bigger, and the scrotum is a 
d rker colour and bigger. The te tes are lso bigger. 
Stage 2.  At this stage the penis is a little bit bigger. 
The scrotum ha  dropped and the skin of the 
scrotum has changed. The testes are also big .
Stage 3.  At this stage the penis has row  longer, and 
t testes hav  grown and droppe lower. 
 
Stage 5.  At this stage the penis, scrotum and testes 
are the size and shape of a man’s. 
 
Please tick this box if you are not sure. 
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Please tick this box if you are not sure. 
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5. As part of development pubic hair will start to grow 
just above your penis. The pictures below show 
different amounts of pubic hair. Please look at each of 
the pictures and read the descriptions carefully. Please 
put a tick in the box that is closest to the amount of 
pubic hair you have at the moment based on both the 
picture and the description. (Your stage of pubic hair 
growth might not be the same as your stage of physical 
development.) 
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4.  Boys go through the different stages of physical development at different ages.  Some 
start as early as 6 years of age, others not until they are 16.  We need your help in letting us 
know the stage of physical development you are going through at the moment.  Look at each 
of the pictures below and read the descriptions carefully.  Please put a tick in the box that is 
closest to your stage of development at the moment. 
 
                
 
              
 
              
 
              
 






Stage 1.  At this stage the size and shape of the testes, 
scrotum (the sac holding the testes) and penis are 
about the same as when you were younger. 
 
Stage 4.  At this stage the penis is longer and wider.  
The head of the penis is bigger, and the scrotum is a 
darker colour and bigger. The testes are also bigger. 
Stage 2.  At this stage the penis is a little bit bigger. 
The scrotum has dropped and the skin of the 
scrotum has changed. The testes are also bigger.
Stage 3.  At this stage the penis has grown longer, and 
the testes have grown and dropped lower. 
 
Stage 5.  At this stage the penis, scrotum and testes 
are the size and shape of a man’s. 
 
Please tick this box if you are not sure. 
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5.  As part of development pubic hair will start to grow just above your penis.  The pictures 
below show different amounts of pubic hair.  Please look at each of the pictures and read the 
descriptions carefully.  Please put a tick in the box that is closest to the amount of pubic hair 
you have at the moment based on both the picture and the description.  (Your stage of pubic 
hair growth might not be the same as your stage of physical development.) 
 
                
 
              
 
              
 
              
 






Stage 1.  There is no hair at all. 
 
Stage 4.  At this stage the hair is dark and curly as 
that of a man, but it hasn’t spread out to the legs. 
Stage 2.  At this stage there is a little soft, long, 
lightly coloured hair at the base of the penis. It may 
be straight or a little curly. 
Stage 3.  At this stage the hair is darker and more 
curled. It has spread out and thinly covers a bigger 
area. 
 
Stage 5.  At this stage the hair is like that of a man.  
It has spread out to the legs. 
 
Please tick this box if you are not sure. 
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Stage 2. At this stage there is a little soft, long, lightly 
colored hair at the base of the penis. It may be straight or a 
little curly. 
 
Stage 3. At this stage the hair is darker and more curled. It 
has spread out and thinly covers a bigger area. 
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Stage 4. At this stage the hair is dark and curly as that of a 
man, but it hasn’t spread out to the legs. 
 
Stage 5. At this stage the hair is like that of a man. It has 
spread out to the legs. 
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5.  As part of development pubic hair will start to grow just above your penis.  The pictures 
below show different amounts of pubic hair.  Please look at each of the pictures and read the 
descriptions carefully.  Please put a tick in the box that is closest to the amount of pubic hair 
you have at the moment based on both the picture and the description.  (Your stage of pubic 
hair growth might not be the same as your stage of physical development.) 
 
                
 
              
 
              
 
              
 






Stage 1.  There is no hair at all. 
 
Stage 4.  At this stage the hair is dark and curly as 
that of a man, but it hasn’t spread out to the legs. 
Stage 2.  At this stage there is a little soft, long, 
lightly coloured hair at the base of the penis. It may 
be straight or a little curly. 
Stage 3.  At this stage the hair is darker and more 
curled. It has spread out and thinly covers a bigger 
area. 
 
Stage 5.  At this stage the hair is like that of a man.  
It has spread out to the legs. 
 
Please tick this box if you are not sure. 
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5.  As part of development pubic hair will start to grow just above your penis.  The pictures 
below show different amounts of pubic hair.  Please look at each of the pictures and read the 
descriptions carefully.  Please put a tick in the box that is closest to the amount of pubic hair 
you have at the moment based on both the picture and the description.  (Your stage of pubic 
hair growth might not be the same as your stage of physical development.) 
 
                
 
              
 
              
 
              
 






Stage 1.  There is no hair at all. 
 
Stage 4.  At this stage the hair is dark and curly as 
that of a man, but it hasn’t spread out to the legs. 
Stage 2.  At this stage there is a little soft, long, 
lightly coloured hair at the base of the penis. It may 
be straight or a little curly. 
Stage 3.  At this stage the hair is darker and more 
curled. It has spread out and thinly covers a bigger 
area. 
 
Stage 5.  At this stage the hair is like that of a man.  
It has spread out to the legs. 
 
Please tick this box if you are not sure. 
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5.  As part of development pubic hair will start to grow just above your penis.  The pictures 
below show different amounts of pubic hair.  Please look at each of the pictures and read the 
descriptions carefully.  Please put a tick in the box that is closest to the amount of pubic hair 
you have at the moment based on both the picture and the de cription.  (Your stage of pubic 
hair growth might not be the same as your stage of physical evelopm nt.) 
 
                
 
              
 
              
 
   
 






Stage 1.  There is no hair at all. 
 
Stage 4.  At this stage the hair is dark and curly as 
that of a man, but it hasn’t spread out to the legs. 
Stage 2.  At his tage there is a little soft, long, 
lightly coloured hair at the base of the peni . It may 
be straight or a little curly. 
Stage 3.  At this stage the hair is darker and more 
curled. It has spread out and thinly covers a bigger 
area. 
 
Stage 5.  At this stage the hair is like that of a man.  
It has spread out to the legs. 
 









Please seal this questionnaire in the 
envelope provided and return it to us. 
Thank you very much for answering this 
questionnaire and for helping us with this 
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5.  As part of development pubic hair will start to grow just above your penis.  The pictures 
below show different amounts of pubic hair.  Please look at each of the pictures and read the 
descriptions carefully.  Please put a tick in the box that is closest to the amount of pubic hair 
you have at the moment based on both the picture and the description.  (Your stage of pubic 
hair growth might not be the same as your stage of physical development.) 
 
                
 
              
 
              
 
              
 






Stage 1.  There is no hair at all. 
 
Stage 4.  At this stage the hair is dark and curly as 
that of a man, but it hasn’t spread out to the legs. 
Stage 2.  At this stage there is a little soft, long, 
lightly coloured hair at the base of the penis. It may 
be straight or a little curly. 
Stage 3.  At this stage the hair is darker and more 
curled. It has spread out and thinly covers a bigger 
area. 
 
Stage 5.  At this stage the hair is like that of a man.  
It has spread out to the legs. 
 











Questionnaire for girls 
About my body 
 
There are important changes to a girl’s body that can start as early 
as 6 years for some girls but can start much later in others, up to 
16 years of age. In this questionnaire we ask you to describe what 
changes you have noticed up to now. We would like you to 
complete the questionnaire yourself but you might want to ask 
your parents for help if you have difficulty answering any of the 
questions. 
All the information in this questionnaire will be treated in the 
strictest confidence. This means that we will not show it to 
anyone outside the study, and the questionnaire will be 
destroyed when we have finished with it. Your name is not 
anywhere on the questionnaire so no one outside the study 
will know who this questionnaire belongs to. 
 









1. Firstly, could you tell us how active you are. In the last 
month, how often have you taken part in strong physical 
activity (such as running, dance, gymnastics, netball, 
swimming, aerobics)? 
None  
Less than once a week 
1-3 times a week 
4-6 times a week  
Daily 
 





If no, please go to Question 8 on Page 5 
If you answered yes, when was your first period? 
3. 
a) In the last year, how many days of bleeding have you 
usually had during each of your periods?  
	324	
b) If you don’t know, is it probably:  
3 days or less 
  4 – 6 days  
7 days or more  
4.In the last year, what was the usual length of your menstrual 
cycle? In other words, how many days were there from the 
first day of one period to the first day of your next period?  






5.Have you ever had any of the following symptoms 
associated with your period?  




If no, please go to Question 5b below 
If you answered yes, did you go to see a doctor for this? 
Yes 
No 
b) Severe muscle cramps (severe pain in the lower part of 





If no, please go to Question 5c below 





c) Period-type pains or pain in the lower part of your tummy 









If no, please go to Question 6 





6. Sometimes, if girls have problems with their periods (e.g., 
heavy bleeding, irregular bleeding or severe cramps), their 
GP might prescribe the oral contraceptive pill (which can be 
called ‘the pill’, ‘birth control pills’’ or ‘oestrogen pills’) to 
help. Have you taken oral contraceptives or birth control pills, 










We would now like to know about the changes that are 
happening to your body. The pictures on the next 2 pages 
show different stages of development that are often used by 
doctors to assess girls’ growth and development. Please 
answer questions 8 and 9 by reading the instructions and 




8. The pictures below show stages in the way breasts 
develop. Not all children follow the same pattern of 
development. A girl can go through each of the 5 stages 
shown below, although some girls might skip some stages. 
Please look at each of the drawings and read the descriptions 
carefully. Please put a tick in the box that is closest to your 
breast stage at the moment based on both the picture and the 
description. 
Stage 1. In this stage the nipple is raised a little. The rest of the 
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8.  The pictures below show stages in the way breasts develop.  Not all children follow the same 
pattern of development.  A girl can go through each of the 5 stages shown below, although some 
girls might skip some stages.  Please look at each of the drawings and read the descriptions 
carefully.  Please put a tick in the box that is clo est to your breast stage at the moment based 
on both the picture and the description. 
 
 
      
 
 
   
 
 
    
 
 
      
 
 
   
Stage 1.  In this stage the nipple is raised a little. 
The rest of the breast is still flat. 
Stage 4.  The areola and the nipple make up a mound 
that sticks up above the shape of the breast. (This stage 
might not happen at all for some girls. Some girls 
develop from Stage 3 to Stage 5 without Stage 4). 
Stage 2.  This is called the breast bud stage. In this 
stage the nipple is raised more than Stage 1. The 
breast is a small round. The dark area around the 
nipple (called the areola) is larger than in Stage 1. 
 
Stage 3.  The areola and the breast are both 
larger than in Stage 2.  The areola does not 
stick out away from the breast. 
Stage 5.  This is the adult stage. The breasts are fully 
developed. Only the nipple sticks out in this stage. 
The areola has moved back in the general shape of 
the breast. 
 
Please tick this box if you are not sure. 
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Stage 2. This is called the breast bud stage. In this stage the 
nipple is raised more than Stage 1. The breast is a small round. 
The dark area around the nipple (called the areola) is larger than 
in Stage 1 
 
Stage 3. The areola and the breast are both larger than in Stage 2. 




Stage 4. The areola and the nipple make up a mound that sticks 
up above the shape of the breast. (This stage might not happen at 
all for some girls. Some girls develop from Stage 3 to Stage 5 
without Stage 4). 
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8.  The pictures below show stages in the way breasts develop.  Not all children follow the same 
pattern of development.  A girl can go through each of the 5 stages shown below, although some 
girls might skip some stages.  Please look at each of the drawings and read the descriptions 
carefully.  Please put a tick in the box that is closest to your breast stage at the moment based 
on both the picture and the description. 
 
 
      
 
 
   
 
 
    
 
 
      
 
 
   
Stage 1.  In this stage the nipple is raised a little. 
The rest of the breast is still flat. 
Stage 4.  The areola and the nipple make up a mound 
that sticks up above the shape of the breast. (This stage 
might not happen at all for some girls. Some girls 
develop from Stage 3 to Stage 5 without Stage 4). 
Stage 2.  This is called the breast bud stage. In this 
stage the nipple is raised more than Stage 1. The 
breast is a small round. The dark area around the 
nipple (called the areola) is larger than in Stage 1. 
 
Stage 3. The areola and the breast are both 
larger than in Stage 2.  The areola does not 
stick out away from the breast. 
Stage 5.  This is the adult stage. The breasts are fully 
developed. Only the nipple sticks out in this stage. 
The areola has moved back in the general shape of 
the breast. 
 
Please tick this box if you are not sure. 
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8.  The pictures below show stages in the way breasts develop.  Not all children follow the same 
pattern of development.  A girl can go through each of the 5 stages shown below, although some 
girls might skip some stages.  Please look at each of the drawings and read the descriptions 
carefully.  Please put a tick in the box that is closest to your breast stage at the moment based 
on both the picture and the description. 
 
 






    
 
 
      
 
 
   
Stage 1.  In this stage the nipple is raised a little. 
The rest of the breast is still flat. 
Stage 4.  The areola and the nipple make up a mound 
that sticks up above the shape of the breast. (This stage 
might not happen at all for some girls. Some girls 
develop from Stage 3 to Stage 5 without Stage 4). 
Stage 2.  This is called the breast bud stage. In this 
stage the nipple is raised more than Stage 1. The 
breast is a small round. The dark area around the 
nipple (called the areola) is larger than in Stage 1. 
 
Stage 3.  The areola and the breast are both 
larger than in Stage 2.  The areola does not 
stick out away from the breast. 
Stage 5.  This is the adult stage. The breasts are fully 
developed. Only the nipple sticks out in this stage. 
The areola has moved back in the general shape of 
the breast. 
 
Please tick this box if you are not sure. 
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8.  The pictures below show stages in the way breasts develop.  Not all children follow the same 
pattern of development.  A girl can go through each of the 5 stages shown below, although some 
girls might skip some stages.  Please look at each of the drawings and read the descriptions 
carefully.  Please put a tick in the box that is closest to your breast stage at the moment based 
on both the picture and the description. 
 
 
      
 
 
   
 
 
    
 
 
      
 
 
   
Stage 1.  In this stage the nipple is raised a little. 
The rest of the breast is still flat. 
Stage 4.  The areola and the nipple make up a mound 
that sticks up above the shape of the breast. (This stage 
might not happen at all for some girls. Some girls 
develop from Stage 3 to Stage 5 without Stage 4). 
Stage 2.  This is called the breast bud stage. In this 
stage the nipple is raised more than Stage 1. The 
breast is a small round. The dark area around the 
nipple (called the areola) is larger than in Stage 1. 
 
Stage 3.  The areola and the breas are both 
larger th n in Stag  2.  The areola does not 
stick out away from the breast. 
Stage 5.  This is the adult stage. The breasts are fully 
developed. Only the nipple sticks out in this stage. 
The areola has moved back in the general shape of 
the breast. 
 
Please tick this box if you are not sure. 
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Stage 5. This is the adult stage. The breasts are fully developed. 
Only the nipple sticks out in this stage. The areola has moved 
back in the general shape of the breast. 
 









UKOS2: Girl’s questionnaire v1, 14.03.11 
9. The pictures below show different amounts of pubic hair. 
Not all children follow the same pattern of development. 
Please look at each of the pictures and read the descriptions 
carefully. Please put a tick in the box that is closest to the 
amount of pubic hair you have at the moment based on both 
the picture and the description. (Your stage of pubic hair 
growth might not be the same as your stage of breast 
development.) 
Stage 1. There is no pubic hair at all. 
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8.  The pictures below show stages in the way breasts develop.  Not all children follow the same 
pattern of development.  A girl can go through each of the 5 stages shown below, although some 
girls might skip some stages.  Please look at each of the drawings and read the descriptions 
carefully.  Please put a tick in the box that is closest to your breast stage at the moment based 
on both the picture and the description. 
 
 
      
 
 
   
 
 
    
 
 
      
 
 
   
Stage 1.  In this stage the nipple is raised a little. 
The rest of the breast is still flat. 
Stage 4.  The areola and the nipple make up a mound 
that sticks up above the shape of the breast. (This stage 
might not happen at all for some girls. Some girls 
develop from Stage 3 to Stage 5 without Stage 4). 
Stage 2.  This is called the breast bud stage. In this 
stage the nipple is raised more than Stage 1. The 
breast is a small round. The dark area around the 
nipple (called the areola) is larger than in Stage 1. 
 
Stage 3.  The areola and the breast are both 
larger than in Stage 2.  The areola does not 
stick out away from the breast. 
Stage 5.  This is the adult stage. The breasts are fully 
developed. Only the nipple sticks out in this stage. 
The areola has moved back in the general shape of 
the breast. 
 




Stage 2. There is a little long, slightly coloured hair. This hair may 
be straight or a little curly. 
 
 
Stage 3. The hair is darker in this stage. It is coarser and more 








Stage 4. The hair is now as dark, curly and coarse as that of an 
adult woman. But, the area that the hair covers is not as large as 
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9.  The pictures below show different amounts of pubic hair.  Not all children follow the same 
pattern of development.  Please look at each of the pictures and read the descriptions carefully.  
Please put a tick in the box that is closest to the amount of pubic hair you have at the moment 
based on both the picture and the description.  (Your stage of pubic hair growth might not be the 
same as your stage of breast development.) 
 
            
 
           
 
            
 
           
  












Stage 1.  There is no pubic hair at all. 
 
Stage 4.  The hair is now as dark, curly and coarse as that of 
an adult woman. But, the area that the hair covers is not as 
large as that of an adult. The hair has not spread out to the 
legs yet. 
Stage 2.  There is a little long, slightly coloured hair.  
This hair may be straight or a little curly. 
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The hair usually forms a triangular pattern as it spreads 
out to the legs. 
Please tick this box if you are not sure. 
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that of an adult. The hair has not spread out to the legs yet. 
 
Stage 5. The hair is now like that of an adult woman. It also covers 
the same area as that of an adult woman. The hair usually forms a 
triangular pattern as it spreads out to the legs 
 
 






Please seal this questionnaire in the 
envelope provided and return it to us. 
Thank you very much for answering this 
questionnaire and for helping us with this 
very important study. 
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C2.	Restless,	overactive,	cannot	stay	still	for	long 	 	 	
C3.Often	complains	of	headaches,	stomach	aches	or	
sickness 	 	 	
C4.Shares	readily	with	other	children	(treats,	toys,	
pencils	etc) 	 	 	
C5.Often	has	temper	tantrums	or	hot	tempers 	 	 	
C6.Rather	solitary,	tends	to	play	alone 	 	 	
C7.Generally	obedient,	usually	does	what	adults	
request 	 	 	
C8.Many	worries,	often	seems	worried 	 	 	
C9.Helpful	if	someone	is	hurt,	upset	or	feeling	ill 	 	 	
C10.Constantly	fidgeting	or	squirming 	 	 	
C11.Has	at	least	one	good	friend 	 	 	
SectionC.StrengthsandDifficulties
For each question, please tick the most appropriate box. Please answer all the questions even if
C1.Considerateofotherpeople’sfeelings


































C12.Often	fights	with	other	children	or	bullies	them 	 	 	
C13.Often	unhappy,	down	hearted	or	tearful 	 	 	
C14.Generally	liked	by	other	children 	 	 	
C15.Easily	distracted,	concentration	wanders 	 	 	
C16.	Nervous	or	clingy	in	new	situations,	easily	loses	
confidence    
C17.	Kind	to	younger	children    
C18.	Often	lies	or	cheats    
C19.	Picked	on	or	bullied	by	other	children    
C20.Often	volunteers	to	help	others	(parents,	
teachers,	other	children)    
C21.Thinks	things	out	before	acting    
C22.	Steals	from	home,	school	or	elsewhere    
C23.	Gets	on	better	with	adults	than	other	children    
C24.	Many	fears,	easily	scared    
C25.	Sees	tasks	through	to	the	end,	good	attention	



















































































































































































D13. Loses things necessary for tasks or activities      
D14.Blurtsoutanswersbeforequestionshavebeencompleted
D15.Iseasilydistracted




























































































































Would you like to tell us anything else about this child? If so please write your comments in the            ,      
boxbelow.
Finally,pleasecompletethefollowingdetails:
Yourname:
Yourrelationshiptothechild:
E.g.,headteacher,classteacher
Today’sdate:
Signature:
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Finally,	please	complete	the	following	details: 
Your	name:	Your	relationship	to	the	child: 
E.g.,	head	teacher,	class	teacher 
Today’s	date:	
	Signature: 
 
 
 
 
 
 
 
Thank	you	for	completing	this	questionnaire;	your	
time	is	greatly	appreciated. 
Please	seal	the	questionnaire	in	the	stamped	
addressed	envelope	provided	and	post	to	the	
UKOS	office. 
 
 
 
For	more	information	please	contact: 
The	Principal	Investigators:	Professor	Anne	Greenough,	Professor	Janet Peacock 
United	Kingdom	Oscillation	Study	(UKOS) 
King’s	College	London		
King's	College	Hospital		
Neonatal	Intensive	Care	Unit	
4th	Floor	Golden	Jubilee	Wing	Denmark	Hill	
London	SE5	9RS 
	 349	
Tel:	0203293030	Email:ukos@kcl.ac.uk	
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